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Computer-aided drug design (CADD) has become an indispensible component in modern drug 
discovery projects. The prediction of physicochemical properties and pharmacological properties of 
candidate compounds effectively increases the probability for drug candidates to pass latter phases of 
clinic trials. Ligand-based virtual screening exhibits advantages over structure-based drug design, in terms 
of its wide applicability and high computational efficiency. The established chemical repositories and 
reported bioassays form a gigantic knowledgebase to derive quantitative structure-activity relationship 
(QSAR) and structure-property relationship (QSPR). In addition, the rapid advance of machine learning 
techniques suggests new solutions for data-mining huge compound databases. In this thesis, a novel 
ligand classification algorithm, Ligand Classifier of Adaptively Boosting Ensemble Decision Stumps 
(LiCABEDS), was reported for the prediction of diverse categorical pharmacological properties. 
LiCABEDS was successfully applied to model 5-HT1A ligand functionality, ligand selectivity of 
cannabinoid receptor subtypes, and blood-brain-barrier (BBB) passage. LiCABEDS was implemented 
and integrated with graphical user interface, data import/export, automated model training/ prediction, 
and project management. Besides, a non-linear ligand classifier was proposed, using a novel Topomer 
kernel function in support vector machine. With the emphasis on green high-performance computing, 
graphics processing units are alternative platforms for computationally expensive tasks. A novel GPU 
algorithm was designed and implemented in order to accelerate the calculation of chemical similarities 
with dense-format molecular fingerprints. Finally, a compound acquisition algorithm was reported to 
construct structurally diverse screening library in order to enhance hit rates in high-throughput screening. 
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1 PREFACE 
Modern drug discovery and development involve a set of organized processes, including drug target 
identification and validation, lead compound discovery, early ADMET-oriented optimization, clinic 
phases, etc. Studies have shown that the cost of the whole drug discovery and development process varies 
from 500 million to 2 billion dollars 1-3. The development of a new drug typically takes 10 to 15 years. 
Among all, clinic testing is the most extensive and expensive phase. The recent trend shows that the 
failure rate of clinic Phase II and Phase III has been rising4-5. The failure of passing clinic experiments 
denies drug candidate compounds and turns the significant amount of investment fruitless.  
The investment on drug discovery is highly risky but highly rewarded. Hence, substantial efforts have 
been devoted to the investigation of novel and economical approaches with the intention to boost the 
productivity of pharmaceutical industry and deliver more products to the market. State-of-the-art high-
throughput screening (HTS) technology points out a potential solution for lead compound identification. 
Modern HTS technology is capable of screening 100,000 compounds per day 6. Furthermore, HTS 
facilities that were exclusively owned by drug discovery enterprise are becoming readily available to 
research institutions. Nevertheless, screening the vast number of compounds is still challenging in 
absence of sufficient funds. 
Nowadays, virtual screening has been integrated into the pipeline of drug discovery process (Figure 
1-1). The whole discovery process approximately costs 800 million dollars and 7 to 12 years, depending 
on the types of disease 7. Virtual screening is a generic computational technique that explores large virtual 
chemical libraries in order to assess the interaction between ligands and a hypothetical protein receptor or 
enzyme. Broadly speaking, computer-assisted ADMET property prediction and lead optimization are also 
part of virtual screening. Virtual screening exhibits two obvious advantages over traditional high-
throughput screening 8. First, virtual screening software is able to evaluate compound collections that do 
not physically exist. Second, the predictions from virtual screening programs refine the scope of to-be-
explored chemistry space and drastically reduce the cost of bioassays.  
xiv 
 
 
 
 
Figure 1-1: The diagram of drug discovery pipeline and associated cost. 
The whole drug discovery project typically includes early-stage research phase, preclinical study phase 
and clinical phase. It takes approximately 10 ~ 15 years and 500 million ~ 2 billion dollar to develop a 
marketable drug. 
xv 
 
Currently, there are two categories of approaches in virtual screening: ligand-based virtual screening 
and structure-based virtual screening. Ligand-based approaches rely on the assumption of “similarity 
principal”, which states that structurally similar compounds usually exhibit similar biological activity. 
Nevertheless, the definition of molecular similarity is still ambiguous up to now. A specific pair of 
compounds may have different similarity score according to various criterions, for example, 3D similarity, 
maximum common structure, fingerprint-based Tanimoto coefficient, etc. On the other hand, structure-
based approaches imitate ligand-receptor interaction, in which ligands are “docked” into a hypothetical 
receptor, and scores are calculated to estimate binding affinity. Thus, the scoring function or ligand 
ranking mechanism is an important component of this methodology. Unfortunately, the performance of 
scoring functions in most “docking” software is far from perfect. Furthermore, the availability of high-
quality protein structures also restricts the application scope of structure-based virtual screening. Despite 
certain limitations, both categories of approaches have been successfully applied to solve practical 
problems in computer-aided drug design (CADD). In this thesis, the reported algorithms and software are 
ligand-based. 
Regardless of ligand-based or structure-based drug design, virtual screening emphasizes on the 
discovery of lead compounds that can bind to a protein receptor or enzyme. Besides bioactivity, lack of 
desired pharmacological and physicochemical properties is another important factor that rejects drug 
candidates from further development. As a complement to modern high-throughput screening, one of the 
primary goals of computer-aided drug design is to explore the enormous chemical and biological 
properties in a time-efficient manner as well as to reduce the cost of experimental screening 9-11. 
Particularly, great emphasis is placed on the “drugability” or “drug-likeness” of compounds using 
cheminformatics tools in the early stages of drug development, with the hope of increasing the probability 
of “lead” compounds, or their derivatives, to pass through the later phases of drug clinical trials12. Thus, 
generic and robust tools are demanded for the prediction of various ligand properties.  
 Modern information technology and software engineering methodology produce many high-
performance programs for cheminformatics and computer-aided drug design. Due to growth of computer 
hardware industry, it is widely assumed that in silico virtual screening and CADD programs are fast and 
high-throughput. On the contrary, the speed of these programs is sometimes achieved at the sacrifice of 
model quality and prediction accuracy. Molecular docking programs may take several seconds or tens of 
minutes to fit a ligand into a binding pocket, depending on searching algorithms and searching parameters. 
Thorough examination of numerous possible conformations of both ligand and binding pocket tends to 
yield convincing binding hypotheses, which has exponential time complexity in the degree of freedom. 
Casual docking strategies, such as rigid-body docking, hardly reveal reliable ligand-receptor binding 
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mode. Moreover, some algorithms require large amount of subjective intervention, resulting in relatively 
low level of automation and unsatisfactory efficiency. The famous field-based pharmacophore algorithm, 
Comparative Molecular Field Analysis (CoMFA)13, is a typical example. CoMFA predicts ligand binding 
affinities or other molecular properties according to the goodness-of-fit between the ligands and 
predefined CoMFA model, which specifies favored and disfavored pharmacophore groups in a three-
dimensional grid. One of the prerequisites of CoMFA is manually searching for the bioactive 
conformations that can be fitted into a developed CoMFA model. Given the same ligand, different 
CoMFA predictions are assigned to different conformations, and the conformation search is usually 
subjective. Therefore, 3D bioactive conformation search still remains as one of its limitations 14 and as a 
barrier for high-throughput virtual screening. 
Despite the development of cheminformatics methodology, it is a challenge to develop reliable, 
interpretable and high-throughput computational algorithms for the automation of modeling assorted 
molecular properties. The success of developing high-throughput algorithms will effectively accelerate 
the process of computer-aided drug design, and produce consistent and objective predictions. Most of the 
developed algorithms in CADD are based on physical models and empirical rules. The solutions are 
generally found by exhaustive search, approximation, or simulation. Physical models are straightforward 
and effective to some extent. Meanwhile, machine learning methodology is gaining popularity in the 
community of computer-aided drug design. In the current decade, machine learning has been successfully 
applied for image analysis, natural language processing, speech and handwriting recognition, etc. 
Informally, machine learning is a branch of artificial intelligence, aiming at identifying complex patterns 
and making intelligent decisions according to presented observations15. The advantage of machine 
learning approaches is the capability to discover certain correlations, the rule of which remains unknown. 
The methods and algorithms reported in this thesis are the instances of machine learning algorithms in 
cheminformatics and computer-aided drug design.  
Recently, the computation power of single-core CPUs is reaching a bottleneck. Going parallel is the 
theme nowadays. Supercomputers and clusters, formed by a set of integrated processing units, were not 
strangers to scientists even 20 years ago. To speed up calculation, scientists usually distribute 
computationally intensive tasks to many “computer nodes”. It is known that the computation time does 
not reduce linearly as the number of computer nodes increases. Molecular dynamics (MD) is a common 
computational technique in structural biology. Performance gain of MD simulation is not obvious by 
adding more computer nodes, when hundreds of nodes have already been utilized. Meaningful MD of 
DNA and proteins simulates a process spanning nanoseconds to microseconds. Unfortunately, CPU-days 
to CPU-years are required to complete the simulation16.   
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With the emphasis on “green high performance computing”, the development of modern graphics 
processing units (GPU) suggests a substitute strategy for scientific computing. GPUs are specialized 
microprocessors for graphics rendering. Modern GPUs feature higher memory bandwidth and more 
floating point operations per second (FLOPS) than CPUs (see Figure 1-2). These days, general-purpose 
computing on graphics processing units (GPGPU) is an active research field. The computation power of 
GPUs resides in their highly parallel architecture. As GPUs are mainly built for graphics rendering, 
developing GPU programs is not as flexible as traditional CPU programs. For example, high memory 
bandwidth is only achieved when global memory (video memory) access is coalesced. In addition, 
execution divergence reduces the degree of parallelism and device utilization. Therefore, extra attention 
should be paid to the design and implementation of GPU algorithms. In this thesis, a novel GPU 
algorithm and its implementation are introduced for fingerprint-based chemical similarity calculation and 
compound database comparison.  
 
 
 
 
Figure 1-2: Performance comparison of CPU and GPU  
This figure compares theoretical computation power and memory bandwidth of CPU and GPU 
models from 2001 to 2010. Computation power (left figure) is measured in Giga FLoating-point 
Operations per Second (GFLOP/s), and memory bandwidth (right figure) is given in Giga-Byte per 
Second (GB/s) 17 
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2 INTRODUCTION 
2.1 OVERVIEW OF QUANTITATIVE STRUCTURE-ACTIVITY 
RELATIONSHIP (QSAR) 
 
 
 
 
About 20 years ago, comparative molecular field analysis (CoMFA) was almost equivalent to 
Quantitative Structure-Activity Relationship (QSAR). Modern machine learning algorithms and 
cheminformatics techniques brought up various methods to model not only biological affinity but also 
pharmacological properties. Significant efforts have been devoted to developing reliable, adaptive and 
robust QSAR algorithms. Although successful QSAR studies have been reported in many fields of 
computer-aided drug design, their true predictability is still questioned by many practitioners 18. The 
development of robust quantitative structure-activity relationship is far beyond automated model training 
from some commercial software. A robust model requires extensive investigation of molecular descriptor 
selection, mathematical model training and, most importantly, model validation. Furthermore, scientists 
should understand the prediction risk when structurally diverse compound collection is involved. In this 
section, the methodologies involved in QSAR, including descriptor generation, statistical modeling, 
model validation and the limitation of QSAR, are briefly discussed.  
 
 
2.1.1 The Basic Concept of QSAR 
 
 
The fundamental goal of computer-aided drug design (CADD) is to predict biological activity and 
pharmacological properties of drug candidates in order to enhance the productivity and reduce the cost of 
drug development project. To certain extent, any CADD project can be reduced to a decision-making 
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process, for example, the prediction of binding affinity, LogP value, toxicity, etc. In general, such 
decision-making can be carried out through two classes of methods: rule-based method and knowledge-
based method. In rule-based method, prediction is made according to widely validated and accepted 
theories. One example is the estimation of ligand-receptor binding energy using force field. In the current 
stage, no complete set of theories are established to handle diverse challenges in rational drug design. 
Then, knowledge-based method becomes a practical approach in these unexplored fields. In one word, 
knowledge-based method attempts to derive an empirical correlation between the observations and 
molecular properties of interest, without understanding their underlying mechanisms. Illustration is given 
in Figure 2-1. In CADD, knowledge is the compound libraries annotated with molecular properties of 
interest, for example, the results from HTS experiments. The knowledge is then presented to a “learner”. 
The learner’s job is to detect patterns that are statistically correlated with properties of interest, and solve 
parameters in mathematical models. Finally, the learner outputs a prediction scheme for future testing 
samples. 
 
 
Figure 2-1: The illustration of knowledge-based inference  
In this diagram, a learner aims at solving a mathematical model (generalization) from training data 
(knowledge) through numerical optimization (learning phase) 
 
Advanced high-throughput screening (HTS) technologies generate great amounts of bioactivity data, and 
this data needs to be analyzed and interpreted with intension to understand how these small molecules 
affect biological systems. As such, there is an increasing demand to develop and adapt cheminformatics 
algorithms and tools in order to predict molecular and pharmacological properties based on these large 
datasets. These techniques belong to an active research area, called quantitative structure-activity 
relationship (QSAR). Figure 2-2 summarizes the major steps of a QSAR study: molecular descriptor 
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generation, variable selection and numerical optimization. Finally, the QSAR model is validated 
retrospectively or prospectively before integrating the model into drug development pipeline. 
 
 
Figure 2-2 : The general steps of modeling molecular properties  
In ligand-based drug design, compound structures are represented in high-dimensional molecular 
descriptors. This is followed by a step called variable selection to choose predictive features. The 
predictive features are used to statistically correlate with molecular properties of interest. 19 
 
2.1.2 Molecular Descriptor Generation and Variable Selection 
 
 
In QSAR, compound structures are usually plugged into mathematical models implicitly. Structures can 
be treated as weighted graphs. Unfortunately, most successful statistical and machine learning algorithms 
adopt numerical vectors as input. In addition, manipulating numerical vectors and matrices is more 
efficient compared to graph operations. Thus, mapping chemical structures to high-dimensional descriptor 
vectors is the recommended strategy for high-throughput virtual screening programs. Another advantage 
of performing pattern recognition on molecular descriptors instead of chemical structures is the 
incorporation of hypotheses and assumptions into the mathematical model. In this case, data mining can 
be restricted in relevant hypothesis space, instead of exploring combinations of noisy structural 
information. Descriptor generation is the foundation for any QSAR studies. A comprehensive review on 
prevailing molecular descriptors will be given later.  
Variable selection targets at removing redundant and irrelevant molecular features, but preserving 
predictive and informative variables. A large number of descriptors may increase model complexity, but 
developed models may be vulnerable to over-fitting. In statistics, parameterization may become 
intractable as the dimensionality of feature space increases, because enormous data are required to depict 
the probability density of combinations of input variables. This phenomenon is called “curse-of-
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dimension”. Modern machine learning algorithms are not as sensitive as traditional statistical models, 
regarding high-dimensional feature space. Some robust pattern recognition methods possess built-in 
mechanism to attenuate the negative effect of irrelevant features. Margin maximization and parameter 
regularization are two common approaches. Therefore, variable selection is not strictly demanded in 
QSAR anymore, but it is still recommended in many cases.  
2.1.3 Mathematical Optimization 
Solving parameters and variables in a quantitative model is the follow-up step of a QSAR study. 
Regardless of mathematical models, the parameterization procedure is equivalent to the optimization of 
an object function. The object function penalizes prediction errors and rewards predictions that are 
consistent with observations. The parameters that optimize the object function become the solution. This 
procedure is also referred as “model training”, and the collection of annotated compounds that the 
solution is derived from is usually called “training set”. In other words, model training is conducted to 
search for an optimal mapping function, ƒ, ƒ ϵ ℱ: x → y, where x is the descriptor vector and y is a 
response value. If y is a discrete scalar, representing compound labels, the inference belongs to 
classification, for example, predicting whether a compound is active or not. If y is a continuous scalar, the 
inference belongs to regression, for example, predicting the binding affinity of a compound. Broadly 
speaking, there exist three schemes for modeling the correlation between x → y 20: 
 
1. Modeling the join probability density p(x, y). This is the most comprehensive solution of estimating 
the generalization error and confidence interval, as the function p(x, y) reveals the distribution of 
descriptor vector x. Furthermore, the conditional probability, p(y|x), can be easily derived to give 
prediction y from input x. Modeling p(x, y) requires vast observations when vector x is high 
dimensional, because of “curse-of-dimension” described above. On the other hand, this scheme is still 
feasible under certain circumstance. In Naive Bayes classifier, the independence assumption 
simplifies the estimation of p(x, y) by formulating it as a product, 𝑝(𝐱, y) = ∏ 𝑝(xi, y)i .  
2. Modeling the conditional probability p(y|x). Knowing the distribution of x is sometimes impractical, 
but the conditional probability p(y|x) is sufficient to make inference on y according to descriptor 
vector x. Given any predefined cost function, g(y�, y), the object function is Ey|x(g(y�, y)) where y� =ƒ(x). This approach neglects the distribution of x and only focuses on the distribution of y|x, so it 
is more robust than scheme 1. Yet, the generalization error, i.e. Ex(Ey|x(g(y�, y)), is unsolvable because p(x) remains unknown. Logistic regression is one example of this scheme. 
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3. Find function y� =ƒ(x) without modeling probability density function. This scheme is adopted by 
most machine learning algorithms. Since no assumptions are made on the distribution of x and y, this 
method is the most robust of all. Without probability and distribution, the generalization error is 
empirically estimated by 1
N
∑ g(y�i, yi)i . Furthermore, no confidence interval can be guaranteed for any 
prediction, y�i. Famous Support Vector Machine and Artificial Neural Network belong to this scheme. 
 
    Correct model assumptions drive parameters to converge faster compared to the case in which little 
information is known. Figure 2-3 demonstrates this principal through a toy model. N training observations ti ϵ {(x1, x2): x1, x2 ϵ [-6, 6]}. The corresponding class or label, yi, for observation, i, is generated 
according to the following rule: yi = 1, if �x12 + x22 ≥ 4;  or yi = −1  otherwise. To make it more simple, 
the data points outside the yellow circle in Figure 2-3 belong to one class, while the data points inside the 
circle belong to another class. In reality, the mechanism of data generation is probably unknown. The goal 
is to find a mapping function y = ƒ(t) that emulates the true mechanism according to the observations y 
and t. Two types of classifiers are trained. One is famous support vector machine (SVM) with polynomial 
kernel of second degree. Theoretically, the SVM classifier is capable of fitting any quadratic functions, 
which definitely covers the true “circle” classifier. The other classifier is y = 2I ��x12 + x22 ≥ r� − 1. I(S) 
is an indicator function, which will be used frequently later. I(S) =1 if the statement S is true, or I(S) = 0 
otherwise. For the second classifier, it is clear that the label is assigned according to the distance to the 
origin, but the threshold value, r, remains unknown. The training procedure aims at making inference on r 
according to the training data.  
The SVM classifier is solved using SVMPath package 21. More details regarding SVM will be given 
in the following chapters. The radius r of the “circle” classifier is solved using the equation r =
1
2
(mini,yi=1‖𝐭i‖2 + maxi,yi=−1‖𝐭i‖2). ‖𝐭i‖2 is the L2 norm of 𝐭i. Its value is equal to �x12 + x22 of the ith 
data point. As shown in Figure 2-3, the “circle” classifier colored in black converges fast to the yellow 
circle, according to which the labels are assigned. When N =35, the black circle starts to overlap with the 
yellow one. The SVM decision boundary is represented by the thick green curve. The thin green curve 
represents the soft margin in SVM. As N increases, the SVM decision boundary gets closer and closer to 
the yellow circle, but noticeable discrepancy between the two exists. Even if SVM is a robust and flexible 
classifier, its convergence speed is much slower. In practice, the correct assumption helps us to develop a 
high-quality QSAR model with only limited training data, however most topics in CADD are not well 
explored, and the assumptions might be wrong. Figure 2-4 gives one example resulted from wrong model 
assumption. The mechanism of data generation is the same except that the yellow circle is centered at 
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point (1, 1). Both classifiers are trained using the same algorithm. The “circle” classifier in this case is 
inaccurate as it is always centered at the origin. In Figure 2-4, SVM classifier is undoubtedly superior to 
the “circle” classifier. Thus, a general-purpose classifier is a good choice if the assumptions are uncertain 
or little is known about the solution.  
 
N=15 
 
N=25 
 
N=35 
 
 
N=60 
 
Figure 2-3: Evolution of two classifiers as the amount of training data increases. 
Each figure shows the developed classification boundaries with different training data sizes (N). Yellow 
circle is the true boundary that is used to generate training data. Green lines represent the decision 
boundary and soft margin of support vector machine. And the black line represents trivial “circle 
classifier” 
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In CADD, the amount of training data is usually limited, and labeling novel compounds is remarkably 
expensive and time-consuming, but an accurate prediction model is still desired in practice. Prior 
assumptions restrict the search space of training algorithms, so limited training data may be still sufficient 
for statistical inference. As illustrated in the toy model, the “circle” classifier only represents a tiny 
fraction of the complete quadratic SVM solutions. Therefore, the parameter in the “circle” classifier 
converges faster than SVM because the training algorithm does not necessarily explore all the quadratic 
solutions. Conversely with incorrect assumptions (Figure 2-4), the true solution actually lies outside of 
the search space, and finally parameters converge in a wrong direction. To conclude, the balanced 
tradeoff between a general-purpose model and a problem-specific model should be well maintained for a 
QSAR study. 
 
 
 
 
Figure 2-4: Specific model with incorrect assumption versus general purpose model 
The yellow circle, centered at (1, 1), represents the true decision boundary. Support vector machine 
converges reasonably well to the yellow circle, and outperforms the trivial “circle classifier” that is 
centered at origin. 
2.1.4 QSAR Validation 
The validation of a quantitative structure-activity relationship is probably the most important step of all. 
The validation estimates the reliability and accuracy of predictions before the model is put into practice. 
Poor predictions misguide the direction of drug development and turn downstream efforts meaningless. 
Validation can be performed either retrospectively or prospectively 22. In retrospective validation, a 
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QSAR model is developed without being exposed to some annotated compounds (testing set). To verify 
model quality, predictions are made on the testing set in order to check the agreement between the 
theoretical values and experimental values. In prospective validation, the model is applied on an external 
unlabeled compound set. Then, physical experiments are carried out to validate the predictions. 
Prospective validation imitates the scenario of actual drug development, which is more trust-worthy. 
Nowadays, prospective validation is required in major cheminformatics journals for QSAR publications 
reporting existing methods. Nevertheless, it is necessary to essay a large number of testing compounds in 
order to draw statistically convincing conclusion, but prospective validation, as a costly and time-
consuming approach, is impractical in many cases.  
Cross-Validation is probably the most popular technique for estimating generalization error of QSAR 
models. Generalization error of QSAR models measures their average performance when the models are 
generalized to the entire possible chemistry space. Thus, generalization error is an important indicator 
showing the risk of utilizing the models in drug development process. Define an error function  ƒM, ƒM ϵ ℱ: x → ℝ, where x represents a compound . ƒM(x) returns the prediction error for compound x with model M. 
Precisely, the generalization error of a specific model M is equal to Ex(ƒM(x)). In almost all the cases, the 
analytical solution to Ex(ƒM(x)) does not exist due to the astronomical number of possible compound 
structures for x. In statistics, the law of large numbers (LLN) is a theorem, stating that X�n → μ for n → ∞ 
where X�n = 1n∑ Xini=1  and μ = E(Xi) , i = 1, 2, …, n. X1, X2, X3, …  are  i.i.d. random variables. By 
applying LLN, generalization error Ex(ƒM(x)) can be approximated by Ex(ƒM(x)) ≈ 1
n
∑ ƒM(𝐱𝐢)ni=1 . 𝐱𝐢 are 
independent testing samples. There are four basic requirements for 𝐱𝐢: (1) the experimental property value 
of 𝐱𝐢 is attainable in order to calculate the cost function ƒ; (2) 𝐱𝐢 are independent training samples, upon 
which QSAR models are developed; (3) 𝐱𝐢  are true random samples without oversampling a specific 
region of chemistry space. (4) n is large and there exist ample testing samples.  
      In reality, these requirements are hardly achieved due to the high expense in acquiring experimental 
values of many testing compounds. Thus, a fraction of annotated compounds is “left-out” from training 
data set for estimating the generalization error, which is called cross-validation. Figure 2-5 illustrates 
some popular cross-validation techniques. In Scheme A, certain percentage of annotated compounds 
(training set) is used to develop QSAR models. Then, the models are evaluated on the remaining 
compounds (testing set). Usually, a set of model candidates are evaluated on the testing set and the one 
with lowest prediction error is selected as the optimal model. This scheme is straightforward but not 
flawless, because the testing set might be overfit. A model overfits a data set when it captures random 
noise instead of the underlying relationship. An overfit model usually shows poor prediction performance. 
In Scheme B, the annotated compound data set is split into k subsample sets and the testing calculation is 
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repeated for k times. Each time, one of the k subsample sets is left out as testing set and the remaining k-1 
subsample sets are used as the training set. The generalization error is simply approximated by the 
average prediction error on the k testing sets. Although the possibility of overfitting still exists, the chance 
is lower compared to Scheme A, because more testing samples are involved in the approximation of 
generalization error. This technique is called k-fold cross-validation. Scheme C, which is also known as 
leave-one-out cross-validation (LOOCV), is a special case of k-fold cross-validation. As suggested by the 
name, each time one annotated compound is kept from the remaining training data as testing sample. The 
procedure is repeated until every compound is used once as testing data. For some statistical models, such 
as linear regression, analytical solution exists for estimating LOOCV error. Generally, LOOCV error is 
calculated by repeating model training and testing for N times (N is the total number of annotated 
compounds), which is computationally expensive. 
 
 
 
 
Figure 2-5: Popular cross-validation schemes 
In scheme A, certain proportion of annotated data (training set) is used to develop a predictive model, 
and the model is validated on the remaining data (testing set). In scheme B (k-fold cross-validation), 1/k 
of annotated data is reserved as testing set, and the remaining is left for model training. This procedure is 
repeated k times. In scheme C (leave-one-out cross-validation), every data entry has chance to serve as 
testing data, leaving the remaining data as training set. 
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Besides cross-validation techniques, error function should be rationally designed for risk estimation and 
model selection, depending on different CADD applications. Regression and classification are two major 
methodologies involved in QSAR. Regression analysis aims at predicting real values, such as dissociation 
constant, boiling point, LogP, etc. The goal of classification is to predicting the categories of compounds, 
for example, active or inactive, selective or unselective, toxic or nontoxic, etc.  
In regression analysis, R2 or correlation coefficient (r) is used to measure the goodness of fit. Let yi 
denote the experimental value for compound i and y�i  denote the corresponding predicted value from 
regression model. The total variance can be decomposed as 23:  
∑ (yi − y�)2ni=1 = ∑ (yi − y�i )2ni=1 + ∑ (y�i  − y�)2ni=1 . 
SStotal          =           RSS         +          SSreg 
SStotal: total sum of squares; RSS: residual sum of squares; SSreg: sum of squares for regression. yi − y�i is 
the difference between observed value and predicted value, which is also called residue. 
According to this decomposition, R2 = 1 − RSS
SStotal
= SSreg
SStotal
. Thus, R2 can be understood as the ratio 
of variance explained by the regression model to the total variance. In other words,  R2 indicates the 
proportion of total variance, traced by the regression model. In an ideal case, a regression model can 
predict 100% of uncertainty and variance of y, then R2 = 1. In the worst case, a regression model is 
uncorrelated with y, then R2 = 0. Sometimes R2 calculated on the cross-validation set can be negative 
when RSS is greater than SStotal. Criteria for judging whether an R2 is satisfactory or not remains flexible. 
Normally for QSAR studies, an R2  value above 0.5 indicates good predictability 24. Another way to 
illustrate the goodness of fit is by plotting experimental value versus predicted value, as shown in Figure 
2-6. 
 
 
Figure 2-6: Demonstration of the goodness-of-fit  
Figure adopted from reference 25 
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In compound classification, compound labels or categories, such as “active” or “inactive”, are represented 
by some integers. One effective measure of prediction quality is the ratio of the number of correct 
predictions to the total number of testing compounds. This measurement was applied in modeling drug-
likeness with binary classifiers 26. Nevertheless, the percentage of correct prediction is meaningless when 
the testing set is overwhelmed by one category of observations or the category of interest is minority, for 
example virtual screening. In virtual screening, a few active compounds are immersed in the sea of 
inactive ones. A classifier that blindly assigns “inactive” label to any testing compound probably achieves 
99% prediction accuracy. The classifiers in sole pursuit of high prediction accuracy probably will never 
recover any active compounds. Therefore, a few other indices have been proposed for unbalanced data 
sets. Take virtual screening as an example, in which a classifier attempts to distinguish active compounds 
from inactive ones. Define the following quantities: 
True Positives (TP): the number of active compounds that are also predicted as active  
True Negatives (TN): the number of inactive compounds that are also predicted as inactive 
False Positives (FP): the number of inactive compounds that are incorrectly predicted as active  
False Negatives (FN): the number of active compounds that are incorrectly predicted as inactive 
Matthews correlation coefficient (MCC) is frequently adapted as a measure of the quality of binary 
classifiers for unbalanced data sets. MCC is calculated according to the following equation: MCC = TP × TN − FP × FN
�(TP + FP)(TP + FN)(TN + FP)(TN + FN) 
The example below demonstrates the difference between MCC and prediction accuracy. Suppose that 
a collection of 1000 compounds has 10 active compounds and 990 inactive compounds. The outcome of 
classifier A and classifier B is listed in Table 2-1 and Table 2-2 respectively. 
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Table 2-1: Imaginary outcome of classifier A 
 
Experimental 
Predict 
Positive Negative 
Positive 8 22 
Negative 2 968 
 
Table 2-2: Imaginary outcome of classifier B 
 
Experimental 
Predict 
Positive Negative 
Positive 2 16 
Negative 8 974 
 
 
 
Classifier A and B have identical prediction accuracy as they produce the same number of TP and TN. So 
the simple classification accuracy is 976/1000 = 97.6%. Nevertheless, classifier A is far superior to 
classifier B because A discovers 8 true positives (true active compounds or hits) and B only has 2. 
Furthermore, classifier A is more precise than B. Among the positives identified by A, 8 out of 30, which 
is 26.7%, are truly active; while only 11.1% of positives identified by B are truly active. According to 
Matthews correlation coefficient, the MCC for classifier A is 0.454, while the MCC for classifier B is 
0.138. Thus, MCC is more informative than simple classification accuracy for unbalanced data sets. 
Besides MCC, sensitivity (or recovery rate, recall rate) and precision (purity) are frequently 
mentioned in scientific articles: 
Sensitive = TP / (TP + FN) 
Precision = TP / (TP + FP) 
More formally, classifier A is more sensitive than classifier B, based on Table 2-1 and Table 2-2. The 
classifier that brings more true active compounds or “hits” is always desirable since it is more likely to 
develop a lead compound out of it. In addition, classifier A is more precise than classifier B. A high-
precision classifier brings more true “hits” in experimental validation and saves the cost of bioassay. 
Sensitive and precision are usually contradictory. Sensitivity can be increased by labeling more testing 
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compounds as active. Sensitive can reach 1.0 by label all testing compounds as active, since FN = 0. On 
the other hand, enhancing the sensitivity usually sacrifices precision as the classifier brings in more false 
positives and increases the cost of experimental validation. Thus, a balanced trade-off should be 
determined between these two quantities. Based on this, it is inappropriate to judge the quality of a 
classifier by simply investigating either sensitivity or precision.  
 
 
 
 
Figure 2-7: Sample ROC curve.  
ROC curve plots sensitivity versus 1-specificity by adjusting decision boundaries. This figure 
illustrates the ROC curves of different virtual screening models. 27 
 
 
ROC curve (receiver operating characteristic) is commonly plotted to measure the performance of several 
models graphically.  
Figure 2-7 shows a typical ROC curve for evaluating several virtual screening models. The X-axis of a 
ROC plot is false positive rate, and the Y-axis is sensitivity. False positive rate (FPR) is equal to FP/ (FP 
+ TN). ROC curve tells how false positive rate responds to the change in sensitivity. For a specific virtual 
screening model, the sensitivity can be only enhanced by reducing prediction threshold (such as docking 
score) and predicting more compounds as active. This approach usually increases FP but reduces TN, 
resulting in higher FPR. Thus, false positive rate monotonically increases with sensitivity. A random 
classifier will show a diagonal ROC curve, while an effective classifier can enrich positives and achieve 
high sensitivity at low false positive rate. A typical characteristic of a ROC curve from an effective 
screening model is the relative large accumulated area under the curve. Therefore, AUC (area under curve) 
is a common measure to assess the performance of a screening model.  
14 
 
 Many metrics are currently used to assess the performance of ligand classification models, but no one 
is perfect. For example, ROC curve is a poor indicator for early enrichment of active compounds 28. The 
performance metric should be carefully selected in order to distinguish optimal models effectively.  
2.1.5 Limitation of QSAR 
Although quantitative structure-activity relationship (QSAR) has been widely applied in drug discovery, 
ranging from virtual screening for lead compound identification, to early-stage drug development for the 
optimization of ADMET properties, the reliability and predictability of QSAR models are still under hot 
debate 28. As pointed out by Truchon et al, the major reason why QSAR fails is attributed to the vast 
number of equivalent models and deficient external validation. In other words, it is because QSAR 
overfits the training data without detecting the true structure-activity relationship.  
QSAR models retain a limited scope of application. The uncertainty and variance are expected for 
predictions made beyond the scope. Figure 2-8 illustrates this concept through another “toy” model. In 
Figure 2-8, X-axis and Y-axis are imaginary descriptor and property of interest, respectively. The data 
points in Figure 2-8 (A) are generated according to the following equation: y = 2 × sin(x + 0.75) + ε, 
where ε ~ Norm(0, 0.5). Three candidate functions are developed to fit the data points: 
a) Quadratic function: y = ax2 + bx + c 
b) Cubic function: y = ax3 + bx2 + cx + d 
c) Sine function: y = a sin(x + b) 
Parameters in quadratic and cubic functions are solved using standard linear regression analysis, with 
fitted R2 being 0.65, 0.85 respectively. The parameters in the sine function are solved using Newton–
Raphson method, with fitted R2 being 0.89. In Figure 2-8 (A), the data points are well fitted by the cubic 
function where x ∈ [0, 6], but neither cubic nor quadratic function shows relevant predictions on the 
testing data set (x, y) where x ∈ [6, 12] in Figure 2-8 (B). 
In QSAR, good predictions are expected for testing compounds that are similar to the training set. For 
example, testing compounds are supposed to be aligned with the training set in CoMFA. In fact, testing 
compounds usually do not share similar scaffold or substitutes with the training compounds. In this case, 
not much knowledge is accessible regarding these new structures. Similar to the case described in Figure 
2-8, QSAR model may fail when it is applied on the chemistry space beyond it modeling scope. 
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Figure 2-8: A “toy” mathematical model illustrating model applicability  
X-axis denotes certain variable to predict the property value along Y-axis. The property value is 
generated by adding random noise to the orange line (real model). Then, quadratic model, cubic model 
and sin wave are used to fit the training data in the left figure. Even if cubic model fits training data well, 
its prediction is irrelevant when the testing data is beyond the range of training data (right figure). 
2.2  REVIEW OF MOLECULAR DESCRIPTORS 
Molecular descriptors transform chemical structures to numerical vectors, upon which QSAR models are 
developed. Hundreds of molecular descriptors have been proposed for solving physicochemical and 
biological properties. The descriptors can be grouped according to dimension invariance, ranging from 
0D to 4D descriptors. The invariance of molecular descriptors in N-dimension means that any structural 
changes in higher dimension do not affect the structural representations in N-dimension. For example, 
conformational isomers have identical 2D representations and descriptors. 0D descriptor is calculated 
based on molecular formula. To calculate 1D descriptor, a structure is represented by a set of linearly 
connected structural fragments, e.g. A-B-A-C where A, B, C denote certain fragments. In 2D descriptor 
generation, a chemical structure is transformed into a connectivity matrix, in which the diagonal elements 
describe atom types and the off-diagonal elements describe nominal bond types. Then topological or 
connectivity indices can be calculated conforming to the matrix. 3D descriptors require 3D coordinates of 
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each atom, so they are sensitive to 3D conformations. 4D descriptors characterize 3D molecular 
conformations as time evolves. They may be calculated from the trajectories of molecular dynamics 
simulation or ensemble sampling. The table below lists some representative descriptors for each 
dimension. 
 
 
Table 2-3: List of representative molecular descriptors 
  
Dimensionality Example Reference 
0D Molecular weight, Number of bonds, Atom 
counts 
29 
1D The count of functional groups, such as H-
bond donors, heterogeneous ring, etc. 
29 
2D Topological indices, Atom paths, Burden 
eigenvalues 
30-32 
3D Polar surface area, Volume, Electrostatic 
field, 3D-MoRSE 
33 
4D Volsurf, 4D-fingerprints 34 35 
 
 
Another way of classifying molecular descriptors rests on the depicted structural characteristics, including 
constitutional descriptor, geometric descriptor, topological descriptor and electrostatic/quantum-chemical 
descriptors. The following subsections will focus on the theory and application of these descriptors. 
2.2.1 Constitutional Descriptor 
Constitutional descriptors depict the composition of a compound structure and capture the properties of 
the elements that constitute the structure. Generally regarded as 0D, constitutional descriptors are 
independent on the geometry and topology of a structure. They are calculated either based on the 
occurrence of different types of atoms, bonds, x-member rings, or as a mathematical function of these 
elements. Table 2-4 lists some popular constitutional descriptors involved in QSAR studies. 
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Table 2-4: List of representative constitutional descriptors 
 
Molecular Weight Number of X-member Rings  
Total Number of Atoms Number of Aromatic Rings 
Numbers of Atoms of Different Identity Number of H-bond Donors 
Number of Bonds Number of H-bond Acceptors 
Number of Rotatable Bonds Sum of Atomic Polarity 
Numbers of Double, Triple or Aromatic 
Bonds  
Sum of Atomic van der Waals Volumes 
 
 
A significant advantage of constitutional descriptors is the ease of calculation and interpretation. Despite 
their simplicity, constitutional descriptors exhibit relevance to many pharmacological properties. 
Particularly, descriptors characterizing oxygen and nitrogen atoms have been shown effective for deriving 
ADMET models, because these atoms affect hydrogen bonding and molecular polarity that are related to 
solvation and absorption 36. Constitutional descriptors are usually insufficient to build any QSAR or 
QSPR model independently. Instead, they serve as complement to 2D or 3D descriptors in modern data 
mining algorithms. Table 2-5 lists some constitutional descriptors and their application for the prediction 
of physiochemical properties, binding affinity and ADMET properties.  
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Table 2-5: List of constitutional descriptors and their applications 
 
Descriptor Application Reference 
number of carbon atoms partition coefficients of 
barbituric acids 
37 
relative number of nitrogen atoms pKa for neutral and basic drugs 38 
relative number of benzene rings 
number of carbon atoms 
relative number of double bonds 
biological activity of carbonic 
anhydrase CA II inhibitors 
39 
number of sulfur atoms 
number of H-bond donors 
number of hydroxyl groups 
general solubility 40 
number of fluorine atoms gas chromatographic retention 
index 
41 
number of acceptor atoms for H-
bonds 
Henry’s law constant 42 
the relative number of single 
bonds 
logk of peptides in HPLC 43 
number of Cl atoms boiling point 44 
atom number in the 
hydrophobic–hydrophilic segment 
critical micelle concentration 45 
relative number of aromatic 
bonds 
classification of the oxindole-
based inhibitors of cyclin-
dependent kinases 
46 
number of all atoms  
number of all bonds 
number of aromatic atoms  
number of hydrophobic atoms 
fraction of rotatable bonds 
Caco-2 permeability 47 
47 constitutional descriptors 
involved in principal component 
analysis 
carcinogenic activity 48 
number of carboxylic acids drug intestinal absorption 49 
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2.2.2 Geometric Descriptor 
The relevance between molecular geometric configuration and bioactivity or physiochemical properties is 
well recognized. For receptor-ligand interaction, the geometric arrangement of ligands influences whether 
the ligands can fit into the receptor pocket. To capture these molecular features, geometric descriptors are 
designed to be a set of mathematical functions of molecular size, shape, position and properties in space. 
The calculation of geometric descriptors is not as straightforward as constitutional descriptors, since it 
involves mathematical integration and numerical approximation. The interpretation of some descriptors 
requires thorough understanding of underlying theories. Table 2-6 shows some prevailing geometric 
descriptors for the investigation of molecular conformation and ligand-receptor interaction.  Brief 
introduction to some of these descriptors is given below. 
 
 
Table 2-6: List of representative geometric descriptors 
 
Molecular Volume Molecular Surface Area 
Charged Partial Surface Area Solvent-accessible Molecular Surface Area 
Gravitational Indices Electric Quadrupole Moments 
Principal Moments of Inertia  Spherisity/Asphericity Index 
Shadow Areas of a Molecule Linearity Index 
Distance Between Atom Pairs WHIM shape index 
 
 
Molecular volume, as suggested by its name, is the total volume enclosed by van der Waals surface. 
Molecular volume calculation is not simply the summation of the volume of every atom, since covalently 
bonded atoms have significant volume overlapping. Thus, the overlapping volume of adjacent atom pairs 
(atom identity, bond type, conjugate system, etc.) should be considered. 
Molecular surface area determines the interactions between the molecule and its surrounding area. 
Molecular surface area as a geometric descriptor has been found statistically correlated with water 
solubility, octanol-water partition coefficients, activity coefficients and boiling points 50.The surface area 
refers to the area of van der Waals surface. Some derived descriptors show better biological relevance, 
such as water-accessible surface area, polar surface area, etc. The surface area can be approximated by 
summing either the areas of triangles of a defined surface or the contributions from all atoms. In addition, 
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efficient algorithms, developed by Pearlman, Lee and Richards, and Hermann, for the approximation of 
surface area have caught the most attention.  
 
 
Table 2-7: List of geometric descriptors and their applications 
 
Descriptor Application Reference 
gravitational index boiling point 51 
molecular surface area 
molecular volume 
octanol/water partition 
coefficients 
52 
electric quadrupole moments 
principal moments of inertia 
alignment-free 3D QSAR 
modeling inhibition of 
cytopathic effects of HIV-1 
53 
Linearity index (L/B index)  classification of carbonic 
anhydrase inhibitors 
54 
partial positive surface area 
partial negative surface area 
biological activity of carbonic 
anhydrase CA II inhibitors 
39 
WHIM descriptors toxicity of heterogeneous 
chemicals 
LogP, Caco-2 permeability  
55 56 
 
Sphericity (or asphericity) index is a measurement of the degree in which the shape of a molecule is 
similar to a sphere. The calculation is based on molecular volume and surface area. The sphericity index 
of a molecule is defined as the ratio of the surface area of a sphere with the same volume to the surface 
area of the molecule. As a sphere has the lowest surface-area-to-volume ratio, the more “round” a 
molecule is, the larger its sphericity index becomes. The maximum of a sphericity index is 1. 
Gravitational index is defined as G = ∑ mimj
rij
2i<𝑗 , where i and j are the atom indices, mi is the mass of 
atom i. Gravitational index is bond-restricted when the summation is only calculated on bonded atom 
pairs 51. This descriptor characterizes the mass distribution of a molecule.  Principal moments of inertia 
are also mechanical descriptors, describing the resistance to changes in rotation. Similar to dipole 
moments, electric quadrupole moments describe the distribution of electric charges over a molecule. 
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Quadrupole moments have higher order than dipole moments. A molecule that has zero dipole moment 
may still have quadrupole moment, as if a molecule that has zero net charge may still have dipole moment.  
Geometric descriptors have been widely used in QSAR and QSPR modeling. Table 2-7 lists some of 
the representative studies. The major disadvantage of most geometric descriptors is the dependence on 
three-dimensional conformations. The calculation of geometric descriptors however mainly relies on 
internal coordinates so that they are independent on molecular position and orientation. This valuable 
feature enables us to build alignment-free 3D QSAR models. 
2.2.3 Topological Descriptor 
Topological descriptor, also known as connectivity index, emphasizes what atoms are connected by 
covalent bound and how they are connected. To generate topological descriptors, compound structures are 
usually treated as molecular graph with suppressed hydrogen atoms. Topological descriptor is usually 
graph invariant, meaning that the descriptor value remains constant regardless of how the structure is 
represented. Topological descriptors have been employed in numerous QSAR and QSPR studies, but their 
interpretation is usually obscure in the context of physicochemical properties. Besides its graph invariance, 
topological descriptor exhibits another apparent advantage, the simplicity in computation. Table 2-8 lists 
some popular topological descriptors involved in many studies. Wiener index and BCUT descriptors will 
serve as examples for descriptor interpretation. And a few representative applications of topological 
descriptors are listed in Table 2-9. 
Table 2-8: List of representative topological descriptors 
 
Wiener Index Hosoya Index 
Balaban J Index Randić Index 
Structural Information Content Index Bonding Information Content Index 
Kappa Shape Index Connectivity Index 
BCUT Descriptors Molecular Path/Walks 
 
 
Wiener index is a classical quantity to characterize the connectivity of a graph. The formal definition is 
given by the following equation: 
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W = 12�� di,jn
j=1
n
i=1
 
Where di,j is the shortest distance between point i and point j, or atom i and atom j in a molecular graph. 
To restate this equation by words, Wiener index is equal to the sum of the nearest distance between any 
pair of atoms. Wiener index can be also interpreted in terms of each individual covalent bond. In acyclic 
case, the contribution of each bond is the product of the total number of atoms at each side, and the 
Wiener index is simply the sum of the contribution of all the bonds. If both sides of a bond show similar 
number of atoms, the product tends to be large, because the total number of atoms is constant and a × b ≤ (a+b
2
)2. Intuitively, the index is mainly affected by the bond located in the center of a structure. 
In other words, the topology of side branches weights relatively less in the index calculation. A structure 
with a large number of atoms tends to have a large Wiener index value. Thus, the index is potentially 
correlated with van der Waals surface area. Examples and explanations of Wiener index and some other 
descriptors are given by Randic and Zupan. 57 
BCUT (Burden CAS University of Texas) descriptors 58-61 incorporate comprehensive information 
regarding molecular structure, atom property and more into decimal numbers. Creating BCUT descriptors 
is one of the most popular approaches to construct low-dimensional chemistry space and perform 
diversity analyses. Briefly, BCUT descriptors are defined by combining atomic descriptors for each atom 
and description of the nominal bond-types for adjacent and nonadjacent atoms into BCUT matrices. The 
value of each chemistry-space coordinate is specified as the highest or lowest eigen value of BCUT 
matrix as illustrated in Figure 2-9. 
 
 
 
Figure 2-9: Illustration of BCUT connectivity matrix (Tripos). 
In the matrix, diagonal elements are filled by atom charge, and off-diagonal elements are filled by 
bond order if any. The remaining elements are filled by a predefined constant (0.01). BCUT descriptor is 
either the lowest or the highest eigen value of this connectivity matrix. 
 
OH
O
1
2
3
4
5
 1 2 3 4 5 
1 -0.047 1.1 0.01 0.01 0.01 
2 1.1 0.046 1 0.01 0.01 
3 0.01 1 0.231 2.1 1.1 
4 0.01 0.01 2.1 -0.371 0.01 
5 0.01 0.01 1.1 0.01 -0.293 
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In Figure 2-9, the diagonal elements of the matrix are filled with estimated partial charge of each atom. 
The off-diagonal elements can be a small number, e.g. 0.01 in this example, if two atoms are not 
connected. Otherwise, a nominal value is filled to represent covalent bond type. An increment (0.1) is 
added to the nominal bond value if the bond connects terminal atoms. Then, the off-diagonal elements 
may be scaled by a preset factor. Finally, the lowest or the highest eigen value of the connectivity matrix 
becomes BCUT descriptor of this query structure. BCUT descriptors have many variants, depending on 
atomic property filling the diagonal elements and the scaling factor. Generally, the optimal subsets of 
BCUT descriptors capture the maximum variance of a compound library, and show little pair-wise 
correlation. 
 
Table 2-9: List of topological descriptors and their applications 
Descriptor Application Reference 
BCUT Library Design, QSAR, 
Diversity Analysis 
62-64; 
 65; 66 
connectivity chi and kappa 
indices 
Prediction of HPLC Retention 
Index 
67 
Wiener index Drug-receptor interaction 68; 
69 
triplet index, Balaban’s J index, 
information contents, Wiener 
index, etc. 
mutagenic potency of aromatic 
and heteroaromatic amines 
70 
Edge-Connectivity Index, 
Hosoya Index, Wiener index, 
Randic’s index, Balaban’s Index, 
etc. 
The study on the relation 
between topological descriptors 
and physicochemical properties 
of Octanes, such as boiling 
point, molecular volume  
 
71 
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2.2.4 Electrostatic/Quantum-Chemical Descriptor 
The prediction of bioactivity and physicochemical properties of drug candidate compounds has become 
more and more important in modern medicinal chemistry. The correlation between structure and property 
is established by mapping molecular descriptors to numeric values. Obviously, the quality and accuracy 
of descriptors are deterministic for QSAR and QSPR studies. The advance of computer hardware and 
computation theory turns the generation of quantum-chemical descriptor feasible, but practical ab initio 
calculation is based on orbital approximation. Semi-empirical methods may also accelerate the calculation 
of quantum-chemical descriptors.  
Quantum-chemical descriptors encode unique molecular information that is hardly covered by other 
descriptors, including atomic charges, HOMO and LUMO energies, orbital electron densities, 
superdelocalizabilities, polarizabilities, dipole moment and total energies 72.  All of these descriptors are 
constantly employed in modeling bioactivities and various ligand properties. For example, LUMO energy, 
HOMO energy and dipole moment are involved in the prediction of oral drug absorption 73. The 
theoretical atomic charges are involved in modeling congeneric  and  non-congeneric  α1-adrenoceptor  
antagonists 74. In Tuppurainen et al.’s study, electron density is shown to be predictive for mutagenicity 75. 
Atom-atom polarizabilities and molecular polarizabilities contribute to the activity of a diverse set of 
enzyme activators 76. These case studies demonstrate the wide applicability of quantum-chemical 
descriptors in QSAR and QSPR modeling. The descriptors provide additional information at atomic and 
orbital level, which is relatively more accurate than empirical molecular descriptors. And quantum-
chemical descriptors generally have physical meaning. A comprehensive variable selection, or descriptor 
selection, is mandatory to build and refine a QSAR/QSPR model, especially for some unexplored 
properties and novel compound scaffolds.  
2.2.5 Hybridized Descriptors and Molecular Fingerprint 
Molecular fingerprints are probably the most frequently used descriptors in modern QSAR/QSPR 
modeling. Broadly speaking, molecular fingerprint could be a high dimensional categorical or real-value 
vector that encodes a diverse set of structural patterns and derived properties. Mapping chemical 
structures to desired molecular properties is challenging and complicated. One of the difficulties is the 
selection of appropriate descriptors. Molecular fingerprint, a high dimensional descriptor, is originally 
designed to discriminate and screen compounds in a compound inventory. As it encodes a variety of 
structural patterns, fingerprint offers great possibilities to build quantitative prediction models. 
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Nevertheless, the risk also exists due to potential overfitting. Recent publications report the application of 
molecular fingerprints for the prediction of ligand bioactivity, ADMET properties, selectivity, 
physicochemical properties, etc. Fingerprints are also the prevailing descriptor for traditional topics in 
cheminformatics, such as similarity calculation, virtual screening, library design, diversity analysis, etc. 
Majority of the chapters covered in this thesis are related to molecular fingerprints. 
 According to representation, molecular fingerprints can be classified into the fixed-length 
fingerprints and dynamic fingerprints. In the former case, the length of the fingerprint is usually preset, 
and the pattern that each dimension encodes is predefined. The length of the fingerprints ranges from 
hundreds to thousands. For example, the classical MACCS key has 166 bits; Unity fingerprint has 992 
bits. The length of dynamic fingerprint depends on the presented compound library because the number of 
possible patterns may be very large or even infinite. These fingerprints are usually represented in sparse 
arrays, but they are sometimes folded into regular vectors for simplicity. ECFP (extended-connectivity 
fingerprint) from ChemAxon is an example. Each dimension of molecular fingerprints can be binary (0 or 
1) indicating the presence or the absence of a feature, integers indicating the occurrence of a feature, or 
real-value properties. For example, MACCS key is a binary structural key, and LINGO counts the 
occurrence of each present feature.  
Molecular fingerprints can also be categorized by encoded features, including pre-defined structural 
keys, atom environment, atom path, and pharmacophore keys. To generate pre-defined structural keys, 
computer program scans a query compound structure to search for a list of structure patterns. Figure 2-10 
illustrates the scheme of Unity fingerprint in Tripos Sybyl software suite. In Figure 2-10, the compound 
structure is “chopped” into fragments that are defined in a fragment dictionary. These fragments are 
further mapped to different fingerprint “bits” by cyclic redundancy check algorithm. MACCS key 166 
and PubChem fingerprints are also typical examples.  
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Figure 2-10: Illustration of the coding scheme of Unity fingerprint by Tripos.  
Each dimension of the molecular fingerprint represents the presence or absence of predefined 
molecular fragments, following hashing algorithm and CRC algorithm. 
 
 
Atom environment fingerprints are mostly favored in recent publication for its optimal performance. 
These fingerprints describe atoms together with their surrounding environment in a structure. Atoms may 
be differentiated by the hybridization, and environment may be defined by connected atoms. Molprint 2D 
fingerprint 77 and ChemAxon extended-connectivity fingerprint (ECFP) are famous examples. The feature 
in Figure 2-11 can be translated as a sp2 carbon atom that is surrounded by another sp2 carbon atom and 
two aromatic carbon atoms at one-bond distance away, and that also has two sp2 carbon atoms, one sp3 
nitrogen atom, one sp2 oxygen atom and one sp3 oxygen atom at two-bond distance away. In Molprint 
2D, atoms are differentiated by Sybyl atom types. ECFP has a similar concept but discriminates atoms in 
a more detailed level. 
 
 
 
Figure 2-11: A graphical representation of a structure pattern in Molprint 2D fingerprint. 
Figure reference77 
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FP2 fingerprint in OpenBabel and Daylight fingerprint belong to path-based fingerprints. In these 
fingerprints, compound structures are treated as graphs. So atoms are vertices and bonds are edges. An 
“atom walk” is the movement from one atom to another if they are connected by any covalent bond. An 
“atom path” is a trajectory of several “atom walks” without revisiting any bonds. The types of atoms and 
bonds visited in an atom path uniquely define a structure pattern. Pharmacophore fingerprints translate 
atoms in a structure into pharmacophore tags, such as H-bond donor, H-bond acceptor, hydrophobic 
group, formal positive charge, formal negative charge, and etc. Pharmacophore fingerprints generally 
encode the pharmacophore groups in a structure and distance between them. PharmPrint 78 and TGT 
fingerprint belong to this category. The changes in 3D conformation generally affect pharmacophore 
fingerprints, opposed to other 2D fingerprints.  
     Many free computer programs are available to generate molecular fingerprints, such as Molprint 2D, 
FP2, MACCS key, PubChem fingerprints. Molecular Operating Environment (MOE) and Discover 
Studio are two popular proprietary drug design programs for fingerprint generation. The successful 
extended-connectivity fingerprint is implemented in JChem module from ChemAxon. Some fingerprints 
need to be generated by in-house scripts, e.g. PharmPrint. Researchers may also design structure patterns 
by SLN and carry out substructure search to generate customized fingerprints.  
Commonly, any high dimensional descriptor vectors that are sufficient to differentiate compound 
structures are molecular fingerprints. This coding strategy accelerates similarity calculation and 
substructure search for large chemical databases. Combined with robust machine learning algorithms, 
fingerprints have become powerful descriptors applied in almost all the fields in QSAR/QSPR modeling. 
Table 2-10 lists some of the application of molecular fingerprints that are introduced in this section. 
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Table 2-10: Example applications of molecular fingerprints 
 
Fingerprints Application Reference 
 
 
MACCS 
Similarity search, virtual screening on 
ChemBL 
79 
Cytotoxicity Prediction 80 
Drug-likeness 81 
ADME property 82 
 
 
Daylight 
Structure ranking and virtual screening 83 
Drug/compound clustering 84 
85 
Classification of kinase inhibitors 86 
Generation of diverse screening library 87 
 
 
ECFP 
Lipophilicity 88 
Melting Point and Aqueous Solubility 89 
QSAR for kinase inhibition 90 
Prediction of biological target 91 
TGT Structure ranking and virtual screening 83 
Virtual screening and QSAR 92 
2.3 STATISTICAL MODELING AND MACHINE LEARNING 
Statistical modeling and machine learning tools, the bridge that connects molecular descriptors and 
molecular properties, are an important component in modern QSAR/QSPR studies. Data mining on the 
vast collection of descriptors determines the optimal descriptor subset that correlates well with properties 
of interest. In addition, parameters in QSAR/QSPR models are solved according to machine learning 
algorithms and numerical optimization. Besides quantitative and qualitative prediction, computational 
learning theory, a subfield in machine learning, guides researchers in model selection and the estimation 
of generalization error. This section highlights classical machine learning algorithms, model hypotheses, 
and applicability in cheminformatics.  
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2.3.1 Linear Regression 
Linear regression assumes that one or more explanatory variables (x) have linearly additive contribution 
to a response scalar variable (y). However, a normally distributed noise in y cannot be explained by x. To 
express this mathematically, 
y = β0 + �βixiK
i=1
+ ε 
ε is an error term, and it follows normal distribution; β is coefficient. The predicted y, denoted by y�, 
is equal to y� = β0 + ∑ βixiKi=1 . The establishment of a linear model is the parameterization of  β based on 
training data. Once β is solved, the prediction of y, y�, can be easily obtained from x. The motivation of 
solving β is to maximize the likelihood of observations, or to minimize the squared sum of error ε. Let 
matrix X represent the training set. Each row of X is a single observation, and each column corresponds 
to variable xi. Thus, a training set that contains K dimension variables and N samples can be represented 
by matrix, X, which has N rows and K + 1 columns. The estimation of 𝛃 is 𝛃� = (X′X)−1X′𝐲, where 𝛃, 𝐲 
are coefficient vector and response vector. The most basic requirement of solving a linear model is that 
matrix must have a full rank. In other words, there must be at least K + 1 linearly independent samples to 
solve 𝛃.  
Linear regression has been used to model physicochemical properties and ligand bioactivities. For 
example, the famous Free-Wilson QSAR model 93: 
LD50 =  μ  + a[H]  + a [CH3]   + b[N(CH3)2]  + b[N(C2H5)2] 
Free and Wilson are the pioneers in QSAR research, and their Free-Wilson model initiated a new 
branch of drug discovery and suggested a quantitative approach for structure-activity study. In this 
equation, bioactivity is the sum of a bias value, μ, the contribution of H group or CH3 group at R1 
position and the contribution of N(CH3)2 or N(C2H5)2 at R2 position. This model can be easily 
transformed into linear regression analysis, in which a four-element binary vector x represents the 
presence and absence of the functional groups at R1 and R2 position, and coefficient 𝛃 represents the bias 
value and the contribution of each group. 
Linear regression analysis relies on a few assumptions, including linearity, normally distributed 
residual and constant variance. Even though the criteria do not necessarily hold in all occasions, the 
numerical optimization still minimizes the discrepancy between observed value and predicted value. 
Running some diagnosis on the regressor may improve fitting. For cheminformatics applications, variable 
transformation is a common remedy. For example, transforming bioactivity into logarithm scale is a 
popular practice in QSAR modeling. Another challenge in linear regression is variable selection. The high 
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degree of freedom tends to over-fit the training data, but yields poor performance in future prediction. 
Ridge regression, the Lasso, and stepwise regression are the techniques for bias-variance tradeoff.   
2.3.2 Logistic Regression 
Linear regression introduced in the previous section is a popular technique to predict real-value response. 
Sometimes, the desired response may be categorical label, such as active or inactive, soluble or insoluble. 
Besides predicting real-value response, linear regression could also be carried out for classification by 
assigning symbolic numbers to different categories. This approach however presents a few challenges to 
the assumptions of linear regression: first, the prediction may be inadmissible due to some extreme 
variables, x; second, the distribution of categorical labels is expressed as a function of explanatory 
variables (x), so the variance is not uniform or follows normal distribution. These impair hypothesis 
testing of coefficients, construction of confidence interval, variable selection, etc., as all the inferences 
assume normality.  
Logistic regression is regarded as generalized linear regression. It models the conditional probability 
of observing y, given its explanatory variables. It expresses the logit of the probability, or the log odds, as 
a linear combination of x: log � P(y)
1−P(y)� = β0 + ∑ βixiKi=1 . Thus, P(Y = y|X) = exp (β0 + ∑ βixiKi=1 )1 + exp (β0 + ∑ βixiKi=1 ) 
With one dimension variable x, logistic regression produces a sigmoid curve, as shown in Figure 2-12. 
The predicted category is the one that has larger than 0.5 probabilities.  
 
 
 
Figure 2-12: Sample sigmoid curve produced from logistic regression 
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The solution to coefficient vector 𝛃, has no analytical form. Instead, 𝛃 is found numerically by 
maximizing the likelihood: 
𝛃� = argmax
𝛃
�( exp (β0 + ∑ βixiKi=1 )1 + exp (β0 + ∑ βixiKi=1 ))yi( 11 + exp (β0 + ∑ βixiKi=1 ))1−yiNi=1  
A popular algorithm of finding 𝛃� is called reweighted least square, which is an iterative procedure. 
And the convergence is shown to be fast. 
Linear regression can be used to predict the real-value bioactivity, while logistic regression is 
designed to predict binary outcome. For example, Cronin et al. 94 uses logistic regression to classify 
compounds according to whether they have antibacterial activity. In their study, multiple physicochemical 
descriptors are involved in logistic regression model. As discussed in their article, logistic regression 
develops “interpretable and transparent” models. 
2.3.3 Partial Least Square 
Comparative Molecular Field Analysis (CoMFA), developed by Cramer et al and published in JACS in 
1988, is probably the earliest and most influential modeling method in QSAR, especially in 3D QSAR. 
After a decade, CoMFA and its derivative methods are still frequently seen in major cheminformatics 
journals. At the beginning stage, Tripos Sybyl implemented the CoMFA methodology and gained 
significant market share in commercial computer-aided drug design platform. As a renovated QSAR 
technology, its success is mainly attributed to a novel statistical method: partial least square regression. 
All the QSAR algorithms correlate activity with structure descriptors, and CoMFA is not an exception. 
The descriptor in CoMFA is the steric energy and electrostatic energy in an aligned 3D grid. According to 
a set of training compounds and their labeled activity, CoMFA figures out favored field energy for ligand-
receptor interaction. Figure 2-13 shows a graphical illustration of a developed CoMFA model. 
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Figure 2-13: A graphical representation of molecular field component in CoMFA studies.  
A CoMFA model depicts favored and disfavored functional groups in 3-D space. 
 
Linear regression and logistic regression are inappropriate techniques in CoMFA. In CoMFA, hundreds 
of energy field values are calculated in a 3-dimensional grid, but labeled training compounds are usually 
less than a hundred. Linear regression cannot solve the coefficients when the degree of freedom is higher 
than the number of constraint. In other words, the variable matrix, X, is not full rank. Before the advent of 
partial least square regression (PLSR), principal component analysis (PCA) was a common dimension-
reduction technique. PCA generates a few components that are linear combinations of original descriptors 
in order to capture the major variance in the distribution. Nevertheless, the major variance does not 
necessarily correlate with some response of interest. For example, minor modification to functional 
groups may induce significant change in bioactivity, but ligands in different scaffold may have similar 
biological profiles. On the contrary, PLSR calculates the principal components that correlate well with 
response values. Anyhow, PCA is in the domain of unsupervised learning, while PLSR is a supervised 
learning algorithm. 
Partial least square regression (PLSR) 95 approximates the original matrix by the hidden variable T: 
FTCY
ETPX
+=
+=
'
'
 
where X is mn× descriptor matrix, T is ln× score matrix, P’ and C’ are ml × and 1×l loading 
matrices, E and F are error terms. In this case, Y is only a vector with selectivity label or activity ratio for 
each compound. T is solved through iterative procedure. 
For each round k, k=1,2…l 
1. Find vector kw  that maximizes the covariance and score vector t: 
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kp  will be the k
th column of matrix P , kc  will be the k
th column of matrix C and kt will be the k
th 
column of score matrix T 
3. Replace matrix X and Y by their residuals, which are the difference between original X, Y 
and their approximation by kp , kc  and kt  
The final regression equation is y=x’b where b=W(T’XW)-1T’y . b is solved by minimizing the 
training error 2''min TCWvTP
v
− and b=Wv. The only variable l, the number of components, can be 
calculate through leave-one-out cross validation. 
The invention of PLSR is a “landmark” in statistics as it is probably the first algorithm motivated by 
pharmaceutical science, and it plays a central role in CoMFA. The theory on force field and field energy 
calculation was well established before CoMFA was developed. It was PLSR that turned modeling 
bioactivity through field energy practical. From CoMFA, the importance of quantitative modeling 
techniques can be easily observed.  
2.3.4 Naive Bayes Classifier 
Bayes' theorem states that the posterior probability is proportional to the prior and likelihood: P(Y = y|𝐱 = x1, x2, … , xK) = P(𝐱 = x1, x2, … , xK|Y = y)P(Y = y)∑ P(𝐱 = x1, x2, … , xK|Y)P(Y)Y  
or  P(Y = y|𝐱 = x1, x2, … , xK) ∝ P(𝐱 = x1, x2, … , xK|Y = y)P(Y = y) 
P(Y) is the prior, P(x| Y) is likelihood and P(Y| x) is posterior likelihood.  
Bayes’ theorem enables us to calculate the probability of Y given its explanatory variables x, based 
on the prior and likelihood. Similar to logistic regression, this theorem is suitable for ligand-based drug 
design, such as virtual screening or ligand classification. Naive Bayes classifier imposes independence 
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assumption on each dimension of descriptor vector x, which notably simplifies the calculation of 
likelihood. By applying the independence assumption, 
P(𝐱 = x1, x2, … , xK|Y = y) = �P(𝐱i = xi|Y = y)K
i=1
 
Where 𝐱i is the ith element in vector x. and P(𝐱i = xi|Y = y) = ∑ I�Xj,i = xi, Yj = y� + aNj=1∑ I(Yj = y)Nj=1 + a + b  I is an indicator function, and a, b are pseudo-counts to avoid zero probability. Although the 
independence assumption is not always accurate, the estimation of likelihood, especially for high-
dimensional variable x, becomes feasible. Otherwise, the sample sizes required for likelihood calculation 
grows exponentially as the number of elements in x increases. This is also called “curse of 
dimensionality”. Naive Bayes classifier decouples the conditional probability and the distribution of each 
variable dimension is approached independently. Although the independence assumption impairs the 
precision of posterior probability, the goal of Naive Bayes classifier is to predict the correct class or label. 
Correct predictions can be still reached as long as the conditional probability of the correct class is higher 
than the one of incorrect ones. Therefore, Naive Bayes classifier is a flexible and robust classification tool 
in practice.  
The success of Molprint 2D descriptor, proposed by Bender et al. 77, is partially due to their software 
package that implements Tanimoto similarity calculation and Naive Bayes classifier for ligand screening. 
They systematically evaluated the performance of Molprint 2D fingerprint and Naive Bayes classifier by 
various classes of ligands 96. Naive Bayes classifier is an appropriate modeling tool in this application. 
The independence assumption on Molprint 2D fingerprint is approximately correct as the presence of one 
feature is relatively irrelevant to another. This does not mean Molprint 2D features in a ligand are 
absolutely independent. For example, atom B is in the environment of atom A, while atom A is also in the 
environment of B. Thus, the presence of a feature centered at atom A has positive contribution to the 
likelihood of the presence of the feature centered at atom B. The molecular weight of small organic 
ligands is usually limited, especially for drug-like compounds. The number of Molprint 2D features is 
equal to the number of heavy atoms in a chemical structure. Therefore, the present Molprint 2D features 
reduce the chance of observing other features. Nevertheless, these influences are only theoretical and 
ignorable in real-world computation because there are more important factors that we should take care of, 
such as the pseudo counts. 
The number of possible Molprint 2D patterns is almost infinite. A regular virtual screening library 
may generate a dictionary that defines thousands of three-bond-length Molprint 2D features. In this case, 
meaningful models cannot be expected from logistic regression or linear regression because of overfitting. 
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On the contrary, Naive Bayes classifier is a suitable choice as discussed above. Furthermore, it can 
provide degree of confidence in terms of probability. Last but not least, feature selection scheme is 
natively incorporated in this algorithm, resulting in transparent and interpretable probabilistic models.  
2.3.5 Artificial Neural Network 
In 1970s, research on artificial intelligence or machine learning was almost equivalent to studying 
artificial neural network (ANN), just like that CoMFA was almost equivalent to QSAR in 1990s. The 
establishment of ANN theories initialized another branch of machine learning methodology that used to 
be dominated by statistical modeling. Statistics means probability and inference. Distribution and 
probability exist in every corner of statistics. ANN, representing the opinions of computer scientists, maps 
explanatory variables directly to response variable. Nowadays, ANN is still a popular method in OCR, 
robotic science, clustering, etc. Figure 2-14 shows the overall paradigm of traditional neural network (NN) 
models. ANN model consists of input layer, hidden layer(s), and output layer. Each layer has a set of 
nodes, or neurons, to receive input, process signal and calculate output.  In Figure 2-14 (A), explanatory 
variables x are passed to the network through the input nodes. Every node in downstream layer receives 
the input (x) from all the nodes from the upstream layer. In Figure 2-14 (B), each of the input value is 
weighted by value w, and a linear combination of the input value becomes the incoming activation of the 
downstream node, i.e. the output of a hidden node j is  
1
1+e−zj
  where zj =  ∑ wijxi + δNi=1  
Note that each hidden note possesses an independent set of weights w. The output of hidden layer 
nodes becomes the input of downstream nodes. The signal passes through the network structures until the 
output layer node is reached. The output node finally predicts the response value. It is clear that the 
parameters in a neural network given its structure are the weights associated with hidden nodes and output 
node(s). Back-propagation is a common algorithm to minimize the square loss of training data by 
gradually adjusting the weights.    
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Figure 2-14: The paradigm of artificial neural network by Sharma. 
Figure adopted from reference97 
 
 
Aoyoma et al. may be the forerunners who bring ANN in to the QSAR world 98. On-line training and 
multi-class classification are major advantages of ANN. Its flexibility and established learning theories 
achieve its popularity in computer science. Nevertheless, ANN may not be the appropriate tool in drug 
discovery. First, the determination of network structure is time-consuming and the structure varies from 
application to application. The high degree-of-freedom in model complexity demands sufficient training 
data for reliable prediction performance.  
2.3.6 Classification and Regression Tree 
Trees are straightforward and effective data-mining technique for both classification and regression. 
Figure 2-15 plots a sample classification tree and corresponding 2D classification scheme. Green color 
indicates safety and yellow color indicates risk. Deeper color means higher prediction confidence in the 
region. The blue boxes indicate the splitting criteria, and the red boxes represent local classification 
hypotheses together with confidence level. By traversing queries through the tree, from root to leaf 
following the splitting rules, predictions are made according to local decision hypotheses. This sample 
tree utilizes two variables, BMI and age, to predict the risk of cardiovascular disease. In fact, the 
classification tree partitions the age-BMI space into disjoint regions, as illustrated in Figure 2-15. 
Separate classification hypotheses are derived for each region in order to achieve better classification 
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accuracy and higher confidence level. The selection of splitting criteria targets at minimizing the impurity 
and reducing the response variance of each region. Technical details on how to derive a tree are given in 
Chapter 4, LICABEDS.  
 
 
 
 
Figure 2-15: A sample classification tree for the prediction of the risk of cardiovascular disease.  
The left figure displays a decision tree classifier, which partitions the AGE-BMI space in the right 
figure. 
 
 
In spite of the simple idea, trees are shown to be quite effective in many data-mining applications. They 
are also widely used in different areas of computer-aided drug design, such as virtual screening99, drug-
likeness prediction100 and ligand property prediction 101. One advantage of tree algorithm is its simplicity 
and flexibility. Tree algorithm has little mathematical assumptions compared to linear regression, logistic 
regression, and Naive Bayes classifier. Tree can be designed for both classification and regression 
purposes. The selection of splitting criteria effectively eliminates irrelevant features, so that we can derive 
a tree model from limited high-dimensional training data. Tree is a non-linear model. Its flexibility may 
handle complicated data patterns that present challenges to linear models. 
The disadvantage of tree algorithm coexists with its advantage. First, trees are supposed to be 
“pruned”, otherwise they can “grow” until all the training data is perfectly fit. Tree pruning is a procedure 
to control overfitting. At the same time, this approach also limits the number of predictive variables in a 
tree structure. Second, tree structures are derived from training data in a greedy manner because the 
search for optimal tree structure is proven to be NP-complete problem. “Greedy” trees are vulnerable to 
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noise in the training data. Little variance in the training data may drastically change the tree structure, 
especially the root nodes.  
2.3.7 Support Vector Machine 
Because of its robustness, Support Vector Machine (SVM) is probably the most successful and popular 
method in binary classification. SVM classifiers can be either linear or non-linear, depending on the 
choice of kernel function. The application domain of SVM has been further extended to regression, 
ranking, structured prediction, etc. Its elegant numerical optimization has guided many variant models in 
digital image processing, probabilistic graphical model, computational genomics, etc. The major 
components in SVM object function are error term and margin term. Error term corresponds to training 
error and margin term represents model robustness. The constraint optimization in SVM can be further 
transformed into quadratic programming, which guarantees the convexity and convergence to the global 
optimal. The outline of SVM is given in this section, and more details are described in Chapter 5, 
SUPPORT VECTOR MACHINE FOR LIGAND CLASSIFICATION. 
In SVM, a set of training samples {xi, yi} derive a decision boundary by minimizing empirical 
generalization error, with xi ∈ RK being the explanatory variables and yi ∈ {+1, -1} being its label. A 
linear decision boundary or decision surface can be defined as wTx + b, where w is the normal to the 
decision surface, x is the descriptor vector, and b is a bias. And the classifier can be formulated as ƒw,b(x) 
= sign(wTx + b). Non-linear case will be discussed in Chapter 5.Any decision surface that satisfies yi 
(wTxi + b) ≥ 1 ∀i, can perfectly separate the training data. SVM assumes that the optimal decision surface 
has the largest distance to the nearest data points of both categories, i.e. margin maximization. Figure 
2-16 demonstrates this concept. Skipping some technical details, the margin optimization problem can be 
formulated as 
 
Minimize w,b ‖𝐰‖2           
Subject to yi (wTxi + b) ≥ 1 ∀i, i = 1, …, n 
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Figure 2-16: SVM, maximum margin classifier, CMU 10-701 2008 spring. 
 
 
This constraint optimization can be further transformed into the dual problem of the Lagrangian 
Maximize Lα = ∑ 𝛼i − 12∑ 𝛼i𝛼j𝑦i𝑦j〈𝐱i, 𝐱j〉ni,j=1ni=1                   
Subject to ∑ 𝛼i𝑦i = 0ni=1  with 0 ≤ αi ≤ C ∀i, i = 1, …, n 
Once we have αi, vector w can be recovered by equation, w =∑ 𝛼i𝑦i𝐱ini=1 . 
The introduction of support vector machine into drug discovery starts a new era. Machine-learning-
based QSAR modeling becomes an alternative choice to CoMFA. SVM is reported in many 
cheminformatics applications, including but not limited to screening for bioactive compounds 102 103, drug 
design for orphan receptor 104, selectivity prediction 105, active learning in high-throughput screening 106, 
structure ranking 107 and calculation of docking score 108. 
The advantage of SVM is robustness and flexibility to build linear and non-linear models. SVM 
models generally have decent performance even if not the best. The multi-class classification is still an 
active research subject for SVM. Also, the choice of non-linear kernel function and parameters 
complicates SVM model training. The training of SVM models is an iterative procedure, so its time 
complexity is significantly higher than the statistical methods introduced earlier. 
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2.3.8 Ensemble Methods 
“Weak learners” may hardly capture the versatile distribution patterns in real life. Combining multiple 
models to attain better performance is the motivation of ensemble learning methods. An important chapter 
of this thesis, LICABEDS, describes an ensemble learning algorithm for ligand classification. Theory 
shows that any better-than-random-guess learners can be combined to build a strong learner. Besides 
support vector machine, ensemble methods become another interesting research topic in machine learning. 
Adaptive boosting and bootstrap aggregating are representative ensemble methods. 
Adaboost, short for adaptive boosting, systematically develops an ensemble model by assigning 
weights to weak learners. Thorough discussion on this method can be found in Chapter 4. Bagging, 
another name for bootstrap aggregating, trains each weak learner using a randomly drawn subset of the 
whole training set with replacement. Weak learners in bagging ensemble model vote equally for the 
outcome. Famous “random forest” belongs to this category.  
The choice of weak learner is influential in ensemble methods. Because of lengthy computation time, 
some fast algorithms are preferred as weak learners, such as decision trees, linear discriminant analysis. 
Some studies show that ensemble methods exhibit better performance than SVM, ANN, Naive Bayes 
classifier. The ensemble nature allows the estimation of variance and confidence band, but its 
optimization stems from robust assumptions. As emerging techniques, their development and applications 
will catch researchers’ attention. 
2.3.9 Miscellaneous 
Some successful machine learning and statistical models for QSAR/QSPR are summarized above. The 
advance of machine learning in a decade builds far more algorithms than these, like K Nearest Neighbor, 
Fisher Linear Discriminant Analysis, Genetic Algorithm, to name a few. No algorithm is always superior 
to another in all aspects. Depending on the applications, hypothesis, complexity, and available training 
data, choosing the appropriate technique is the foundation of successful modeling. Examples in Figure 2-3 
and Figure 2-4 are provided to demonstrate this point.  
An overview of QSAR/QSPR theory is covered so far. Biologists, chemists, and pharmacologists who 
are not familiar with statistics and computer science need some automated tools for QSAR/QSPR 
modeling. Tripos Sybyl, Molecular Operating Environment, Discovery Studio, and Schrödinger are well-
known drug discovery platforms, implementing the whole pipe line of QSAR/QSPR modeling. Table 
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2-11 lists some commercial QSAR software products. These commercial products are highly automated, 
including management of compound library, descriptor generation, model training, validation, prospective 
prediction, and visualization. This is definitely an advantage for most users, but the flexibility and 
transparency are their disadvantage, even if these platforms provide scripting language to customize 
computation. As a scientific platform, Accelrys’ Pipeline Pilot is another choice for QSAR/QSPR 
modeling. In Pipeline Pilot, users design the whole experiment by connecting functional modules and 
controlling data flow. Nevertheless, this approach heavily relies on the availability of published modules. 
Researchers who have sufficient IT techniques may customize descriptor generation and statistical 
modeling. All of major drug discovery platforms are capable of generating and exporting a large 
collection of molecular descriptors. For example, Unity fingerprint in Sybyl, ECFP in Discovery Studio, 
pharmacophore fingerprints in MOE. Software development kits, such as OpenBabel, ChemAxon, 
OpenEye, CDK, can be also used to generate molecular descriptors.  
 
 
Table 2-11: Machine learning algorithms in major drug discovery platforms 
Software Platform Algorithms Product Name 
Tripos Sybyl PLSR CoMFA, HQSAR 
Molecular Operating Environment 
(MOE) 
Tree, Linear Regression, 
PCA, PLSR 
QuaSAR 
Discovery Studio ANN, Bayesian model, 
PLSR, Linear Regression 
QSAR and Library Design 
Schrödinger PLSR, Linear 
Regression, PCA 
Strike 
Field-based QSAR 
 
 
As to machine learning and statistics software, SPSS is a famous interactive platform implementing 
routine algorithms. WEKA implements many machine learning algorithms with graphical interface 
support. R, Matlab, S-PLUS and SAS are powerful statistical analysis software that delivers scripting 
languages. Most of the machine-learning algorithms are implemented as package importable to these 
platforms, such as LibSVM. Sometimes, modeler may seek implementations from third party, for 
example, the preference ranking algorithm in SVMLight package (http://svmlight.joachims.org/). 
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3 AIMS OF THE STUDY 
 
The aims of the study cover the development and implementation of cutting-edge machine learning and 
statistical modeling algorithms for handling large-scale cheminformatics data in order to guide drug 
discovery programs and boost productivity. The more specific aims of this dissertation include: 
1. Developing general-purpose linear and non-linear machine learning classifiers for the prediction 
of a variety of molecular properties that influence drug-likeness of candidate compounds 
(LiCABEDS and Support Vector Machine); 
2. Evaluating their performance on diverse pharmacological properties and validating the 
predictions in prospective screening (ligand functionality, blood-brain-barrier passage and ligand 
selectivity); 
3. Designing high-throughput parallel computing strategy to accelerate existing data mining 
algorithms in order to extend their application to terabyte compound database (GPU computing); 
4. Proposing and justifying compound acquisition approach to construct structurally diverse 
screening libraries that could potentially enhance hit rate and enrichment factor.  
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4 LICABEDS 
 
 
 
 
LiCABEDS is the acronym of Li
  
gand Classifier of Adaptively Boosting Ensemble Decision Stumps. It is 
an instance of adaptive boosting, and it belongs to ensemble methods in supervised learning. This chapter 
is focused on the description of LiCABEDS algorithm, its implementation, and applications. First, 
mathematical concepts of LiCABEDS are provided, which is followed by a case study on modeling 5-
HT1A ligand functionality. LiCABEDS is implemented as user friendly software that integrates data 
import/export, modeling training, prediction, etc. The software specification is given in the second section. 
Then, another case study, the prediction of CB1/CB2 ligand selectivity using LiCABEDS, demonstrates 
its effectiveness in quantitative structure-property relationship. This chapter ends with brief results for 
predicting ligand blood-brain-barrier passage. 
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4.1 LICABEDS AND MODELING LIGAND FUNCTIONALITY 
Advanced high-throughput screening (HTS) technologies generate great amount of bioactivity data, and 
this data needs to be analyzed and interpreted with attention to understand how these small molecules 
affect biological systems. As such, there is an increasing demand to develop and adapt cheminformatics 
algorithms and tools in order to predict molecular and pharmacological properties based on these large 
datasets. In this section, a novel machine-learning-based ligand classification algorithm, named Ligand 
Classifier of Adaptively Boosting Ensemble Decision Stumps (LiCABEDS), is reported for data-mining 
and modeling of large chemical datasets to predict pharmacological properties in an efficient and accurate 
manner. The performance of LiCABEDS was evaluated through predicting GPCR ligand functionality 
(agonist or antagonist) using four different molecular fingerprints, including MACCS, FP2, Unity and 
Molprint 2D fingerprints. Studies showed that LiCABEDS outperformed two other popular techniques - 
classification tree and Naive Bayes classifier - on all four types of molecular fingerprints. Parameters in 
LiCABEDS, including the number of boosting iterations, initialization condition, and a “reject option” 
boundary, were thoroughly explored and discussed to demonstrate the capability of handling imbalanced 
datasets, as well as its robustness and flexibility.  In addition, the detailed mathematical concepts and 
theory are also given to address the principle behind statistical prediction models. The LiCABEDS 
algorithm has been implemented into a user-friendly software package that is accessible online 
at http://www.cbligand.org/LiCABEDS/.  
4.1.1 Introduction 
As a complement to modern high-throughput screening, one of the primary goals of virtual screening 
and cheminformatics techniques is to explore the enormous chemical and biological properties in a time-
efficient manner as well as to help reduce the cost of experimental screening9-11. In particular, great 
emphasis is placed on the “drugability” or “drug-likeness” of compounds using cheminformatics tools in 
the early stages of drug development, with the hope of increasing the probability of “lead” compounds, or 
their derivatives, to pass through the later phases of drug clinical trials12.  
Despite numerous molecular properties and various mathematical models, the prediction of ligand 
binding activity and biological properties can be addressed by two types of approaches: a classification 
model for categorical response and a regression model for continuous response. For example, some 
pharmaceutical properties, such as mutagenicity, can be modeled by ligand classification109. To build up a 
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quantitative structure-property relationship (QSPR) model, pattern recognition methodology can be 
applied to map molecular descriptors to continuous value or categorical value via regression or 
classification 19. These molecular descriptors are usually binary or continuous vectors describing various 
aspects of molecular attributes or structural patterns. Many ligand properties pertaining to drug discovery 
have been successfully modeled with hundreds of molecular descriptors or fingerprints through statistical 
or machine learning techniques110-112.  As one of the representative regression models, Comparative 
Molecular Field Analysis (CoMFA)13 applies partial least square regression to make predictions from the 
principal components that are linear combinations of electrostatic and steric energy fields at 3D grids. 
CoMFA was successfully applied in the prediction of membrane flux113, modeling structure-
pharmacokinetic relationships114 and antagonist binding affinities at cannabinoid receptor subtype115. A 
CoMFA model was also developed to distinguish 5-HT1A agonists and antagonists116, which is also one of 
the focuses in this section. Another classification technique, Naive Bayes classifier, has also been used to 
model quantitative structure-selectivity relationships117. 
Despite the advance of cheminformatics methodology, it remains a challenge to develop a robust, 
reliable, and interpretable ligand classifier to tackle different scenarios in computer-aided drug design. 
Although any regression method like CoMFA can be adapted as a ligand classifier, such an approach 
often suffers from overfitting due to the model complexity of the regression method. In addition, the 
ability to find a 3D bioactive conformer remains as one of the limits 14. Many existing modeling methods 
may require researchers to perform variable selection. In practice, variable selection is still a complicated 
procedure that ultimately has a large effect on the final predictive model. Free parameters are manually 
specified in most computational models, for example, the number of components in the CoMFA method. 
Besides, cross-validation is often carried out to find optimal values of those parameters, but this practice 
could be computationally inefficient, and its performance also heavily relies on the choice of cross-
validation datasets. 
Thus, reliable and robust ligand classifiers are needed to aid scientists and researchers in discovering 
compounds with desired properties in both the lead discovery as well as the drug development process. 
The adaptive boosting algorithm, or Adaboost, introduced by Freund and Schapire118, is a general method 
used to produce a “strong” classifier by combining a series of “weak learners”. Sharing certain 
resemblance with the support vector machine (SVM) algorithm, Adaboost is also a maximum-margin 
classifier and tends not to overfit the training data119. Advantageously, the number of boosting rounds is 
the only essential parameter in Adaboost training, which simplifies the computational process of machine 
learning algorithms. In spite of the advantages, this algorithm has rarely been applied and discussed in 
drug discovery. In this study, a novel ligand classifier, LiCABEDS, was proposed and implemented by 
adaptively boosting sets of decision stumps based on 2D molecular fingerprints. In the established 
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algorithm, important features are automatically selected and weighted accordingly to build “weak 
learners” in model training. The performance and the characteristics of our novel algorithm are 
demonstrated and tested through the application on modeling ligand functionality for serotonin receptors 
or 5-hydroxytryptamine (5HT) receptors, belonging to an important family of G protein-coupled receptors 
(GPCRs). In addition, across-target studies indicate the potential application of LiCABEDS on orphan 
receptors. This section also describes the detailed mathematical concepts of the LiCABEDS algorithm. It 
is anticipated that LiCABEDS, as a general-purpose ligand classifier, can be applied to model more 
biochemical and pharmacological properties. The model development is free of conformation search and 
is readily automated with the robustness of 2D molecular fingerprints. Its performance and application are 
described below. Finally, the algorithm is implemented in a freely available and user-friendly software 
package, allowing the easy importing of datasets and model development.  The fully functioning software 
package is available online to the scientific community. 
4.1.2 Methods, Materials and Calculations 
The detailed mathematics concepts of Ligand Classifier of Adaptively Boosting Ensemble Decision 
Stumps (LiCABEDS) and its application on modeling ligand functionality are described below. As case 
studies, LiCABEDS was first used to model the ligand functionality for the 5HT-subtype GPCR families 
by predicting a given ligand to be either an agonist or an antagonist. For a parallel study, the performance 
of LiCABEDS was compared to two other popular data-mining methods: classification tree120 and Naive 
Bayes classifier121.  The underlying theory of these two methods is also introduced in this section. 
 
 
4.1.2.1 Ligand Classifier of Adaptively Boosting Ensemble Decision Stumps Adaptive 
boosting, initially introduced by Yoav Freund and Robert Schapire 118, is a general machine learning 
technique to create a strong classifier by combining a series of “weak learners” for improving the 
accuracy of prediction. In LiCABEDS, “decision stumps” are designed to be the weak learners. As 
illustrated in Figure 4-1, the “decision stump” denotes a heuristic classification hypothesis that a 
compound will be classified as an agonist (+1) if the ith bit of fingerprint ( ix ) is equal to a target value 
(t); or as an antagonist (-1), otherwise. 
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            A      B 
 
Figure 4-1: Graphical illustration of LiCABEDS 
(A) Illustration of a “decision stump based on molecular fingerprint. (B) Illustration of the 
composition of LiCABEDS. 
 
 
Instead of using the graphic representation, a “decision stump” can be formulated by a function: 
1)(2),,( −== txItixy i , where I is an indicator function,  I(Z) = 1 if the statement Z is true; I(Z) = 0, 
otherwise. x is the molecular fingerprint vector, i is the index of the fingerprint, and t is the target value. 
For example, if ix , the ith bit of fingerprint, is equal to the target value t, then )( txI i = = 1 and ),,( tixy = 
1 (agonist). If ix , the ith bit of fingerprint is different from t, then )( txI i = =0 and ),,( tixy = -1 
(antagonist). 
Different from many other machine-learning algorithms, LiCABEDS, as an ensemble method, is 
designed to achieve stronger classification power by boosting many “weak” classification hypotheses. As 
illustrated in Figure 4-1, a series of “decision stumps” with corresponding weights am vote for the final 
prediction, which can be formulated as the weighted summation of the outcome of every “decision 
stump”:  
)),,((∑=
M
m
mmmmM tixyasignY
 
    (4-1) 
1)( =zsign if 0>z , or -1 otherwise. The unknown variables, am, im and tm, for each weak classifier m 
can be “learned” from training datasets using the following algorithm: 
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1. Initialize the sample weights for each training compound n, NnNwn ,...,1,/1 == , N is the 
total number of training compounds. 
2. For each round of calculation m = 1,…,M 
 Find mm ti , for weak learner my  by minimizing the weighted error function 
∑ ≠=
=
N
n
nmmnmn
ti
mm ltiXyIwti
mm 1,
)),,((minarg),(                     (4-2) 
where argmin is the function to return the arguments which minimize the object 
function, nX   is the descriptor vector for compound n; nl = 1± is the label of compound 
n. mm ti ,  uniquely define a “decision stump”, and their optimal values can be found by 
enumerating all possible combinations of mm ti , . 
Evaluate the quantities: 
∑
∑
=
=
≠
= N
n
n
N
n
nmmnmn
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1
1
)),,((
ε ;
ε
ε−
=
1lnma
            (4-3)
 
am becomes the weight for the “decision stump” m. Then update the weights of 
training compounds for next round of calculation: 
))),,((exp( nmmnmmnn ltiXyIaww ≠←                        (4-4) 
 
 
The number of training steps, M, is the only parameter that must be specified manually in the algorithm. 
Cross-validation is one of the options to specify the optimal value of M, Moptimal. Training error is steadily 
minimized as M increases. While the training algorithm aims to minimize the exponential loss function,  
boosting algorithm may have potential to overfit the training data as pointed by others 122. Despite such 
potential, Freund and Schapire have shown the underlying mechanism that adaptive boosting does not 
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often suffer from overfitting 119. Discussion is given later on the difference between a large value of M (by 
default) and Moptimal in order to address the overfitting issue. 
Training compound datasets may potentially be overwhelmed by one category of training samples. In 
this case, the majority class is usually favored in the prediction. To minimize the effect of 
disproportionate training samples in each category, balanced class weight can be set as an alternative 
initialization condition to equal initial weight. In other words, the total weights for each class are equal at 
the initialization step: ∑∑
==
−===
N
n
nn
N
n
nn lIwlIw
11
)1()1( . For example, all the labeled agonists in the 
training set may have initial weights 1/1 +N , where 1+N  is the total number of agonists in the training 
data. Similarly, all of the antagonists may have an initial weight 1/1 −N . 
Heuristically, the absolute value of ∑=
M
m
mmmm tixyaA ),,(  indicates the degree of confidence in the 
prediction, because a relatively large population of “decision stumps” vote for the corresponding class. 
On the other hand, a low absolute value of A indicates uncertainty in the prediction. Better prediction 
accuracy is anticipated by avoiding uncertain cases, which we also refer to as “reject option”. In our 
study, a prediction is only made for a test compound if cA > , where c is rejection threshold. Otherwise, 
an “unknown” label is assigned to the test compound. 
 
 
4.1.2.2  Classification Tree Classification tree is a straightforward and effective data-mining 
technique. It has been widely applied to different areas of computer-aided drug design, such as virtual 
screening99, drug-likeness prediction123 and ligand blood-brain-barrier passage101.  
A classification tree consists of a set of split criterions and leaf nodes. The split criterions control the 
region that a ligand belongs to, while the leaf nodes represent classification hypotheses that are derived 
from training datasets in the same regions. The structure of a decision tree can be induced from training 
datasets in a greedy manner. By recursively partitioning the entire training dataset into regions, impurity 
)(timpurity is minimized regarding each possible partitioning t: 
)()(min ttimpurity
s
st
∑= λ , 
where s is the new region created from split t, and ∑−=
=
1
0
2)(ˆ1)(
j
ss jptλ . In this study, splitting rule is 
chosen from xi = 0 or xi = 1, where xi is the ith bit of descriptor vector. )(ˆ jps is the maximum likelihood 
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estimator of a ligand being j, j = 0 or 1 (0 represents antagonists, and 1 represents agonists), in region S. 
Training data can be perfectly fitted by growing the tree until 100% purity is achieved at each node. To 
avoid overfitting, k-fold cross-validation is commonly employed to control the “height” of a decision tree. 
After “pruning” the whole tree according to the cross-validation score that is defined as the percentage of 
correct predictions on cross-validation sets in this study, the optimal tree structure will be used to make 
predictions for novel ligands. 
 
 
4.1.2.3  Naive Bayes Classifier The Naive Bayes classifier method is a simple classification 
method based on applying Bayes' theorem with independence assumptions121. The method relies on the 
assumption that the presence or absence of a particular feature or class is unrelated to the presence or 
absence of any other feature. This independence assumption, with regard to molecular fingerprints 
simplifies the estimation of the likelihood function, which makes the method applicable to many 
computer-aided drug design tasks, such as virtual screening124 and selectivity prediction117. In this study, 
Naive Bayes classifier was used to model the probability of one ligand being an agonist or an antagonist, 
given its molecular fingerprint: )|Pr( FpCl where Fp is the molecular fingerprint vector, and Cl = 1 for 
agonist or 0 for antagonist. By applying Bayesian theory, )Pr()|Pr()|Pr( ClClFpFpCl ∝ , the 
predicted class of a given ligand is antagonist, lC

= 0, if 5.0)|0Pr( ≥= FpCl ; and lC

= 1, otherwise. 
)|Pr( ClFp can be approximated by applying the independence assumption to molecular fingerprints: 
∏=
i
i ClFpClFp )|Pr()|Pr( where iFp  is the i
th bit of fingerprint. 
Due to the difference between Molprint 2D and other types of fingerprints, the equation used in 
calculating the likelihood was also different. For example, we had Molprint 2D string “2;0-1-0; 2;0-2-2;” 
and MACCS fingerprint “0101” for a testing compound (only for illustration). The likelihood of the 
Molprint 2D fingerprint was calculated as:  
)|;220;2Pr()|;010;2Pr()|;220;2;010;2Pr( 21 ClFpClFpClFp −−=×−−==−−−−=  
The likelihood of MACCS key was calculated as: 
)|1Pr()|0Pr()|1Pr()|0Pr()|0101Pr( 4321 ClFpClFpClFpClFpClFp =×=×=×===  
The presence or absence of predefined MACCS features are considered in the likelihood calculation, 
while only present Molprint 2D features are modeled in the calculation.  
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4.1.2.4  Dataset Preparation, Molecular Fingerprint and Computation Protocol 
To evaluate the performance of LiCABEDS, all the labeled human 5-HT1A , 5-HT1B, 5-HT1D, and 5-HT4R 
agonists and antagonists were retrieved from the GLIDA database 125-126. The ligand quantity and their 
properties are summarized in Table 4-1 (properties were calculated using the Sybyl8.0 www.tripos.com).  
 
 
Table 4-1: Molecular properties of agonists and antagonists  
 
Receptor Ligand 
Category 
Quantity Molecular 
Weight 
No. of 
Rotatable 
Bond 
No. of  
H-Bond 
Acceptor 
No. of  
H-Bond 
Donor 
HUMAN 
5-HT1A 
Agonist 1102 346.7 ± 72.6 5.4 ± 2.4 2.8 ± 1.5 1.3 ± 0.9 
Antagonist 595 385.8 ± 70.7 5.0 ± 2.5 3.2 ± 1.3 1.7 ± 0.9 
HUMAN 
5-HT1B 
Agonist 104 348.4 ± 104.1 4.3 ± 2.5 3.6 ± 1.8 1.2 ± 0.8 
Antagonist 38 359.6 ± 88.4 4.1 ± 1.8 2.6 ± 1.4 1.2 ± 0.7 
HUMAN 
5-HT1D 
Agonist 685 339.1 ± 82.3 5.8 ± 2.6 3.3 ± 1.6 1.2 ± 0.7 
Antagonist 335 420.2 ± 71.0 4.1 ± 2.2 3.9 ± 1.4 1.7 ± 0.9 
HUMAN 
5-HT4R 
 
Agonist 287 369.4 ± 65 3.9 ± 2.5 2.8 ± 1.1 1.1 ± 0.5 
Antagonist 262 367.3 ± 61.5 5.7 ± 2.1 3.6 ± 1.4 1.1 ± 0.4 
*Molecular properties are given by sample average and standard deviation. 
 
 
With the published compound datasets, the prediction accuracy of different data-mining methods along 
with different molecular descriptors was assessed on the labeled agonists and antagonists of the human 5-
HT1A subtype G-Protein Coupled Receptor (GPCR) by ten rounds of calculation. For each round of 
calculation, three classification methods were compared, including LiCABEDS, classification tree, and 
Naive Bayes classifier.  Each was trained on the same randomly selected training compounds. The set of 
training compounds was composed of 75% labeled agonists and antagonists (827 5-HT1A agonists and 
446 5-HT1A antagonists). The remaining 25% ligands (275 5-HT1A agonists and 149 5-HT1A antagonists) 
were used as a testing dataset in order to evaluate the prediction accuracy of different methods. The 
prediction accuracy was estimated by comparing the predictions to the real ligand labels (agonists or 
antagonists). With Molprint 2D77, 124 as descriptor, the across-target ligand functionality prediction was 
also made by LiCABEDS. In this case, a LiCABEDS model was trained on all the labeled human 5-HT1A 
ligands (totally 1697 ligands), and then predictions were made on the ligands for human 5-HT1B, 5-HT1D, 
and 5-HT4R receptors. (Dr. Lirong Wang collected structure and bioactivity data from GLIDA database) 
In this study, four types of molecular fingerprints were generated for each compound, including 
MACCS key13, Unity (www.tripos.com), FP2127, and Molprint 2D 77, 124 fingerprint. (Unity and FP2 
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fingerprints were generated by Dr. Lirong Wang). The MACCS key fingerprint was calculated by 
Chemistry Development Kit (CDK)128-129 and the Unity fingerprint was calculated by Sybyl 8.0 
(www.tripos.com). Openbabel127 was used to generate the FP2 fingerprint, and Molprint 2D package was 
used to generate the Molprint 2D fingerprint. Variable selection was not carried out before model 
trainings, so all the dimensions of these molecular fingerprints were exposed to the learning algorithms. 
To ensure a fair amount of overlapping in Molprint 2D patterns, a three-layer atom environment was used 
for predicting ligand functionality for the human 5-HT1A receptor, while a two-layer atom environment 
was preferred for across-target predictions. Each feature defined by Molprint 2D was mapped to a unique 
bit in the descriptor vector by an in-house program.  
The implementation of the classification tree presented in this study came from a Tree package in “R” 
120, 130. To avoid overfitting, a tree node was not split unless more than ten training compounds were 
observed in the parent node and more than five were present in both child nodes.  Lastly, each 
classification tree was “pruned” according to ten-fold cross-validation scores. The implementation of 
Naive Bayes classifier on the Molprint 2D fingerprint was from the Molprint 2D software package.  An 
in-house Naive Bayes classifier was also developed for other fingerprints. The implementation of 
LiCABEDS is discussed in the following section (LiCABEDS Software Package). 
LiCABEDS models were initially developed using a large value of M (M = 10000), for all fingerprint 
types to ensure a convergence of training error. Furthermore, the influence of M was studied, and optimal 
values of M were determined by running cross-validation with 10% of training compounds as a cross-
validation set. LiCABEDS models were developed using balanced weights when compared to 
Classification Tree and Naive Bayes classifier on human 5-HT1A ligand datasets. Next, equal weights 
were compared to balanced weights as initialization conditions, which was conducted on the same 
training and testing datasets. Finally, the prediction accuracy was assessed with the “reject option” 
boundary ranging from 0 to 3.  
 
 
4.1.2.5  LiCABEDS Software Package A user-friendly interface was developed for 
LiCABEDS in order to simplify the steps involved in project management, model training and making 
predictions. The software integrates automated importing of training and testing datasets. The training 
module features automatic cross-validation, flexible initialization and interruptible model development. 
The “Reject option” is also implemented for making predictions. The graphical user interface allows for 
flexible model editing, prediction browsing, and result exporting. In addition, a work session can be saved 
to local hard disk, so that the previous workspace can be restored by the program. The program has been 
tested on Intel i7 860 2.8GHz CPU to evaluate the computational time. To iterate 10000 steps on 1697 
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compounds, model training takes 44 minutes for Molprint 2D fingerprint, 5 minutes for FP2 or Unity 
fingerprints, and 1 minute for MACCS fingerprint. The calculation time for model training is related to 
the amount of training samples, the number of boosting iterations and the dimension of descriptors. Once 
the model is established, the predictions can be made instantly by the program.  
4.1.3 Results and Discussion 
According to the distribution of physical properties listed in Table 4-1, simple classification hypotheses 
do not distinguish agonists from antagonists very well, if even at all. On the other hand, molecular 
fingerprints encode a large amount of chemical information regarding structural patterns of small 
molecules. The strength of the LiCABEDS method lies in its ability to robustly process this fingerprint 
information and make better predictions on the small molecules. I will discuss the performance of 
different fingerprints and computational models.  The effect of different parameters in LiCABEDS is also 
discussed in detail. 
4.1.3.1 Accuracy of LiCABEDS, Tree, and Naive Bayes Classifier  
 
Figure 4-2: The distribution of prediction accuracy from ten rounds of calculation  
X-axis is organized according to descriptor and prediction model. Y-axis is simply prediction 
accuracy. M: MACCS key fingerprint; U: Unity fingerprint; F: FP2 fingerprint; A: Molprint 2D 
fingerprint. Tree: Classification tree; NB: Naive Bayes classifier; boost: LiCABEDS. 
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Even if the predictions are made in the same descriptor space, the derived decision boundaries of 
different machine learning algorithms rarely agree, because of the discrepancy of underlying model 
assumptions, as well as object optimization functions.  The results of systematic comparisons among 
classification tree, Naive Bayes classifier and LiCABEDS are plotted in Figure 4-2 (M: MACCS key; U: 
Unity fingerprint; F: FP2 fingerprint; A: Molprint2D fingerprint. Tree stands for classification tree, NB 
stands for Naive Bayes classifier and boost is short for LiCABEDS.). A summary of the results can also 
be found in Table 4-2, which reports the distribution of prediction accuracy out of ten rounds of 
calculation on human 5-HT1A ligands. 
 
Table 4-2: Sample mean and standard deviation of prediction accuracy  
 
                                Model 
Fingerprint 
Tree Naive Bayes LiCABEDS 
MACCS 0.759 ± 0.026 0.685 ± 0.027 0.799 ± 0.016 
Unity 0.810 ± 0.023 0.753 ± 0.023 0.869 ± 0.013 
FP2 0.831 ± 0.018 0.771 ± 0.021 0.879 ± 0.010 
Molprint2D 0.820 ± 0.013 0.883 ± 0.013 0.901 ± 0.008 
The table lists the sample average and standard deviation of prediction accuracy out of 10 rounds of 
calculation. 
 
 
As shown in Figure 4-2 and Table 4-2, LiCABEDS uniformly outperforms both classification tree and 
Naive Bayes classifier regardless of the choice of molecular fingerprints. First, LiCABEDS exhibits the 
highest average prediction accuracy on ten different testing compound datasets. When Unity and FP2 
fingerprints are used as the descriptor, the highest number of mistakes made by LiCABEDS on testing 
sets is still lower than the lowest of the Tree or Naive Bayes classifier methods. With the Molprint 2D 
fingerprint as descriptor, the lowest accuracy from LiCABEDS is 0.894, which is almost the same as the 
highest accuracy from Naive Bayes classifier, 0.896. Not only does LiCABEDS show the highest average 
prediction accuracy, but also it possesses the lowest standard deviation on four kinds of fingerprints. This 
indicates model stability as well as model reliability.  This is further seen in the standard deviation of 
prediction accuracy from LiCABEDS.  As listed in Table 4-2, the standard deviation is 0.008 on the 
Molprint 2D fingerprint, while the standard deviation of both the Classification Tree and Naive Bayes 
classifier methods is 0.013.  A similar pattern is also observed using the other three types of molecular 
fingerprints.  The standard deviation from LiCABEDS ranges from 0.010 to 0.016 using the FP2, Unity 
and MACCS fingerprints.  On the other hand, the standard deviation of both the Tree and Naive Bayes 
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methods range from 0.018 to 0.027 using these three fingerprints.  Therefore, LiCABEDS is less affected 
by the distribution of training compounds compared to the Tree and Naive Bayes methods.  
Molprint 2D was the most predictive descriptor among the four types of fingerprints. In this study, a 
total of 6839 features were defined in the whole human 5-HT1A dataset. The length of the Unity and FP2 
fingerprints were 992 and 1024, respectively. The MACCS key had the shortest bit length of 168.  
Although Molprint 2D encoded many structural patterns in comparison to the Unity or FP2 fingerprints, it 
did not significantly improve the performance of the classification tree. As the “height” of tree was 
limited after “tree pruning” to avoid overfitting, a limited number of features could be considered in the 
classification hypothesis. The LiCABEDS method, on the other hand, consisted of 10000 weighted 
“decision stumps” and many factors contributed to the final prediction. This might explain the reason why 
LiCABEDS yielded more accurate and reliable predictions than the classification tree method. 
The Naive Bayes method outmatched the Tree method using Molprint 2D as a descriptor, but the Tree 
method outmatched the Naive Bayes method with other fingerprints. As previously mentioned in the 
method section, the Naive Bayes models were slightly different with different fingerprints. Molprint 2D, 
as an atom environment descriptor, only considered the features present, while FP2, MACCS and Unity 
predefined a set of substructures and modeled both the presence and absence of structural patterns. When 
the Naive Bayes classifier from Molprint 2D was applied to the other three fingerprints, the test 
calculation showed that the result was even worse. The Naive Bayes classifier treated each dimension in 
the fingerprint equally.  Thus, the performance could be affected by noise from irrelevant features. The 
independence assumption in the Naive Bayes model was not necessarily true for molecular fingerprints, 
which was one of the factors impairing the estimation of the likelihood function.  In addition, the training 
algorithm of LiCABEDS selected the most predictive “decision stump” and assigned its weight 
accordingly in order to build the classifier systematically. In that sense, not all the dimensions of the 
fingerprint vectors contributed to the prediction equally, and predictive features and corresponding 
“decision stumps” were emphasized with relatively large weights, am. Without much assumption 
regarding the fingerprints, LiCABEDS built robust models and produced more accurate predictions than 
the Naive Bayes classifier. 
4.1.3.2  Initialization Condition As previously mentioned in the Methods section, the equal 
initial weight in the training algorithm considers each training compound equally, while the balanced 
initial weight considers two compound categories (agonist and antagonist) equally. The two different 
initializations in LiCABEDS were compared on the same ten sets of training and testing compounds with 
M = 10000. Figure 4-3 shows the distribution of the overall accuracy of predictions from combinations of 
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different initialization conditions and molecular fingerprints. aefp stands for Molprint2D, b stands for 
balanced initial weight and e stands for equal initial weight.  Table 4-3 lists the average accuracy and 
standard deviation for each ligand category, as well as for the whole testing dataset. 
 
Figure 4-3: Prediction accuracy with different initialization conditions  
“aefp” represents Molprint 2D fingerprint. When letter “b” follows a fingerprint, it means the model is 
trained with balanced initialization condition. Otherwise, equal weight is specified as initialization 
condition 
 
Table 4-3: Initialization condition for LiCABEDS training  
  Agonist Antagonist Overall 
Molprint 2D Balanced weight 0.913 ± 0.018 0.879 ± 0.041 0.901 ± 0.008 
Equal weight 0.924 ± 0.018 0.856 ± 0.038 0.900 ± 0.009 
FP2 Balanced weight 0.888 ± 0.021 0.864 ± 0.026 0.879 ± 0.010 
Equal weight 0.901 ± 0.021 0.848 ± 0.029 0.882 ± 0.009 
Unity Balanced weight 0.891 ± 0.018 0.830 ± 0.023 0.869 ± 0.013 
Equal weight 0.901 ± 0.020 0.816 ± 0.022 0.871 ± 0.014 
MACCS Balanced weight 0.803 ± 0.025 0.792 ± 0.033 0.799 ± 0.016 
Equal weight 0.860 ± 0.018 0.702 ± 0.049 0.805 ± 0.020 
The sample mean and standard deviation of prediction accuracy for each category of ligands, using equal 
initial weight and balanced initial weight. 
 
 
According to Figure 4-3 and Table 4-3, these two initialization conditions result in differences with 
respect to the overall performance, even if equal initial weight is slightly better. As displayed in Table 
4-3, the balanced initial weight correctly predicts antagonists at a percentage of 87.9%, 86.4%, 83.0% and 
79.2% with Molprint 2D, FP2, Unity and MACCS descriptors, while the equal initial weight predicts 
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antagonists at the accuracy of 85.6%, 84.8%, 81.6% and 70.2% on the same descriptors. The opposite 
pattern is observed for agonist prediction, in which the equal initial weight uniformly outperforms the 
balanced initial weight. To explain this, LiCABEDS training algorithm with equal initial weight aims to 
minimize the error function by making fewer mistakes on the training datasets, while balanced weight 
emphasizes both ligand categories and each training sample.  For example, at the initial step of training 
algorithm with balanced weights, the cost to make a mistake is 1/1 −N for one antagonist and 1/1 +N for 
one agonist. As there are 827 agonists and 446 antagonists in the training datasets, LiCABEDS may tend 
to avoid making mistakes on antagonists because one mistake on an antagonist costs more than the one on 
an agonist ( 1/1 −N > 1/1 +N ). On the other hand, the equal initial weight favors the majority category, 
because the mistake on any training compound costs N/1 . Although the weights for each training 
sample are updated in the follow-up training iteration, the initialization condition still significantly affects 
the model development. As a result, the balanced initial weight makes the predictions that are more 
accurate on antagonists. In reality, training sets are sometimes overwhelmed by one category of samples, 
but correct predictions are still desired for the minority group. The balanced initial weight seeks a tradeoff 
between the accuracy for each category and the overall performance, which makes the algorithm 
generally applicable to many data mining situations.  
4.1.3.3 Training Parameter Besides the initialization condition, another parameter crucial to the 
LiCABEDS training algorithm is M, the number of boosting iterations. To minimize overfitting, the 
optimal value of M, Moptimal (Moptimal < 10000) can be determined through cross-validation.  In this process, 
a fraction of the training compounds (10% of the whole training sets) was left out as a cross-validation 
set. Moptimal was then compared to the default condition, a large value of M, M = 10000, on the same 
training and testing datasets. Models were developed using a balanced initial weight and the four types of 
fingerprints. The percentages of correct predictions on the ten testing datasets are shown in Figure 4-4. 
The x-axis denotes the choice of fingerprint and M. aefp stands for Molprint2D fingerprint. cv means that 
number of boosting rounds is set to Moptimal. The label without cv means M=10000 by default. 
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Figure 4-4: The boxplot showing the effect of number of boosting rounds  
 
 
According to the distribution shown in Figure 4-4, models developed by Moptimal iterations are moderately 
better than M = 10000 on FP2, Unity and MACCS fingerprints, but not as good as M = 10000 on 
Molprint 2D fingerprint. Because M = 10000 is much larger than the length of FP2, Unity and MACCS 
fingerprints, some dimensions in the fingerprint are overrepresented in the classifier. This may result in 
overfitting.  If this is the case, running cross-validation could control the overfitting and improve the 
performance. Nevertheless, the length of the Molprint 2D fingerprint used in this study is 6839, which is 
at the magnitude of M = 10000. Thus, cross-validation is not essential for the Molprint 2D fingerprint. 
Hypothesis testing was carried out to quantify the difference between Moptimal and M= 10000.  The 
distribution of correct predictions on the testing datasets was examined.  The null hypothesis was “the 
models trained with and without cross-validation have the same performance”, while the alternative 
hypothesis was “cross-validation improves the model performance”.  Student’s t-test showed that the one-
sided p-values for the four types of fingerprints (Molprint 2D, FP2, Unity and MACCS) were 0.954, 
0.357, 0.290 and 0.354, respectively.  This result does not significantly favor the alternative hypothesis, 
indicating cross-validation does not significantly influence on the prediction generated. The data mining 
studies and the results presented also indirectly support the conclusion that LiCABEDS is not so 
susceptible to overfitting in the studied datasets, which is also supported by boosting theory119. Although 
cross-validation is not strictly required by LiCABEDS, parameter tuning may still be beneficial under 
certain circumstances, such as the application of LiCABEDS on FP2, Unity and MACCS fingerprints. 
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4.1.3.4 Reject Option To assess the confidence-rated predictions, LiCABEDS uses the raw value of 
∑=
M
m
mmmm tixyaA ),,( to address the degree of belief for each prediction. By applying the concept of 
“reject option”, accurate prediction is anticipated, provided a high absolute value of A , whereas an 
“unknown” label is output to prevent uncertain prediction for a low absolute value of A . To validate this 
hypothesis, predictions were made on the ten testing compound datasets with different “reject” boundaries 
and molecular descriptors. The difference in the average performance of different “reject option” 
boundaries is reported in Figure 4-5. Each figure corresponds to a type of fingerprint. X-axis denotes the 
value of decision boundary. When Molprint 2D was used as the descriptor, an average accuracy of 90.1% 
(Table 4-2) was reported without using the “reject option”.  As shown in Figure 4-5A, the average 
proportion of predictions made on the testing datasets readily decreases when the “reject” boundary 
increases from 0.5 to 2. Because more “unknown” labels are output when a higher boundary value is 
specified, a relatively smaller fraction of predictions is made. In the meantime, the average prediction 
accuracy increases from the original value of 90.1% (reported in Table 4-2) to 91.1%, 92.1%, and 93.8% 
with corresponding boundaries being 0.5, 1 and 2, respectively.  A similar trend can be observed with the 
other three types of fingerprints as well.  For example, using the FP2 fingerprint, the predictions are made 
on 92.3% of the testing compounds when the boundary is set to 2.  An accuracy of 91.1% is obtained 
from the “reject option”, which is a noticeable improvement from the original accuracy of 87.9% 
(reported in Table 4-2). Therefore, LiCABEDS is not only able to attain better performance by making 
selective predictions, but is also able to estimate the classification risk for testing compounds through the 
absolute value of A , or the confidence-rated prediction. In practice, it is sometimes economical to 
sacrifice some testing compounds to achieve accurate predictions.  The boundary value can be determined 
by examining the distribution of A and leaving a fair prediction ratio.  
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A. Molprint 2D B.  FP2 
 
 
  
 
C. Unity D.  MACCS  
  
 
Figure 4-5: “Reject option” with LiCABEDS 
The plot shows average prediction accuracy and percentage of prediction by changing the prediction 
boundary. X-axis represents a value above which a prediction is made. 
4.1.3.5 Across-target Ligand Functionality Prediction In addition to the ligand functionality 
classification, I have explored the potential of across-target ligand bioactivity prediction using 
LiCABEDS program. With the assumption that agonists and antagonists might share some common 
pharmacological features for similar receptor subtypes, the LiCABEDS model, which was developed 
from human 5-HT1A  ligands on Molprint 2D fingerprint, was used to predict the ligand functionality for 
other human 5-HT subtype receptors, including 5-HT1B,  5-HT1D, and  5-HT4R receptors. 5-HT1A, 5-HT1B 
and 5-HT1D GPCRs can be classified as serotonin receptor subtype 1 (or 5-HT1) while 5-HT4R belongs to 
the family of serotonin subtype four. 5-HT1B receptor has the shortest evolution distance to 5-HT1A. On 
the other hand, 5-HT4R receptor has the largest evolution distance to 5-HT1A of all. As sufficient number 
of known agonists and antagonists has been reported for these receptors, the correlation between model 
predictability and target similarity can be studied in order to understand the scope of application of 
established models. 
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Table 4-4: Across-target ligand functionality prediction  
 
Receptor Accuracy for 
agonists 
Accuracy for 
antagonists 
Overall 
accuracy 
Blastp 
similarity 
scorea 
Sybyl 
similarity 
scoreb 
Human 5-HT1B 0.875 0.816 0.859 304 397.80 
Human 5-HT1D 0.812 0.609 0.745 279 393.60 
Human 5-HT4R 0.826 0.267 0.559 142 340.90 
a Blastp similarity score is calculated by blastp using default scoring parameters 
b Sybyl similarity score is calculated by Sybyl Biopolymer131 using “pmutation” scoring matrix. 
  
 
The performance of LiCABEDS models for each category of the 5-HT ligands, as well as entire datasets, 
can be seen in Table 4-4.  The sequence similarity scores compared to human 5-HT1A are calculated by 
blastp132 and Sybyl Biopolymer131, respectively. The calculations based on the 5-HT1A model show that 
85.9% of predictions are correct on 5-HT1B ligands, with 87.5% accuracy for agonists and 81.6% 
accuracy for antagonists, respectively.  The data is congruent with the relative high sequence similarity 
between 5-HT1B and 5-HT1A (blastp score:  304; Sybyl score: 397.80).  The studies show that the model 
trained from 5-HT1A ligands is still predictive for 5-HT1B ligands, but the overall accuracy for 5-HT1D 
ligands drops to 74.5%, which may be attributed to the lower sequence similarity between 5-HT1D and 5-
HT1A (blastp score:  279; Sybyl score: 393.60). 5-HT4R, which possesses the lowest sequence similarity to 
5-HT1A (blastp score:  142; Sybyl score: 340.90), was also evaluated, and its prediction is not necessarily 
better than a random guess.  The results are consistent with the known data that the drugs Ergotamine 
(agonist) and Methiothepin (antagonist) are active to 5-HT1A, 5-HT1B and 5-HT1D receptors but not to 5-
HT4R. The results may also suggest that LiCABEDS prediction models may have potential of applying to 
other targets with limited known ligands, as long as the models are developed for a closely related 
receptor family. This concept could extend the application of LiCABEDS to the drug discovery process 
targeting at orphan receptors that has no known ligand reported. 
4.1.3.6 Model Interpretation The interpretability of the LiCABEDS model may help us understand 
the underlying classification mechanism and significant features regarding ligand properties.  The model 
developed on the first set of 5-HT1A training compounds, which consist of randomly selected 827 agonists 
and 446 antagonists, is used to demonstrate this process.  As presented in the method section, each 
“decision stump” contributes to the final prediction according to its weight, ma , as described in equation 
(4-1). In the LiCABEDS model, four out of 6839 highly weighted Molprint 2D features, which are the 
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few highly weighted ones to distinguish agonists and antagonists, are listed in Table 4-5. Feature 1 and 2 
are favored by agonists, while feature 3 and 4 are preferred in antagonists.  In order to illustrate the 
structural patterns of these features, Figure 4-6 shows a graphical atom environment according to the four 
features. Each feature depicts a central atom and its atom environment up to a specific topological 
distance. The atom environment in Molprint2D is defined as the quantity of heavy atoms surrounding the 
central atom. Heavy atoms are distinguished by Sybyl atom types. For example, feature 1 (0;0-1-0;0-1-
4;1-3-0;2-3-0;) translates to a substructure of a central sp3 carbon atom (C.3) neighbored by one sp3 
carbon atom and one sp3 nitrogen atom (N.3),  and surrounded by three sp3 carbon atoms (C.3) located 
two or three bonds away. The Molprint2D features in Table 4-5 are generated by Molprint2D software 
package, and the detailed explanation can be found in original publication 77, 124. 
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Figure 4-6: Four sample Molprint 2D features in graphic representation  
 
 
 
Figure 4-7:  Compounds used to exemplify four features 
 
 Table 4-5: List of important Molprint features regarding ligand functionality 
 Bit Index Molprint 2D featurea Weight 
Feature 1 3474 0;0-1-0;0-1-4;1-3-0;2-3-0; 0.869 
Feature 2 808 8;0-1-1;1-1-2;1-1-27;2-2-0;2-2-2; 0.328 
Feature 3 362 8;0-1-1;1-1-0;1-1-27;2-3-0;2-1-2; 0.343 
Feature 4 4322 18;0-2-0;0-1-2;1-2-0;1-2-2;2-2-
2;2-2-4;2-1-7; 
0.639 
a Features listed in this table are extracted from Molprint 2D software package. The interpretation of the 
listed features is presented graphically in Figure 4-6. 
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Figure 4-7 lists seven compounds selected from the testing compound dataset in order to exemplify the 
four features. The first three compounds (L008638, L006280, L006274) are labeled as agonists, and the 
other four compounds (L022154, L018611, L001620, L018612) are labeled as antagonists. It is worth 
pointing out that thousands of features are involved agonist/antagonist prediction, but only four highly 
weighted Molprint 2D features are picked up to illustrate model interpretation. Molprint2D fingerprint 
(feature) is a highly sparse descriptor, and the number of features that a compound possesses is equal to 
the number of its heavy atoms. The agonists from the testing set, which possess both feature 1 and 2 
(listed in Table 4-5), are involved in Model Interpretation. The same analogy is applied to antagonists. 
Even if the agonists or antagonists do not share the same structural scaffold, certain substructures may 
still match in three-dimensional space. Figure 4-8 displays that feature 1, 2 from the three agonists are 
well aligned, with the central carbon atom from feature 1 labeled in grey and the central oxygen atom 
from feature 2 labeled in red. Similarly, Figure 4-9 displays the alignment of feature 3, 4 for the four 
antagonists. The result suggests that those features might be related to ligand functionality and ligand-
protein interaction. The interpretability of LiCABEDS models is rooted in the explanation of each 
“decision stump”, especially the highly weighted ones. Therefore, LiCABEDS models can be easily 
understood and interpreted, which could potentially guide chemical modification to achieve better 
pharmacological or physicochemical profile. 
 
Figure 4-8: 3-D alignment of three agonists 
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Figure 4-9: 3-D alignment of four antagonists 
4.1.3.7 Model Robustness Model robustness is the potential to handle diverse training data and 
provide consistent predictions. Section 3.1 has shown that LiCABEDS models render the most consistent 
and accurate predictions on any of the molecular fingerprints. To analyze the composition of the 
classifiers, important dimensions of Molprint 2D fingerprints are extracted from the LiCABEDS models, 
which are developed on ten different 5-HT1A training datasets. All the Molprint 2D features are observed 
totally more than 50 times in all the models and possess weights, ma , larger than 0.08. To visualize the 
major components of the classifiers, Figure 4-10shows the distribution of occurrence of six important 
Molprint 2D features that are favored in agonists, for which LiCABEDS training algorithm may select a 
feature several times to minimize generalization error. The occurrence of features mainly ranges from 4 to 
7, except dimension 2828. Even if the ten models are developed on the randomly selected training 
datasets, only three outliers (labeled as circles in Figure 4-10, two in dimension 1694, one in dimension 
2828) are identified in the boxplot. Thus, the occurrence of the six major components has moderate 
variance in each of the ten models. The stability of the influential “weak-learners” leads to consistent 
prediction accuracy, although only a few features are visualized.  
 
Figure 4-10: The occurrence of the six major LiCABEDS components in ten 5-HT1A models 
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4.1.4 Conclusion 
This chapter reports a novel ligand classification algorithm, Ligand Classifier of Adaptively Boosting 
Ensemble Decision Stumps (LiCABEDS), and thoroughly investigated it through the case studies of 
ligand functionality prediction for the GPCR 5-HT subtypes. The performance of LiCABEDS is 
compared to the Classification Tree model and Naive Bayes classifier using four types of molecular 
fingerprints:  Molprint 2D, FP2, Unity and MACCS. The results show that LiCABEDS uniformly 
produces the most accurate and consistent predictions, especially with Molprint 2D fingerprints as the 
descriptor.  Additionally, unique characteristics of LiCABEDS make it applicable to model various ligand 
properties.  The flexible initialization conditions of LiCABEDS allow the development of predictive 
models and emphasize minority categories on unbalanced training datasets. Parameterization is usually a 
complicated procedure in many machine-learning algorithms, however, model development in 
LiCABEDS is simplified because the number of boosting iterations, M, is the only parameter required for 
model training.  The result from cross-validation suggests that a large value of M still yields satisfactory 
performance, which makes the model training process simplified in practice.  Another valuable 
characteristic of LiCABEDS is the “reject option”, which returns the degree of confidence for each 
prediction.  Higher prediction accuracy can be achieved by rejecting some “low-confident” testing 
samples. The capability of LiCABEDS is further demonstrated through the application on a cross-target 
prediction.  The interpretation of LiCABEDS models may reveal the correlation between structural 
pattern and molecular properties of interest. The robustness of LiCABEDS models is further 
demonstrated by examining the principal components of “decision stumps”. Lastly, LiCABEDS has been 
implemented into an easy-to-use and freely available (http://www.CBLigand.org/LiCABEDS/) software 
platform that provides a graphical user interface for automating model development and predictions. As a 
general classifier, LiCABEDS may also have great potential for modeling and predicting other ligand 
properties, such as ADME prediction and other applications on in-silico drug design research. These are 
ongoing projects and will be reported in future studies. 
4.2 SOFTWARE MANUAL FOR LICABEDS 
LiCABEDS is implemented as highly automated software to simply the whole modeling process. 
Computer program, Fingerprint-based Compound Classifier (FCC), integrates data import/export, project 
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management, model training, and model testing into an integrated pipeline. Currently, LiCABEDS is the 
major machine learning algorithm in this platform. This section introduces the functions of FCC program 
and provides a walk-through project. The program and sample tutorial files are available 
at www.cbligand.org/LiCABEDS.  
FCC is developed as “green” software for Microsoft Windows system, which means that software 
installation is not strictly required. To launch the program, locate the executable file and double click the 
“FCC.exe” icon.  
 
The interface of the program is displayed in the figure below. Similar to most Windows programs, 
FCC has a title bar, showing the title of current project and “minimize, maximize, close” buttons. A menu 
bar and a tool bar are displayed below the title bar. The tool bar provides shortcuts to some frequently 
used functions, such as new project, copy-and-paste function, model training, etc. Besides toolbar, all the 
program functions are listed in the menu. A main window is designed for information exchanging. In the 
screenshot, the main window displays a welcome page, project status and brief introduction to each 
module. Underneath the welcome page is a message board, displaying system message and project 
parameters.  
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In FCC, a ligand classification project mainly consists of four steps: 
• Define a project in “Project Profile”: name the project title and specify ligand categories of 
interest. 
• Load Fingerprints: import training and testing compound datasets in predefined fingerprint 
format. 
• Setup Training: develop a LiCABEDS model.  
• Make Predictions: use the developed model to make predictions on testing compound dataset. 
 
The homepage also shows the progress of current project by putting different colors on each tag. A 
module tag will turn green after the corresponding step is completed. A red tag indicates that this step 
remains unexplored, whereas a yellow tag indicates this step is partially finished. 
The toolbar lists frequently accessed functions: 
File functions:   
• New project: current project profile and data are restored to default settings. All the changes made 
to the project are discarded. A warning message will be displayed to remind saving your work if 
any modification is detected. 
• Open project: a previous saved workspace will be restored. All the changes made to the current 
project are discarded. 
• Save project: a work session will be saved to a FCC file on hard drive. The project will resume 
next time by opening the FCC workspace file. 
 
Editing Functions:  
• Cut: delete selected items and deposit the content into system clipboard. The button turns grey if 
the action is not applicable. 
• Copy: Deposit the selected items into system clipboard. The button turns grey if the action is not 
applicable. 
• If a compatible format is available in the clipboard, the contents will be pasted to the current 
project. This function only works in prediction window.  
 
Project Functions:  
• Start a new model training process or continue with previous model training 
• Stop undergoing model training. 
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• Make predictions using developed predictive model 
• Go to home page 
• Go to training window for model browsing 
• Go to prediction window to view prediction results. 
 
Step One: Define a Project 
 A new project starts with defining its aim and two compound categories. Click “Project Profile” tag 
at home page or go to “Edit Project Title” in “Edit” menu to define a project. A dialog box will pop up 
and its interface is displayed below: 
 
In “Project Title”, input a name to distinguish the current project from others. The title name will 
become the default file name to save the workspace (to be discussed later). The project title is also 
displayed in the “Message Board”, so users can easily identify the aim and content in this project. Next, 
specify two classification categories. For convenience, the categories could be the properties to be 
modeled, e.g. agonist and antagonist in the screenshot. The program will automatically output the 
predicted category for each testing compound after predictions are made. Click “OK” button to finish 
project definition. Users can always repeat the same procedure to change the settings. User may start a 
new project by clicking  button on the toolbar or go to menu “File->New Project…”. 
Step Two: Load Fingerprints 
The imbedded classification algorithm in FCC is called Ligand Classifier of Adaptively Boosting 
Ensemble Decision Stumps (LiCABEDS). The theory and performance of LiCABEDS have been 
discussed previously. Like many other supervised learning algorithms, LiCABEDS also relies on training 
data to derive predictive models. 
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The screenshot above shows the interface that imports training and testing datasets. In FCC, 
compounds are represented in molecular fingerprints instead of structure information. Molecular 
fingerprints define the hypothesis space, within which possible decision stumps in LiCABEDS can be 
generated. Sample fingerprints are given below: 
 
In this format, each line corresponds to a compound. The first field of every row is the index of 
training or testing compounds. It is then followed by fingerprints in 0/1 binary format. Data fields are 
separated by single space. To import compound datasets, select a category which the dataset will be 
imported to (e.g. agonist in the picture). Then click “…” button to locate a fingerprint file. Compound 
datasets can be additively imported to the same category several times. Users still have the option to 
check “Clean Existing Compounds in The Selected Dataset”.  Once this option is checked, existing data 
in the selected category will be overwritten by new fingerprint contents. Both categories of training 
compounds have to be loaded before model training starts. Testing compound dataset could also be 
loaded at the same time. Note that the fingerprint data needs to comply with the fingerprint specification 
mentioned above. Sample training and testing datasets are available for downloading. Refer to the simple 
walk-through project below for more technical details. Message Board always displays the updated status 
of the project after data is successfully imported: 
 
Step Three: Setup Training 
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Once both categories of training compound datasets are imported, automatic datamining can be 
carried out to derive a predictive LiCABEDS model. This procedure is called model training or model 
development. In model training, FCC will examine the distinct patterns between two categories of 
compounds and build classifiers accordingly.  
To setup training, click  on the toolbar, or go to “welcome page” and click “Setup Training”. 
Then, a dialog will pop up to collect a few parameters: 
 
The most important parameter in LiCABEDS training is the number of iteration, which is equal to M 
mentioned previously. Users have the option to carry out cross-validation to search for its optimal value. 
In this case, check “Training with Cross Validation” and select the percentage of training datasets to be 
used as cross-validation set. Users can also choose initialization condition: equal initial weight or 
balanced class weight. If equal initial weight is chosen, then all the training compounds are treated 
equally. Nevertheless, this initialization condition may not be suitable for many ligand classification 
tasks, e.g. virtual screening. In virtual screening, thousands of compounds are labeled as inactive but only 
a few are reported as active. The program can simply treat all the compounds as inactive to achieve nearly 
100% accuracy. To solve this problem, balanced class weight assigns equal weight to each category 
instead of treating each training sample equally. Balanced class weight is encouraged if unbalanced 
training datasets are provided. Interruptible training is another competitive feature of LiCABEDS. Users 
can always continue with the previous training by checking “Continue the previous training” checkbox.  
In this case, training error will be minimized based on the established model by adding more weighted 
decision stumps. For example, a model is developed using M = 1000, but the model performance is not 
satisfactory on the cross-validation set or testing dataset. Users can simply continue the previous training 
by setting M = 1000 again. Then, the final model will contain totally 2000 decision stumps. This feature 
allows reusing the developed model to generate a new classifier instead of start-over from the beginning.  
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After clicking “OK” button, model training will start automatically and a real-time error curve will be 
displayed in the main window. 
 
The screening shot displays undergoing model training. Certain functions are disabled during model 
training. To activate disabled functions, click  button to interrupt the calculation. The vertical grids 
indicate the number of decision stumps, and the horizontal grids indicate training error or cross-validation 
error (measured by error ratio). As time passes by, the training error curve moves towards right-hand side 
until M steps are finished. The legends in the upper-left corner explain the meaning of each curve. For 
example, the blue curve in this figure shows training error whereas the brown curve shows cross-
validation error. In general, training error is minimized in a stepwise manner. As m (the number of 
finished iterations, m<M) increases, training error usually decreases. Conversely, cross-validation error 
may not necessarily follow the same trend. The cross-validation (CV) error may forms a “U” or an “L” 
shape as a function of m. LiCABEDS also has the risk of overfitting like most supervised learning 
algorithms. Therefore, the CV error may reduce at the beginning when the training error is minimized, 
and then increase due to overfitting, which forms a “U” shape error curve. Running cross-validation is a 
choice to pick up an optimal value of M.  
 The program has a default style for displaying training curves. Other styles can be specified as well. 
Click right mouse button in the main window to show a pop-up menu:    
 
Select “Display Option..”: 
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First, choose line width of either training error curve or cross-validation error curve in the unit of 
pixels. Then, users can specify line color and style, such as dotted line and dashed line. The grid section 
controls the number of vertical and horizontal grids. Un-checking “Show Grids” box will disable any 
assistant grids in the main window. Finally, set the zoom ratio through “Vertical Ratio” and “Horizontal 
Ratio” drop-boxes. After clicking “OK”, the setting will become the default display format for all FCC 
program sessions.   
To keep track of coordinate information, check “Show Coordinates” from the popup menu (click right 
mouse button). Next, move the cursor in the window, FCC will automatically track selected “weak 
learner” or decision stump, which is illustrated in the screenshot below: 
 
The selected “weak learner” is shown in the status bar: 
. 
In this example, the cursor is pointing to the 77th “weak learner” (Num: 77 in zero-based index). 
When m = 78, the training error is 0.113, which means the LiCABEDS model can classify 88.7% of 
training samples correctly. As cross-validation is enabled, cross-validation (CV) error is also reported at 
the same time. In this case, the CV error is 0.167. The last part of the text string, “000675 0 -> 1” depicts 
the 77th decision stump in the LiCABEDS model. This decision stump states that if the 675th bit (zero-
based index) of fingerprint is 0, this compound is classified as positive (positive or negative class is 
defined in project profile). 
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FCC also supports selection of range “weak learners” by “dragging” the mouse with left button down. 
The color of selected decision stumps is inverted, and the summary will be given in the Message Board. 
All of these features help users to interpret the model and search for the optimal parameters. 
 
Tip: FCC can calculate the best display ratio to fit the training curve in the window. Go to View menu 
and select “Fit to Window Size”. If the size of the 2D-plot is larger than the display window, scroll 
bars will automatically show up. Shortcut keys are listed to scroll vertically or horizontally and zoom 
in/out: 
Roll the mouse wheel to scroll horizontally 
Roll the mouse wheel with “Shift” key down to scroll vertically 
Vertical Zoom-in:  Ctrl + Z 
Vertical Zoom-out: Alt + Z 
Horizontal Zoom-in:  Ctrl + H 
Horizontal Zoom-out: Alt + H 
Selected “weak learners” can be copied and pasted into any text-editing software, e.g. Wordpad. 
Select part of the model, click  button, and paste the content into a text editor: 
  
id field indicates the zero-based index of decision stumps. 
bit field tells the hypothesis in the corresponding decision stump, e.g. the 158th decision stump means 
if 626th bit is equal to 1, then the compound is classified as positive.  
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weight is equal to am in LiCABEDS model, which tells the contribution to final prediction. 
These fields are followed by T error (training error) and CV error (cross-validation error if enabled). 
LiCABEDS error curve can be output to any installed physical or virtual Windows printer, like PDF 
printer. FCC supports what-you-see-what-you-get printing preview. Click “File -> Print Preview” and the 
printing preview will be shown in the program window: 
 
The figure can be sent to a specific printer through a uniform printing dialog for archive or 
publication. 
Step Four: Make Predictions 
Once a predictive LiCABEDS model is developed and testing compound dataset is loaded, 
categorical labels can be predicted for the testing compounds. Click  button on the toolbar, a 
prediction dialog will popup: 
 
It is optional to use part of the decision stumps to make predictions, even if model is trained using a 
large value of M. For example, a LiCABEDS model is trained with 10000 iterations, only the first 1000 
decision stumps may be used for predictions. If “Use All the Weak Classifiers” is checked, the 
corresponding edit box turns grey and the whole LiCABEDS model is used for prediction. Otherwise, 
users can input arbitrary number, as long as it is smaller than M. The other parameter in the dialog is the 
boundary of reject option. LiCABEDS can not only output the categorical value for each testing sample, 
but also output the degree of confidence for each prediction. The rationale and benefit have been 
discussed in previous chapter. If prediction confidence is below the boundary value, LiCABEDS will 
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output an “unknown” label instead of making a risky prediction. A typical view of the prediction window 
is displayed below:  
 
At the same time, a prediction summary is also given in the Message Board. The toolbar at the top of 
the prediction page allows user to browse through the predictions and change display layout. Click the 
button  to expand this toolbar: 
 
 “<<” : go to the first page; “<”: go to the previous page; “>” go to the next page; “>>” go to the last 
page. These buttons are followed by page number. It is allowed to change the number of rows and 
columns displayed in each page. When the program starts, the number of rows and columns are specified 
automatically to fit content in one page.  
In the prediction window, four data fields are displayed for each testing compound: compound ID, 
compound name, predicted categorical value and raw output value from LiCABEDS model. By default, 
all the testing compounds are ranked according to their indices in the testing dataset. They can also be 
sorted according to other fields. Move the mouse cursor to the first row of the table. The shape of the 
mouse cursor will be automatically changed to up-arrow or down-arrow. Click left mouse button to sort 
all the testing compounds according to the pointed data field.  
Click left mouse button to select a testing compound entry or multiple entries with “Ctrl” key down. 
Users can open a popup menu by clicking right mouse button to select all the data (Ctrl + A) or inverse 
the selection. The “Cut” function deletes selected testing data and put them into clipboard (Note: the data 
in the clipboard will be overwritten if another copy or cut request is made). 
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The selected data entries can be copied to clipboard and pasted to text editing software or a session of 
FCC program. The content copied to text editor still includes compound id, name, predicted category and 
raw prediction value (screenshot is shown below) 
 
The data saved in the clipboard can be also pasted to the same session of FCC or another session of 
FCC program. Nevertheless, different sessions of FCC may hold different predictive LiCABEDS models, 
so the copied predicted category value is not necessarily consistent with the existing model. Predictions 
have to be made for the pasted data entries; otherwise, “unknown” labels will be assigned. 
A “Find” dialog is provided to facilitate text searching. The dialog consists of text search box and 
page/line locating box. 
 
In the “Find what” textbox, input the exact or partial string of a compound name. Then click “Find 
Previous” or “Find Next” to carry out forward or backward searching. If no item is selected, the searching 
will start from the first entry in the table. Message board will report whether a matched compound name 
is found. The retrieved item will be automatically selected and labeled by red rectangle. It may be a good 
idea to jump directly to a certain page or line instead of clicking “>” button many times, especially when 
large amount of testing data is imported into the program. Check “Page” or “Line” option button and 
input a page or line number. After clicking “OK” button, the desired page or data entry will be displayed 
if available. 
Similar to the printing function in model training module, the prediction results can also be sent to a 
virtual or physical printer. Once paper size is set, the program formats the layout and outputs the 
predictions line by line. Printing preview function is not implemented for this purpose. The snapshot 
shows part of the PDF printout. 
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Save Your Workspace and Export Your Results 
A work session can be serialized and saved into a file, so that the project can be reloaded by another 
program instance. The saved workspace contains project profile, training and testing compound datasets, 
developed model and predictions. Before exiting the program, a dialog box will popup to remind saving 
the workspace if any changes has been made to the project. To save the project, click  button on the 
toolbar. If the project is not associated with a workspace file, a file name is needed to save the project. 
Otherwise, the project will automatically overwrite the associated file. To provide an alternative file 
name, go to “File” menu and select “Save Workspace As”. 
The project workspace file has a default “FCC” extension. To restore a previous workspace, open 
another FCC program and drag a FCC workspace file into the main window. Another way to open a FCC 
workspace file is to click  button and select a saved workspace file with extension .FCC. FCC 
automatically records the most recent workspace files and provides shortcuts for opening those files in the 
“File” menu.  
 
FCC workspace format is in binary format that can only be understood by the FCC program. 
Meanwhile, an “export” function is implemented to enable exporting legible text results, such as 
predictive models and LiCABEDS predictions. To get access to this function, go to “Edit menu” and 
select “Export”.  
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Specify an output file name by clicking “…” button and select to output either predictive model or 
predictions. The exported model is in pure text format: 
 
Each row includes the index of a weak classifier, its hypothesis and its contribution weight to the final 
prediction (All the indices are zero-based). For example, the first weak classifier is “if the 722nd bit of 
fingerprint is equal to 0, the compound is classified as positive, which has weight 0.866193”. The final 
prediction is the weighted summation of the outcome of each weak learner. If the summation is larger 
than 0, then output is positive categorical value, otherwise, negative categorical value. Use the exported 
result to interpret the model and extract key features. The exported predictions are similar to the clipboard 
text format that is mentioned in the previous section: 
 
Molprint2D Fingerprint Generation 
Molprint2D fingerprint characterizes a two-dimensional compound structure by a set of atom 
environment defined by Sybyl atom types. Reference regarding Molprint2D fingerprint is available 
at http://cheminformatics.org/molprint_download/. In our test calculation, Molprint2D outperforms FP2, 
Unity and MACCS fingerprint. Thus, a short tutorial is given on how to generate Molprint2D fingerprints 
and import the descriptors into an FCC project.  
First step, convert your compound structure file to mol2 format using Openbabel or other 
cheminformatics toolkit. Molprint2D prefers chemical structures with implicit hydrogen atoms. A FCC 
project requires three separate files: positive-category training data, negative-category training data and 
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testing data (if available). Molprint2D software package is developed for Linux platform. Install the 
software on a Linux computer and use the following command to generate raw Molprint2D fingerprint: 
mol22aefp input output 
Input is your mol2 structure file and output is a file name to save the raw fingerprints. Generate the 
fingerprints for all the datasets. 
 The raw Molprint2D fingerprint is in the following format: 
L000007 4;0-3-0;1-4-0;2-4-0;2-1-2; 10;0-1-2;0-1-10;1-1-0;1-2-2;2-2-0;2-2-2; 10;0-1-2;0-1-
10;1-2-2;2-2-0;2-2-2;………  
Each of the Molprint2D feature will be mapped to a unique index that indicates the presence or 
absence of the feature in a compound. To achieve this, a mapping list should be created. Molprint2D 
package provides a command “build.pl” to generate a histogram of all the features. In this case, merge all 
of your structure data files into a single mol2 file and generate raw Molprint2D fingerprints of the merged 
structure file. Then, use the following command 
build.pl input his-file –l min max 
“input” is raw fingerprint file of the merged dataset. His-file is output histogram file. The last 
parameter “-l min max” means how many layers of neighboring atoms are considered in atom 
environment. It is usually set to “–l 0 2” for “–l 0 3”. Finally, variable selection can be carried out by 
modifying the output histogram file or deleting noisy features. Note that only features present in the 
histogram will be mapped to a dense-format descriptor. A feature will be discarded if it does not exist in 
the list. 
 
Download Molprint2D converter from the LiCABEDS website. The screenshot of the program is 
displayed above. A string-matching algorithm is implemented in the converter using hash table. It only 
takes a few seconds to process a megabyte data file. The converter requires five parameters, including two 
input files, two output files and one fingerprint parameter. First, locate histogram file by clicking adjacent 
“…” button and find the histogram file that is generated from “build.pl” command. In the command 
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“build.pl”, users have an option to specify the number of layers that are considered in atom environment, 
such as “-l 0 2”. “-l 0 2” means the atom environment contains neighboring atoms up to two bonds away 
(more details can be found from official Molprint2D website). Choose the number of layers from the drop 
box. This value has to be consistent with the number of layers in the histogram file. For example, if no “-
l” argument follows the “build.pl”, the default maximum layer is 2. If a “-l min max” argument is 
specified in the command, then the number of layers in the Molprint2D converter should be equal to 
“max”. The histogram file serves as a mapping table. Next, in the “Molprint Fingerprint File” edit box, 
locate the raw Molprint2D fingerprint file that will be converted into binary vector format. Finally, 
specify “log” file name and binary fingerprint file name for output. Press “Convert” button to start data 
processing. Sample data files are available online: 
Histogram.his:  a preprocessed histogram file for the converter 
Sample Molprint2D.fp: a raw Molprint2D fingerprint file 
The output binary fingerprint and corresponding log file are given below: 
 
The “log” file illustrating mapping mechanism: 
 
Note: only part of the result is displayed. 
The output binary fingerprint complies with the requirement of FCC program, so it can be imported to 
the program without any modification. Log files reveal the interpretation of fingerprint vector. For 
example, feature “2;0-2-2;0-1-10;1-4-2;2-4-2;2-1-9;” is mapped to the second bit in the fingerprint vector. In 
other words, if the second bit of the fingerprint is 1, it indicates the presence of this feature in a 
compound; otherwise, this feature is absent. Therefore, users can interpret a predictive model and results 
according to the mapping schema. 
Simple Walk-through Project 
Sample training and testing datasets can be downloaded together with the program, FCC. The goal of 
the walk-through project is to model ligand functionality for 5-HT1A G-protein coupled receptor (GPCR). 
Ligands are classified into two categories: agonists that active the receptor and antagonists that inhibit or 
deactivate the receptor. In this experiment, a LiCABEDS model will be developed based on labeled 
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agonists and antagonists. Then, the model will be used to make predictions on the testing compound 
datasets. The model performance is evaluated by comparing predicted categorical values with the real 
labels. Molecular fingerprints have already been generated for all the compounds so that the datasets can 
be directly imported into FCC program. Here is a list of training and testing data files: 
daylight_agonist_train.fp 
daylight_antagonist_train.fp 
The training agonist and antagonist datasets. These two datasets are used to develop a 
predictive model. 
daylight_agonist_test.fp 
daylight_antagonist_test.fp 
The testing agonist and antagonist datasets. These two datasets are used to evaluate the 
performance of a developed LiCABEDS model. All the compounds in  “daylight_agonist_test.fp” 
are labeled as agonists. Ideally, the program should output “agonist” for all the testing samples in 
this dataset. Similarly, all the testing samples in “daylight_antagonist_test.fp” are known to be 
antagonist.  
Protocols: 
a) Launch the “FCC.exe” 
b) Click “Project Profile” and input the content as shown below: 
 
Click “OK” button. 
c) Click “Load Fingerprints”. Select “Agonist” option and locate file “daylight_agonist_train.fp” 
(click “…” button for browsing).   
d) Select “Antagonist” option and locate file “daylight_antagonist_train.fp” 
e) The Message Board should display the following information
 
f) Click “Setup Training” and input parameters: 
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g) Click “OK” and training will start automatically. This process may take a few minutes.  
h) The training error is minimized in a stepwise manner. The screenshot of the error curve is given 
below: 
  
i) Load the testing dataset. Go to “File menu” and click “Load Fingerprints…”. Select “testing 
dataset” and locate file “daylight_agonist_test.fp”. Click “OK”. 
j) The main window will automatically display the home page. Click “Make Prediction”. Take 
default parameters and click “OK”. 
k) The predictions are listed in the main window, and a summary is given in the Message Board. 
The programs identified 258 compounds as agonists and 17 as antagonists. As we know, all the 
compounds were labeled as agonists. Therefore, the program made 17 mistakes out of 275 
samples. 
 
l) Load the other testing dataset. Go to “File menu” and click “Load Fingerprints…”. Select “testing 
dataset” and check “Clean Existing Compounds in the Selected Dataset”. This is an important set 
to clean up the data imported before. Locate file “daylight_antagonist_test.fp”. Click “OK”. 
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m) Click “Make Predictions” and the result is summarized in the Message Board:
 
n)  As all the testing compounds are labeled as antagonists, 28 mistakes were made by the program. 
The overall prediction accuracy is about 89% (45 mistakes out of 424 testing samples). Finally, press 
“Ctrl + S” to save your work session. The workspace will be restored to the previous status by loading the 
work session file. 
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4.3 LICABEDS AND MODELING LIGAND SELECTIVITY 
 
 
 
 
 
The cannabinoid receptor subtype 2 (CB2) is a promising therapeutic target for blood cancer, pain relief, 
osteoporosis, and immune system disease. The recent withdrawal of Rimonabant, which targets at another 
closely related cannabinoid receptor (CB1), accentuates the importance of selectivity for the development 
of CB2 ligands in order to minimize their effects on CB1 receptor. In the previous study, LiCABEDS 
(Li
4.3.1 Introduction 
gand Classifier of Adaptively Boosting Ensemble Decision Stumps) was reported as a generic ligand 
classification algorithm for the prediction of categorical molecular properties. Here, I attempted to extend 
the application of LiCABEDS to modeling cannabinoid ligand selectivity with molecular fingerprints as 
descriptors. The performance of LiCABEDS was systematically compared with another popular 
classification algorithm, support vector machine (SVM), according to prediction precision and recall rate. 
In addition, the examination of LiCABEDS models revealed the difference in structure diversity of CB1 
and CB2 selective ligands. The structure insight from data mining could be useful for the design of novel 
cannabinoid lead compounds. More importantly, the potential of LiCABEDS was demonstrated through 
successful identification of a newly synthesized CB2 selective compound.  
 
The selectivity to specific drug targets has been a crucial pharmacological property of drug candidates105. 
Since the advent of chemical genetics and chemical genomics 133-134, more attention has been paid to 
ligand selectivity for studying biological systems and exploring mechanism of action.  
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The endocannabinoid system is assumed to regulate psychological process, and is directly related to 
human mental and physical health. The first cannabinoid receptor was discovered in 1988 135, later named 
as CB1 receptor. And a second cannabinoid receptor, CB2 receptor, was identified in human peripheral 
organs in 1993136. These two receptors share high sequence similarity, especially in transmembrane 
portions. Thus, selective cannabinoid ligands are desired to ensure minimal effect on the other receptor. 
Recent studies show that cannabinoid CB2 receptor may serve as potential targets for many diseases, 
including neurodegenerative disorders137, blood cancer138 and osteoporosis139. On the other hand, a 
famous drug, rimonabant that targets cannabinoid CB1 receptor to treat obesity, was withdrawn from the 
market due to its side psychotropic effects140.  In spite of the therapeutic potential of CB2 receptor, the 
suspension of rimonabant reemphasizes the importance of selectivity regarding the design of CB2 
agonists and antagonists.  
Felder et al reported the first CB2 selective ligand, WIN-55,212-2, that showed 19 fold higher 
binding affinity for CB2 than for CB1141. Since then, the discovery of novel CB2 selective ligands has 
become the endeavor of many scientists, including medicinal chemist J.W. Huffman 142. Nowadays, 
computer-aided drug design has been integrated into the pipeline of drug discovery process to accelerate 
traditional experimental screening, which requires significant efforts. Thus, the search for CB2 selective 
ligands is undoubtedly one of its application domains. For example, Ashton et al applied homology 
modeling and molecular docking to develop CB2 specific ligands143. Besides structure-based drug design, 
machine learning and pattern recognition are gaining popularity for virtual screening and the prediction of 
various molecular properties. In the context of selectivity profiling, Wassermann et al presented the 
prediction of ligand selectivity using support vector machine ranking strategies105.  
Li 144gand Classifier of Adaptively Boosting Ensemble Decision Stumps (LiCABEDS)  is a generic 
ligand classification algorithm for the prediction of categorical ligand properties. LiCABEDS is 
established on Freund and Schapire’s ensemble learning framework118. The underlying theory and its 
application on modeling ligand functionality have been outlined before. In this study, the performance 
and applicability of LiCABEDS for the prediction of cannabinoid ligand selectivity are explored. 
LiCABEDS was compared with famous supervised learning algorithm, support vector machine (SVM), in 
order to evaluate their performance in recovering true selective ligands. Performance measures were 
given by precision, recall rate, the geometric mean of both, and ROC curve with area-under-curve (AUC). 
An ideal classifier would recover all selective ligands from a screening library (100% recall rate), and 
have no false positive error (100% precision). In addition, the investigation of LiCABEDS models 
brought certain insight into structure diversity of CB1 selective and CB2 selective ligands. Supported by 
scaffold and fragment analysis, it was hypothesized that CB2 selective ligands tended to be more 
structurally diverse than CB1 selective compounds among discovered cannabinoid ligands. More 
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interestingly, LiCABEDS model successfully identified a true CB2 selective ligand from newly 
synthesized compounds. The following sections report datasets involved in model training and validation, 
comprehensive computation protocol of LiCABEDS and SVM, and results of systematic calculations.  
4.3.2 Methods, Materials and Calculation 
To demonstrate the performance and robustness of machine learning algorithms in the prediction of 
cannabinoid ligand selectivity, 703 chemical structures and their bioactivity (Ki value) to CB1 and CB2 
receptors were retrieved from public cannabinoid ligand database (www.cbligand.org). A selective ligand 
is usually defined descriptively as its differing binding affinity to form ligand-protein complex with 
different receptors. In this study, a ligand was regarded as CB1selective (or CB2 selective) as long as its 
ratio of CB1 Ki to CB2 Ki (CB2 Ki to CB1 Ki) was less than 0.1. In other words, a ligand possessed 
selectivity of cannabinoid receptor subtypes if it exhibited more than 10-fold Ki difference. The 
rationality of this criterion was supported by an expert in selective cannabinoid ligand discovery, J.W. 
Huffman 142, who commented that O,2-propano-∆8-THC analogues 145 exhibited modest CB2 selectivity. 
The CB1/CB2 Ki ratio of these analogues, reported by Reggio et al, ranged from 2.8 to 4.5. Following 10-
fold Ki threshold, 149 compounds were identified as CB1 selective; 147 compounds were identified as 
CB2 selective; the remaining compounds were treated as non-selective. The goal of the study was to 
distinguish CB1 selective compounds from the CB1 non-selective (including CB2 selective and non-
selective), and CB2 selective compounds from the CB2 non-selective (including CB1 selective and non-
selective). 
4.3.2.1 LiCABEDS The performance, robustness, interpretability and parameters of LiCABEDS were 
thoroughly discussed through modeling 5-HT1A ligand functionality144. Here, LiCABEDS is extended to 
model cannabinoid ligand selectivity. Briefly, the prediction in LiCABEDS is determined by weighted 
summation of a set of “weak” classifiers, i.e. decision sumps. Each decision stump outputs a predicted 
categorical label according to weather the testing sample possesses a specific compound fragment or 
structure pattern.  
Figure 4-11 visualizes the underlying mechanism of LiCABEDS prediction model. Each decision stump 
outputs a categorical value (+1 or -1) that represents selectivity label by examining the presence of a 
predefined structural pattern. The final prediction is the summation of the predictions of individual 
decision stumps weighted by constant ai. Even though the performance of each individual decision stump 
88 
 
is not necessarily much better than a random guess, ensemble learning theory shows that strong classifiers 
can be obtained by boosting these weak learners. 
 
 
 
 
Figure 4-11: Graphical illustration of the constitution of a LiCABEDS classifier  
4.3.2.2  Support Vector Machine Support Vector Machine (SVM) shares certain similarity 
with adaptive boosting regarding margin maximization. Both algorithms have native margin-
maximization mechanism to control overfitting except that margins in these two algorithms are expressed 
in different norms. The binary classification in standard SVM setting is formulated by function ƒw,b(x) = 
sign(wTx + b). w is the normal vector to the decision hyperplane. The motivation of support vector 
machine lies in that the optimal decision surface has the largest distance to the nearest data points of both 
categories, i.e. margin maximization, and still classifies training samples correctly by satisfying yi (wTxi + 
b) ≥ 1 ∀i where yi is label of training data. Given the same training data sets {xi, yi}, i = 1 to n, the margin 
optimization problem can be transformed into constraint optimization: 
Minimize w,b ‖𝐰‖2 
Subject to yi (wTxi + b) ≥ 1 ∀i, i = 1, …, n 
Among all the constraints, the training samples that are relevant to the determination of margin are called 
“support vectors”. Nevertheless, this optimization is not guaranteed with a solution since the training data 
may be not linearly separable due to outliers, higher-order data patterns, and many other reasons. To 
avoid this issue, some “hard-to-classify” training data are ignored by introducing the concept of soft 
margin. In this case, the previous optimization setting becomes  
Minimize w,b ‖𝐰‖2 + C ∑ ξi
n
i=1   
Subject to yi (wTxi + b) ≥ 1 – ξi  with ξi  ≥ 0, ∀i, i = 1, …, n 
ξi is an error term. Besides margin maximization (or minimizing ‖𝐰‖2), another goal is to maintain a low 
training error (∑ ξi
n
i=1 ). The tradeoff between margin and training error is regularized by a specified 
constant, C. Even if this constraint optimization can be solved by standard quadratic programming 
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packages, it is beneficial to investigate its dual form because it brings some valuable properties, for 
example, insight into support vectors: 
Maximize Lα = ∑ 𝛼i − 12∑ 𝛼i𝛼j𝑦i𝑦j〈𝐱i, 𝐱j〉ni,j=1ni=1                  (1) 
Subject to ∑ 𝛼i𝑦i = 0ni=1  with 0 ≤ αi ≤ C ∀i, i = 1, …, n 
αi are support vector coefficients, and vector w can be recovered by equation, w =∑ 𝛼i𝑦i𝐱ini=1 . Four types 
of molecular fingerprints, including MACCS key146, Unity (www.tripos.com), FP2127, and Molprint 2D 77, 
124, were generated as descriptors to represent each cannabinoid ligand in machine learning algorithms. 
MACCS key (166 bit) and FP2 (1024 bit) were calculated using OpenBabel, and Unity fingerprints (992 
bit) were generated in Tripos Sybyl. The whole cannabinoid ligand dataset produced 2530 three-layer 
Molprint 2D features from Bender et al’s program. These features were mapped to binary vector 
according to previously published protocol 144. To systematically evaluate prediction accuracy, 50% CB1 
selective and 50% CB1 non-selective compounds were randomly selected as training set in order to build 
a prediction model. The remaining compounds, which were not present to learning algorithms, were used 
to test the model. The calculation strategy was also applied to CB2 selectivity modeling. Two machine 
learning algorithms (LiCABEDS and SVM) combined with four types of fingerprint and two receptor 
subtypes resulted in 16 calculation settings. Each calculation setting was repeated for 20 times on 
different randomly selected training and testing samples, with intention to assess stability and reliability.  
All calculation regarding LiCABEDS was automated with published program 
(www.cbligand.org/LiCABEDS). The SVM-based selectivity modeling approach was carried out using 
library “e1071”, which included an R wrapper of LIBSVM147. This chapter also reports the effect of 
cross-validation on the prediction performance of testing data sets. With cross-validation, 30% of training 
data was left out as cross-validation set in order to choose optimal training parameters. For LiCABEDS, 
the training parameter was the number of “decision stumps”, or training iterations; while the parameter of 
SVM was the constant C that regularized the tradeoff between training error and margin size. Then, all 
the training data was used to train a model with the optimal parameter specified during cross-validation. 
During this study, a LiCABEDS model was developed using all labeled compounds to predict the CB2 
selectivity of 12 newly synthesized compounds.  
The following performance metrics were calculated for each calculation setting:  
-   Precision = #True Selectives #True Selectives +#False Selectives 
 -  True Positive Rate (TPR) = #True Selectives #True Selectives +#False Non−selectives  
-   False Positive Rate (FPR) = #False Selectives#False Selectives+#True Non−selectives 
Precision measured the percentage of correctly identified selective compounds, and Recall Rate (or True 
Positive Rate) depicted the capability of prediction model to retrieve or recover selective compounds. 
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Geometric mean of Precision and Recall Rate could serve as a single criterion for performance rating. 
ROC (receiver operating characteristic) curve, plotting TPR versus FPR, showed the enrichment of true 
selective compounds with varying decision threshold. 
Structural skeletons of cannabinoid ligands were generated and compared for the exploration of 
structure diversity in selective CB1 and CB2 ligands. Briefly, compounds were reduced to carbon 
skeletons by deleting all non-ring substituent except linkers between ring systems, replacing all hetero-
atoms with carbon atoms, and converting all bond orders to single bonds 148. Following these steps, 
generic compound scaffolds were generated by shrinking the linker chain from a sequence of two or more 
CH2s to only one CH2. Figure 4-12 exemplifies the procedure of scaffold generation with a CB1 
selective ligand, SR141716. (A) The original structure of SR141617. (B) Its carbon skeleton after deleting 
the side chains, such as the ‘=O’ , “-CH3’ and ’-Cl’ groups, replacing all non-carbon atoms, in this case 
nitrogen atoms, with carbon atoms and converting all bond orders to single bonds. (C) General carbon 
skeleton is produced by shrinking the linker chain of the carbon skeleton from two or more CH2s to one 
CH2. (Scaffold analysis was carried out by Dr. Lirong Wang) 
 
 
 
 
Figure 4-12: Illustration of scaffold generation 
SR141716, a CB1 selective ligand, as an example to show the procedure of scaffold generation.  
4.3.2.2 Experimental Section 12 compounds with a novel scaffold were synthesized and tested 
against CB1 and CB2 receptors. The synthetic route is shown in Scheme 1. The hydrolysis of the 
substituted 2-phenylacetonitrile in concentrated H2SO4 gave the intermediate amides. And then, the 
coupling reaction between the amide and aldehyde was performed in anhydrous dichloroethane with the 
catalyst TMSCl149. Alternatively, the coupling reaction was performed in anhydrous DCM with the 
catalyst F3CSO3SiMe3150. The nitro compound was reduced with palladium (10%) and hydrazine in 
ethanol to give the amine, which react with halide to give the final product.  
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 Scheme 1. General Synthesis of PAM Analogues 
 
Reagents and conditions: (a) concentrated H2SO4, 0 oC, 12 h; (b) method 1: aldehyde, anhydrous 
dichloroethane, TMSCl, 70 oC, 3-12 h; (c) method 2: aldehyde, anhydrous DCM, F3CSO3SiMe3, 
r.t, 12 h; (d) ethanol, palladium (10%), hydrazine, 70 oC, 3 h; (e) DMF, K2CO3, r.t, 12 h. 
 
 
The binding affinities of these 12 derivatives to CB2 receptor were determined by performing 
[3H]CP-55,940 radioligand competition binding assays using membrane proteins of  the CHO 
cells stably expressing human CB2 receptor. The CB1 binding assay was also conducted for those 
compounds with high CB2 receptor binding potency (Ki < 1,000 nM) using membrane proteins 
harvested from the CHO cells stably transfected with the human CB1 receptors. CB2 receptor 
ligand SR144528 and CB1 ligand SR141716 were used as positive controls respectively along 
with the tested compounds. (experimental section was summarized by Dr. Peng Yang) 
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4.3.3 Results and Discussion 
This section is focused on the analysis of LiCABEDS, SVM and different molecular fingerprints for their 
capability of distinguishing cannabinoid selective compounds from non-selective ones. The results are 
quantitatively supported by various performance metrics that depict aspects of prediction outcomes. The 
effect of cross-validation on LiCABEDS and SVM is also discussed. In addition, the cross-validation 
studies reveal that the LiCABEDS model complexity is positively correlated with the recall rate of CB2 
selective compounds, but not CB1 selective ones. A possible explanation to this is provided in terms of 
structure diversity, which gives us deeper understanding of the LiCABEDS mechanism. In the end, a case 
study shows how LiCABEDS could direct drug discovery and chemical modification by predicting the 
selectivity of newly synthesized compounds. 
4.3.3.1 LiCABEDS and SVM in Default Settings  
LiCABEDS was originally designed as a general-purpose ligand classifier for the prediction of 
categorical ligand properties. The theoretical framework of LiCABEDS shows that LiCABEDS is not 
necessarily a linear classification algorithm. Nevertheless, when the feature space is represented in binary 
molecular fingerprints, the training algorithm mentioned in the method section produces a linear classifier. 
Given that a type of fingerprint defines a pattern set S, and that a function NSf →:  maps each 
structure pattern to a unique index, there are 2| S | possible decision stumps 1)(2),,( −== tItiy ixx , 
because }),(:{ Sssfididi ∈=∈ and }1,0{∈t . Due to the sample space of t in the context of binary 
fingerprint, the indicator function, I, can be omitted by expressing a decision stump as 
)12(),,( −= iktiy xx , }1,1{ −+∈k . k = +1 if t = 1, k = -1 otherwise. Therefore, the LiCABEDS 
prediction function )),,((∑=
M
m
mmmmM tiyasignY x can be updated as ))12('(∑ −=
M
m
imM masignY x ,
mmm kaa ='  For a specific i, define a set iA that contains any ma'  associated with ix .  
Thus, )()))12('(( 0
11 '
ββ +=−= ∑∑ ∑
== ∈
i
K
i
i
K
i Aa
ikM signasignY
ik
xx . This proves the linearity of 
LiCABEDS with decision stumps created in a binary feature space.  
In previous studies, LiCABEDS was compared with naive Bayes classifier and classification tree (or 
recursive partitioning method). Support Vector Machine (SVM) is another popular classification 
algorithm for building linear and non-linear models. SVM has been widely applied in cheminformatics 
and ligand-based drug design. For the linear nature of LiCABEDS models here, we present a back-to-
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back comparison between LiCABEDS and linear SVM. Note that non-linear SVM models may exhibit 
advantages over linear ones in certain circumstances 151. Nevertheless, the selection of non-linear kernel 
functions and parameters is computationally expensive, and could become a risk factor for over-fitting.  
This section presents the performance of LiCABEDS and SVM models trained with default 
parameters (parameter tuning will be discussed later), to show the robustness of these two algorithms. The 
only parameter in linear SVM is the “C”-constant of regularization. Its default value is 1, meaning that 
training error and margin size are equally important. The only parameter in LiCABEDS training is the 
number of training iterations or decision stumps, M. A reasonable default value of M is 2| S |, so that 
every possible decision stump could be incorporated in the ensemble classifier, even though only some 
relevant decision stumps contribute to the prediction in real-world problems. By following this principal, 
the number of LiCABEDS training iterations for Molprint 2D, FP2, Unity and MACCS fingerprints are 
5000, 2000, 2000, 400, respectively.   
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Figure 4-13: The performance of selectivity prediction without cross-validation 
The boxplot displays the precision and recall rate out of 20 rounds of calculation, using either LiCABEDS 
or SVM.  
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Table 4-6: Model performance without cross-validation 
  
Molecular 
Fingerprint 
Classification 
Algorithm 
CB1 Selectivity CB2 Selectivity 
Precision(%) Recall(%) GM Precision(%) Recall(%) GM 
Molprint LiCABEDS 64.8±4.5 67.4±5.7 66.1 64.9±5.1 61.2±7.6 63.0 
SVM 66.8±5.1 66.6±6.3 66.7 65.3±5.1 60.3±7.8 62.8 
FP2 LiCABEDS 63.8±2.9 67.8±5.2 65.8 63.7±3.7 63.4±5.9 63.5 
SVM 65.6±3.8 67.2±5.7 66.4 66.3±4.5 64.5±7.0 65.4 
Unity LiCABEDS 67.1±3.9 68.3±4.6 67.7 61.0±4.6 60.7±6.6 60.8 
SVM 67.0±3.0 65.8±5.5 66.4 60.9±3.6 62.6±7.0 61.7 
MACCS LiCABEDS 66.0±6.1 64.6±6.5 65.3 64.4±6.0 50.3±7.0 56.9 
SVM 65.6±5.3 69.5±6.0 67.5 63.4±3.9 54.7±5.2 58.9 
The average and standard deviation of precision and recall rate out of 20 rounds of calculation 
 
The results of systematic evaluation of cannabinoid-subtype selectivity prediction are summarized in 
Figure 4-13 and Table 4-6. Figure 4-13 plots the distribution of precision and recall rate of different 
computational methods in 20 rounds of calculation. The performance metrics of LiCABEDS and SVM 
that are trained with different fingerprints are shown. LiCABEDS and SVM models are trained with four 
types of fingerprints (indicated along X-axis) and default training parameters for the prediction of either 
CB1 selective or CB2 selective ligands. Y-axis shows performance metrics in percentage value. 
Correspondingly, Table 4-6 lists the average, standard deviation, and geometric mean of precision and 
recall rates. The numbers are reported for each combination of machine learning algorithm (SVM or 
LiCABEDS), molecular fingerprint (Molprint, FP2, Unity or MACCS), and selectivity type (CB1 or CB2 
selective). All the SVM and LiCABEDS models are trained with default parameters. GM: geometric 
mean. GM = sqrt(Precision × Recall). Overall, satisfactory results are achieved. LiCABEDS + Unity 
outperform other combinations for CB1 selectivity prediction, with the highest geometric mean, 67.7. 
SVM + FP2 lead the CB2 selectivity prediction, with the highest geometric mean, 65.4. Regardless of 
fingerprint types, the range of precision and recall of LiCABEDS models covers 56.1%-77.9% and 
49.3%-80.0% for CB1 selectivity, 52.1%-74.1% and 33.8%-74.3% for CB2 selectivity. At the same time, 
SVM models yield precision of 57.7%-76.4% and recall of 54.7%-80.0% for CB1 selectivity, and 
precision of 55.7%-76.3% and recall of 43.2%-77.0% for CB2 selectivity. In spite of the variability, the 
precision and recall rate stay above 50% in most cases.  
In general, all the fingerprints exhibit decent predictability in LiCABEDS and SVM. According to 
Table 4-6, Unity fingerprint is the optimal choice for screening CB1 selective compounds, since it 
achieves a 67% precision rate in both machine learning algorithms. FP2 fingerprints produce the highest 
geometric mean of precision and recall for CB2 selective compounds (63.5% for LiCABEDS and 65.4%). 
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Also, the best recall rate of CB2 models are established on FP2 fingerprints (63.4% for LiCABEDS and 
64.5% for SVM). Figure 4-13 reveals consistent high precision rate of Molprint 2D fingerprint for both 
CB1 and CB2 selectivity prediction. MACCS key is weak at recovering the CB2 selective, but is 
surprisingly sufficient for the CB1 selective. Altogether, Molprint 2D, FP2 and Unity have subtle 
difference in terms of performance metrics, leaving MACCS key slightly behind.  
With four types of fingerprints, the geometric mean (GM) gap of LiCABEDS and SVM models falls 
in the interval (-2.2, 1.3). Table 4-6 suggests that SVM generally outperforms LiCABEDS. However, the 
outperformance is insignificant when visualized in Figure 4-13 or compared with the standard deviation 
in Table 4-6. Another interesting fact is that the precision and recall rate of CB1 models are uniformly 
higher than those of CB2 models, even if the computation protocol is identical. Section 3.3 will explain 
and discuss this in depth.  
The evaluation and comparison of modeling strategies are quantified according to precision, recall 
rate, and the geometric mean of both. Precision should be emphasized when the cost of validating a 
predicted selective is high. On the other hand, recall rate catches our attention when many lead 
compounds are desired at an early stage of virtual screening. Precision and recall rate are usually 
negatively correlated. An astringent strategy guarantees a high precision rate by selecting high-confident 
samples, but sacrifices recall rate by ignoring potential true positives. Even if geometric mean is not 
perfect as a single-number performance measure, it is still a reasonable way to rank screening strategies.  
These analyses assume correct selectivity label of training and testing compounds. Due to systematic 
and random error in bioassays, this assumption is obviously not rigorous in practice. For example, 
Huffman et al pointed out that the CB2/CB1 affinity ratio of a famous cannabinoid, WIN-55,212-2, was 
reported in range 0.6 to 30 142. Here, this compound could be CB2 selective or non-selective. The 
inconsistent selectivity label in training and testing compounds cause confusion and uncertainty. To 
minimize this effect, bio-affinity values of a cannabinoid ligand were extracted from the same literature if 
possible, and use the Ki values reported for the same cell line. However, this systematic error cannot be 
fully eradicated.  
 
 
4.3.3.2  LiCABEDS and SVM with Cross-validation The ultimate goals of supervised 
learning algorithms are to minimize generalization error and achieve optimal performance for prospective 
predictions. In this sense, LiCABEDS and SVM are not exceptions. The sole pursuit of reducing training 
error may lead to poor predictions for new testing samples (overfitting), while the over-emphasis on 
margin maximization may result in lack-of-fit. This paradox is also known as “bias-variance tradeoff” in 
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statistics. Cross-validation is an effective approach to figure out optimal model parameters. In this study, 
the parameters evaluated in cross-validation are the number of training iterations in LiCABEDS (M) and 
C-constant in SVM. For LiCABEDS, M ∈ [minstep, maxstep]. maxstep is the default training iterations 
mentioned previously. minstep = 50 if MACCS is used as descriptor, otherwise minstep = 100. C ∈ {2i: i 
= -16, -15,…,15, 16}. Although the parameter space of LiCABEDS is much larger than SVM, dynamic 
programming technique makes the cross-validation in LiCABEDS as fast as training a single model. The 
M and C that perform best on cross-validation data are selected for model training. The performance of 
these models is further evaluated on the same testing sets, and results are shown in Table 4-7 and Figure 
4-14.  
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Figure 4-14: The performance of selectivity prediction with cross-validation 
The boxplot resembles Figure 4-13 in figure layout. 
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 Table 4-7: Model performance with cross-validation 
Molecular 
Fingerprint 
Classification 
Algorithm 
CB1 Selectivity CB2 Selectivity 
Precision(%) Recall(%) GM Precision(%) Recall(%) GM 
Molprint LiCABEDS 69.1±5.0 68.5±6.5 68.8 68.4±4.5 58.2±8.9 63.1 
SVM 70.7±4.0 72±7.8 71.3 68.5±3.3 64.5±7.9 66.5 
FP2 LiCABEDS 68.0±4.0 68.5±5.8 68.2 69.2±4.1 61.8±6.5 65.4 
SVM 67.5±5.0 70.8±7.4 69.1 71.1±4.0 60.9±6.7 65.8 
Unity LiCABEDS 70.7±4.8 69.2±4.7 69.9 65.0±3.6 59.2±7.4 62.0 
SVM 69.8±3.6 72.2±5.3 71.0 65.2±3.6 60.9±7.8 63.0 
MACCS LiCABEDS 68.0±5.5 66.1±6.2 67.0 63.8±6.5 47.7±8.4 55.2 
SVM 69.0±5.3 72.9±5.6 70.9 65.9±6.6 48.3±10.4 56.4 
The performance of LiCABEDS and SVM combined with different fingerprints after running cross-
validation 
 
Cross-validation brings consistent improvement for both LiCABEDS and SVM, except for CB2 
selectivity prediction using MACCS fingerprint. The geometric mean (GM) of LiCABEDS grows Δ1.7 – 
2.7 for CB1 selectivity prediction, and Δ-1.7 – 1.9 for CB2 selectivity prediction. Correspondingly, the 
geometric mean (GM) of SVM grows Δ2.7 – 4.6 for CB1 selectivity prediction, and Δ-2.5 – 3.7 for CB2 
selectivity prediction. Both algorithms are robust enough to deliver satisfactory predictions with default 
model parameters. Even if cross-validation has positive impact, the improvement is inconclusive when 
compared with performance variance. SVM seems to be more sensitive to the choice of parameters than 
LiCABEDS, since the increment of its geometric mean is relatively higher. After parameter tuning, SVM 
+ Molprint 2D outruns other models in both CB1 and CB2 selectivity prediction for its highest GM (71.3 
and 66.5). Figure 4-14 shows that, the precision rate of LiCABEDS and SVM is similar among all 
fingerprints, but SVM is capable of retrieving more selective compounds than LiCABEDS, especially for 
CB1 selective compounds. In the end, the GM of SVM is 0.4 to 3.9 higher than that of LiCABEDS.  
4.3.3.3  Training Iterations of LiCABEDS Training iterations (M) of LiCABEDS are 
directly related to model complexity, as every round of training adds one more “weak classifier” to the 
ensemble model. Parameter M was thoroughly discussed in the previous study144, and the hypothesis was 
that large M produced close-to-optimal models. Running cross-validation might improve prediction 
performance, but its effect was statistically insignificant.  The results in section 3.2 also support this 
hypothesis. Thus, assigning a relatively large value to M not only guarantees model convergence, but also 
avoids costly cross-validation procedures and potential overfitting of cross-validation data.  
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Figure 4-15: Training iteration and CB2 selectivity prediction 
The plots show the average and standard deviation interval of recall and precision rate of CB2 selectivity 
models versus model training iterations.  
 
 
Apart from machine learning language, the meaning of M can be also interpreted in applied domain 
knowledge. This section is primarily focused on how M affects the recovery of selective ligands.Naturally 
selective compounds are supposed to be overwhelmed by non-selective ones, which is also true for the 
training and testing sets. Thus, what LiCABEDS training algorithm faces is unbalanced data. Treating 
each training sample equally at the initialization stage, the training algorithm first assures the correct 
classification of non-selective compounds even at the cost of misclassification of selective ones. As 
majority is non-selective samples, this is an effective way of minimizing training error when the 
classification power of LiCABEDS is limited. Later when the model complexity grows, the training 
algorithm aims at recovering selective ligands from the training pool by picking up discriminative 
features and building “decision stumps” accordingly. This process is visualized in Figure 4-15. Figure 
4-15 plots the average and standard deviation of recall and precision rates on the testing data sets as a 
function of training iterations, M. The average and standard deviation are calculated based on 20 rounds 
of test calculation. Each row represents a specific fingerprint type. The Y-axis of each plot is in 
percentage. The values along X-axis represent M. Note that the growth of X-axis values is not linear. As 
shown in the left column, the recall rate steadily increases as M grows. For example, with Molprint 2D 
fingerprint, the recall rate starts from 20%. It converges to a plateau (approximately 60%) when M is 
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more than 500. Similar trend can be observed in other plots.  Meanwhile, the precision is more stable 
compared to recall rate. It mainly fluctuates from 60% to 70% for Molprint 2D, FP2, Unity fingerprints, 
and from 50% to 60% for MACCS fingerprint. The precision rate seems to be negatively correlated with 
training iterations, meaning that a large M reduces prediction precision. To explain this, easy-to-classify 
selective ligands are correctly labeled at the beginning stage of training. As training continues, the 
algorithm tries to recover more selective ligands that are harder to classify. At the same time, more non-
selective ligands may be also predicted as selective, which reduces precision. The positive effect of a 
large M on recall rate is obviously more significant than its negative effect on precision. Therefore, 
training error is effectively minimized in the early stage of training. As recall rate reaches the plateau, 
adding more “decision stumps” only impairs precision rate. The value that seeks a balanced trade-off 
between these two metrics can be figured out through cross-validation, which has been well addressed in 
the previous section.  
      The precision and recall rate of CB1 selectivity models are quite different from those of the CB2 
selectivity models. Their values as a function of training iterations are displayed in Figure 4-16. One 
major difference is that the recall rate of CB1 selectivity models reaches the plateau when M is about 50 
for Molprint 2D, FP2 and Unity fingerprints. The uptrend of recall rate is almost not observable with 
MACCS fingerprint. Figure 4-16 suggests that precision rate gradually reduces as M grows, which is 
similar to Figure 4-15. Thus, a large M is less favored compared to CB2 selectivity models. This also 
explains why cross-validation is more beneficial to CB1selectivity prediction than CB2 selectivity 
prediction. As mentioned in Section 3.2, cross-validation enhances the geometric mean of CB1 selectivity 
models by Δ1.7 – 2.7, but Δ-1.7 – 1.9 for CB2 selectivity models. Furthermore, the average of optimal M 
for CB1 selectivity prediction is 283 with Molprint 2D fingerprint. The average for CB2 selectivity 
prediction is 736 with the same fingerprint. A straight-forward conclusion is that the complexity of CB2 
selectivity models is higher than the CB1 models. It also indirectly suggests that the structure of CB2 
selective ligands is more diverse, so more factors need to be considered in the classifier. 
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Figure 4-16: Training iteration and CB1 selectivity prediction 
The average and standard deviation interval of recall and precision rate of CB1 selectivity models versus 
model training iterations.  
 
 
 
Figure 4-17: Principal component analysis of fragments of CB ligands 
2D scatter plot shows the spatial arrangement of selective ligands in the coordinates of two principal 
components.  
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A universal quantitative definition of structure diversity does not exist, since it can be evaluated according 
to aspects of criteria, such as molecular weight, number of rings, etc. We attempt to illustrate the structure 
diversity of cannabinoid selective ligands in both fragments and scaffolds. Principal component analysis 
(PCA) is an unsupervised learning skill that transforms original data into a new orthogonal coordinate 
system in order to capture the maximum variance. In the new coordinate system, the first component has 
the largest possible variance; the second component has the second largest possible variance; and so on. 
Figure 4-17 displays the first two components of MACCS fingerprints of all selectivity ligands. The 
principal components are solved according to MACCS fingerprints of all selective ligands. The X-axis 
and Y-axis represent the two most significant components. CB1 and CB2 selective ligands are 
represented in different color. PCA reduces the dimensionality of 166-bit fingerprint for visualization 
while maintaining minimum information loss. In Figure 4-17, CB1 selective ligands form three clusters 
that are approximately centered at (-3,1), (2,1), and (2,-3). Only a few points are scattered near origin. 
Similarly, CB2 selective ligands also form three clusters that roughly centered at (-4,0), (0,0), and (-3,-4). 
The radius of each cluster is associated with the structure variance of the compounds in the cluster. It is 
apparent that the CB2 selective ligands near the origin of Figure 4-17 show larger variance than the CB1 
selective ligands in any cluster. The other two CB2 selective clusters have similar pattern to those of CB1 
selective. Thus, CB2 selective compounds may have more diverse structure features defined in MACCS 
fingerprint than CB1 selective.  
 
Figure 4-18: The top five scaffolds in CB selective compounds 
(A) CB1 selective compounds (B) CB2 selective compounds 
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To assess structure diversity in a different aspect, the scaffolds of CB1 and CB2 selective compounds 
were generated according to the protocol described in Method section. Results showed that 149 CB1 
selective compounds possessed 22 scaffolds. Meanwhile, 147 CB2 selective compounds were reduced to 
38 scaffolds. Figure 4-18 lists five most populated scaffolds in each compound category. An interesting 
finding is that the top three CB1 scaffolds have significant overlapping. In other words, the second 
scaffold in Figure 4-18(A) is a substructure of the other two. On the other hand, CB2 scaffolds have 
relatively more variation. These observations also support the hypothesis that CB2 selective compounds 
could be more structurally diverse than CB1 selective compounds. This information could be useful clues 
for the design of CB selective compounds. (Scaffold analysis was conducted by Lirong Wang) 
4.3.3.4  ROC Analysis of LiCABEDS models 
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Figure 4-19: ROC curves of LiCABEDS models for the prediction of CB1 selectivity 
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Sensitive and specificity are classical statistical measures of the performance of binary classification 
function. ROC curve visualizes the true positive rate (sensitivity) as a function of false positive rate (1-
specificity) by changing classification boundary value. Visual inspection of enrichment of positive 
samples is straightforward by examining ROC curve. Besides the convenience of visualization, the area 
under curve (AUC) serves as quantitative performance measure of enrichment of relevant samples. The 
ROC curve of a random guess function (curve in dashed line) yields an AUC of 0.5. A perfect 
classification function has an AUC of 1.  
As discussed, ∑=
M
m
mmmm tiyaA ),,(x indicates the degree of confidence in each prediction. The 
default classification boundary is 0=A . Thus, changing the decision criteria generates a set of TPR and 
FPR values and allows inspecting the enrichment of selective ligands. Figure 4-19 and Figure 4-20 plot 
the ROC curves of LiCABEDS models for the prediction of CB1 and CB2 selectivity with four types of 
fingerprints. Each individual plot contains four curves that represent different fingerprints. Out of 20 
rounds of test calculation, the average AUC of CB1 selectivity models (Figure 4-19) are 0.883, 0.893, 
0.897 and 0.895 with Molprint 2D, FP2, Unity and MACCS fingerprints respectively. Correspondingly, 
the average AUC of CB2 selectivity models (Figure 4-20) are 0.839, 0.880, 0.855 and 0.839 with the 
same set of fingerprints. The visualization of these two figures and AUC values confirm that LiCABEDS 
models effectively enrich selective ligands. In addition, the ROC curve also supports that large || A  
suggests high probability of observing relevant samples, since the left region of ROC curve corresponds 
to astringent decision criteria. Figure 4-19 and Figure 4-20 reveal that the performance of fingerprints 
involved in LiCABEDS models is comparable, especially for CB1 selectivity models. Molprint 2D 
models produce relatively low AUC for CB2 selectivity prediction (average 0.839), which seems to be 
contradictory to previous findings. In real-world problem, a practical decision boundary corresponds to 
the left region of ROC curve because large FPR is mostly disfavored and remains unexplored. Partly, the 
slope of the left part of ROC curve is more important than AUC. As shown in Figure 4-19 and Figure 
4-20, as well as AUC calculation, the LiCABEDS models for CB1 selectivity prediction exhibit better 
enrichment than CB2 models. This also agrees with the previous hypothesis that the structure patterns of 
CB2 selective ligands are more diverse.  
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Figure 4-20: ROC curves of LiCABEDS models for the prediction of CB2 selectivity 
4.3.3.5 Prediction of Selectivity of Novel Compounds 
 
 
 
Figure 4-21: The structures of newly synthesized CB2 selective ligands. 
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Besides retrospective validation, a LiCABEDS model was developed to predict the CB2 selectivity of 12 
novel compounds before they were tested. The training set consisted of all the CB2 selective and CB2 
non-selective compounds in our cannabinoid database. The training iteration was set to 2000 with 
Molprint 2D as molecular descriptor. The LiCABEDS model predicted PY-63 (Figure 4-21) as CB2 
selective, while the other 11 compound as CB2 non-selective. Later, the experimental validation showed 
that the three structures in Figure 4-21 (PY-42, PY-61 and PY-63) were CB2 selective, and that the 
remaining compounds were either non-selective or inactive. Therefore, LiCABEDS successfully 
discovered PY-63, but missed the other two potential selective compounds. These compounds possessed a 
novel scaffold that was not present in training data. Interestingly, the prediction model still recovered a 
true selective without reporting any false positive. Even though the number of testing compounds was 
limited, this case study illustrated that the expense of drug discovery projects could be minimized by 
introducing in silico ligand profiling calculation. 
4.3.4 Conclusion 
When introduced as a general-purpose ligand classifier, LiCABEDS demonstrated its application for 
the classification of 5-HT1A ligand functionality144. This chapter reports a follow-up study of LiCABEDS 
algorithm in the prediction of cannabinoid ligand selectivity. In-depth discussions are presented on 
LiCABEDS theoretical framework, performance measures compared with SVM, vulnerability to 
overfitting, choice of training parameter, and prospective validation. The results show that LiCABEDS 
models effectively recover 60%-70% selective compounds from testing data sets, and maintain 
satisfactory false positive rates in the meantime. All fingerprints deliver decent performance metrics, 
showing the flexibility of LiCABEDS to adapt assorted hypothesis space. More importantly, LiCABEDS 
successfully identifies a CB2 selective compound out of twelve newly synthesized ones without any false 
positive error. Another advantage of LiCABEDS is straightforward parameter setting. Default training 
iteration significantly reduces calculation time by skipping costly cross-validation procedure, but conveys 
close-to-optimal models. LiCABEDS is not a black-box method, since models are interpretable by 
examining individual “decision stumps” that ensemble models are composed of. Furthermore, the 
investigation of LiCABEDS models provides insight into structure diversity of cannabinoid selective 
ligands. The correlation between performance metrics and model complexity reveals that reported CB2 
selective ligands are more diverse than CB1 selective ligands. This hypothesis is later supported by 
principal component analysis of fragments and analysis of compound scaffolds. It is also well agreed by 
106 
 
some performance metrics, such as AUC of ROC curve. This could suggest that there were more binding 
modes to form ligand-protein complex for CB2 receptor and for CB1 receptor. To conclude, LiCABEDS 
has potential to model the pharmacological properties that are not well addressed by traditional QSAR 
methodology. It could also guide screening strategy in early stage of drug development project.   
4.4 LICABEDS AND MODELING BBB PASSAGE 
Blood-brain barrier (BBB) is protective mechanism to prevent hazardous substances, e.g. some drugs, 
from entering brain tissues, while maintaining the permeability of some chemicals to the brain. The 
ability to pass blood brain barrier is one of the most important pharmacological properties for ligands 
targeting at central nervous system. Evaluating the passage of the barrier also helps to predict the 
potential side effects on central nervous system, which may be caused by ligands targeting at periphery 
organs. Thus, BBB passage is part of Distribution (D) properties in ADME.  
 
To demonstrate the feasibility, a LiCABEDS model was developed on published BBB compound datasets 
152 using FP2 fingerprint as descriptor. The training datasets consisted of 832 BBB+ ligands (able to cross 
the barrier) and 261 BBB- ligands (unable to pass the barrier). The model performance was then 
evaluated on labeled testing compounds containing 451 BBB+ ligands and 49 BBB- ligands. The result is 
summarized in Table 4-8.  
 
 
Table 4-8: Blood-Brain-Barrier passage prediction for BBB+ and BBB- ligands 
Label 
Prediction  
BBB+ BBB- 
BBB+ 440 7 
BBB- 11 42 
 
 
The overall accuracy of LiCABEDS on the testing dataset is 96.4%, with 97.6% accuracy for BBB+ 
category and 86.7% accuracy for BBB- category respectively. The LiCABEDS model outperforms some 
methods in the publication 152 that reports an overall accuracy ranging from 75% to 97%. 
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LiCABEDS demonstrates straight-forward prediction logic and high prediction accuracy. Furthermore, an 
online BBB passage prediction tool is developed based on the LiCABEDS model. The prediction toolkit 
is accessible at www.cbligand.org/BBB/predictor.php. 
 
The screenshot atop displays the online BBB passage prediction, maintained by Dr. Lirong Wang. 
Users can either sketch a compound structure or upload a chemical structure file as queries. Two 
supervised learning algorithms have been implemented, SVM and AdaBoost (LiCABEDS); and four 
types of molecular fingerprints are available as descriptors, MACCS, FP2, Molprint 2D and PubChem 
fingerprints.  
(* Chao Ma developed the back-end prediction program. Dr. Lirong Wang developed SVM classifier 
and built this webpage.)   
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5 SUPPORT VECTOR MACHINE FOR LIGAND 
CLASSIFICATION 
 
 
This chapter is an extension to differentiating 5-HT1A agonists and antagonists by developing robust non-
linear support vector machine (SVM) classifiers. Upon binding to a receptor, agonists and antagonists can 
induce distinct biological functions and thus lead to significantly different pharmacological responses. 
Thus, in silico prediction or in vitro characterization of ligand agonistic or antagonistic functionalities is 
an important step toward identifying specific pharmacological therapeutics. In this study, we investigated 
the molecular properties of agonists and antagonists of human 5-hydroxytryptamine receptor subtype 1A 
(5-HT1A). Subsequently, intrinsic functions of these ligands (agonists/antagonists) were modelled by 
support vector machine (SVM), using five 2D molecular fingerprints and the 3D Topomer distance. Five 
kernel functions, including linear, polynomial, RBF, Tanimoto and a novel Topomer kernel based on 
Topomer 3D similarity were used to develop linear and non-linear classifiers. These classifiers were 
validated through cross-validation, yielding a classification accuracy ranging from 80.4% to 92.3%. The 
performance of different kernels and fingerprints was analyzed and discussed. Linear and non-linear 
models were further interpreted through the illustration of underlying classification mechanism. This 
study expands the scope and applicability of similarity-based methods in cheminformatics, which are 
typically used for the identification of active molecules against a target protein. These findings provide a 
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good starting point for further systematic classifications of other GPCR ligands and for the data mining of 
large chemical libraries. 
5.1  INTRODUCTION 
Agonists and antagonists usually bind to the same site or pocket of a receptor, 153 but they trigger distinct 
biological responses, resulting in significantly different pharmacological responses. It is known that 
agonists stimulate the receptor, while antagonists inhibit the receptor function. Nonetheless, agonists and 
antagonists may share many common features. Analysis of their structures-bioactivity correlation may 
help to identify important structural patterns and develop agonist/antagonist prediction models.154 These 
models further help to design functional molecules. Nevertheless, many of the reported Quantitative 
Structure-Activity Relationship (QSAR) approaches suffer from low throughput due to the requirement of 
3D structure alignments, which may limit their applications in the screening and data-mining of large 
chemical databases.155 Herein, we report our investigation of agonists and antagonists for the 5-
hydroxytryptamine receptor subtype 1A (5-HT1A), since diverse ligands are available to evaluate the 
various computational approaches for large-scale agonist and antagonist classification. 
    The 5-HT1A receptor is a 5-HT or serotonin (Figure 5-1) receptor belonging to the G protein-coupled 
receptor (GPCR) family. Primarily expressed in the central nervous system,156 5-HT1A receptor influences 
biological and neurological processes, such as aggression, anxiety, appetite, mood, and sleep157. 
Numerous studies have demonstrated the therapeutic potential of 5-HT1A ligands. For example, the 5-
HT1A receptor agonists, flesinoxan and buspirone (Figure 5-1), mediate the efficient relief of anxiety 158 
and depression 159. Another agonist, serotonin, has recently been reported to be involved in bone 
formation 160. Conversely, evidence supporting the role of 5-HT1A receptor antagonists, such as lecozotan 
(Figure 5-1), in facilitating an enhancement of certain types of learning and memory functions in rodents 
has led to their current development as novel treatments for Alzheimer's disease 161. 
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Figure 5-1: The structures of some representative 5-HT1A ligands 
 
 
 In addition to elucidating several distinct biological responses induced by 5-HT1A agonists and 
antagonists, many studies have examined their structural requirements. Aganval et al. generated a 
pharmacophore model based on a small set of 5-HT1A agonists and antagonists using comparative 
molecular field analysis (CoMFA). Their analyses showed that the agonists tended to be “flatter” and 
more coplanar than the antagonists 116. Sylte et al., using molecular dynamics simulation of the binding 
process of 5-HT1A ligands, found that the agonists induced larger conformational changes into helix 3 and 
6 162. Han et al. developed a decision tree model to discriminate 5-HT1A agonists or antagonists from high-
throughput screening data 163.  
Most of the previous studies only focused on a small subset of the 5-HT1A ligands, and the predicting 
power and throughput of calculations were limited. For example, CoMFA requires 3D conformers to be 
pre-aligned and target compounds to possess identical or similar scaffolds 154. Moreover, the structures of 
decision trees are usually developed based on heuristic algorithms, as learning an optimal tree structure is 
proven to be NP-complete. Therefore, decision trees are substantially influenced by sampled training 
datasets. Consequently, robust 2D and 3D linear/non-linear predictors were developed for the 
classification of the agonists and antagonists of the 5-HT1A receptor, by data mining 1697 diverse ligands 
from the GLIDA 126 database. First, the properties of the human 5-HT1A agonists and antagonists were 
analyzed and compared. Subsequently, intrinsic biological functions of the ligands were classified via 
support vector machine (SVM) algorithm, invented by Vapnik. SVM is a popular classification algorithm 
in many fields. As the parameter regularization is built into a constraint optimization, it generally tends 
not to overfit training datasets. In SVM, compound structures were mapped to high dimensional 
descriptor vectors, called molecular fingerprints. When 2D molecular fingerprints were used as descriptor 
vectors, polynomial kernel, RBF kernel (Radial Basis Function) and Tanimoto kernel were used to 
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develop non-linear classifiers. Furthermore, a novel Topomer kernel is proposed to incorporate the 
concept of 3D fragment similarity. Different from traditional fingerprint representation of compound 
structures, the Topomer kernel in the SVM does not require an explicit structure-descriptor mapping 
mechanism. Instead, the Topomer similarity score between any pair of compounds suffices to train a 
model, which is an application of “kernel trick”. The rationale of these algorithms is supported by the 
principle that an active compound usually behaves as an agonist if it structurally resembles agonists, and 
as an antagonist if it structurally resembles antagonists. Test calculations showed that the SVM yielded 
average 88.3% to 92.3% prediction accuracy with five types of molecular fingerprints and three non-
linear kernels (Polynomial, RBF and Tanimoto kernels), and the Topomer kernel produced average 90.9% 
prediction accuracy.  
5.2  METHODS, MATERIALS AND CALCULATION 
5.2.1 Support Vector Machine 
The motivation and concepts of Support Vector Machine (SVM) have been brought up in 4.3.2. Continue 
with the standard setting of linear SVM: 
Maximize Lα = ∑ 𝛼i − 12∑ 𝛼i𝛼j𝑦i𝑦j〈𝐱i, 𝐱j〉ni,j=1ni=1                  (5-1) 
Subject to ∑ 𝛼i𝑦i = 0ni=1  with 0 ≤ αi ≤ C ∀i, i = 1, …, n 
Once we have αi, vector w can be recovered by equation, w =∑ 𝛼i𝑦i𝐱ini=1 . Sometimes a linear 
classifier in the original feature space fails to identify the pattern of non-linear observations, e.g. using a 
linear classifier to learn an XOR function. This problem could be tackled by mapping the non-linear 
observations to some higher dimensional feature space: x → φ(x), in which the data are linearly 
separable. The linear classifier in the higher dimensional space may correspond to a non-linear hypothesis 
in the original feature space.  Nevertheless, it is rather difficult to identify an appropriate mapping 
function, φ. In equation (5-1), observations 𝐱i  and 𝐱j  only appear as inner product, 〈𝐱i,𝐱j〉. After the 
observations are mapped by function φ, the observations appear as the inner product in the new feature 
space, K�𝐱i, 𝐱j� = 〈φ(𝐱i), φ(𝐱j)〉 . Therefore, the mapping function φ does not have to be identified 
explicitly, as long as the inner product in the higher dimensional space, K�𝐱i, 𝐱j� , can be solved. This 
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technique is named as “kernel trick”, and function K�𝐱i, 𝐱j� is called “kernel” function. This important 
character enables us to derive a SVM model only based on the relationship between any pair of training 
samples without knowing their vector representation. In this case, the prediction becomes 
sign(∑ 𝛼i𝑦iK(𝐱ini=1 , 𝐱test) + b) for a given testing case xtest, where xi is the ith training sample. 
  In this study, four types of popular kernel functions were considered. A standard support vector 
machine employs the linear kernel (eq. 5-2). Polynomial kernel (eq. 5-4) and RBF kernel (eq.5-5) have 
been applied widely, delivering decent performance in many applications. Thus, the polynomial and RBF 
kernel were tested along with other kernel functions. The Tanimoto kernel function (eq. 5-6), which has 
been used intensively in cheminformatics, incorporates prior knowledge on how to calculate chemical 
similarity.  
  Besides these four popular kernel functions, we propose a novel kernel function, Topomer kernel, to 
integrate the concept of 3D similarity into SVM. Sybyl Topomer Search directly generates 3D similarity 
scores, which can be plugged into the Topomer kernel function (eq. 5-3) for model training. Conversely, 
it is difficult for non-kernel machines, e.g. naive Bayes classifier, to make use of this information. “A 
topomer is a specific alignment or pose of a molecular fragment, prescribing both its conformation and 
position” 164. In the Topomer similarity algorithm, the molecule is split into two or three fragments and 
the similarity of two molecules is evaluated by the similarity between the topomers of these fragments. 
Generally, the Topomer similarity considers both overall steric and pharmacophoric features, which 
enables it to function as a powerful 3D similarity tool in both virtual screening and QSAR studies 165-166.  Klinear(𝐱i, 𝐱j) = 〈𝐱i, 𝐱j〉                                     (5-2) KTopomer�𝐱i, 𝐱j� = (1 − Topomer(𝐱i,𝐱j)maxi,j Topomer(𝐱i,𝐱j))d                                                (5-3) 
Note: for consistent notation, assume Topomer distance and Topomer kernel are calculated from 
virtual vector xi. Kpolynomial�𝐱i, 𝐱j� = (〈𝐱i, 𝐱j〉 + 1)d                        (5-4) KRBF�𝐱i, 𝐱j� = exp ( −g�𝐱i−𝐱j�2  )                                                                   (5-5)    KTanimoto�𝐱i, 𝐱j� = 〈𝐱i,𝐱j〉〈𝐱i,𝐱i〉+〈𝐱j,𝐱j〉−〈𝐱i,𝐱j〉                                                             (5-6)   
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5.2.2 Materials and Calculations 
A collection of 1102 5-HT1A agonists and 595 5-HT1A antagonists was retrieved from the GLIDA 
database 125-126. The whole 5-HT1A data set was randomly split into 10 different training and testing sets, 
with 75% agonists and antagonists representing the training sets and the remaining forming the testing 
sets. MACCS, Unity, FP2, Molprint 2D and PubChem fingerprints were generated for all the training and 
testing compounds. MACCS and PubChem fingerprints are dictionary-based fingerprints, each dimension 
of which indicates the presence or absence of a set of predefined fragments 167. Unity and FP2 fingerprints 
encode atom-path patterns with variable length. Molprint 2D fingerprint 168-169 is a circular atom 
environment fingerprint, which depicts all the neighboring atoms around each central heavy atom. Tripos 
Sybyl was used to calculate the Topomer distance, Topomer(𝐱i, 𝐱j), between any pair of compounds. 
  The performance of linear, polynomial, RBF and Tanimoto kernel functions was measured together 
with five types of fingerprints, resulting in 20 different models (descriptor × kernel). Another SVM model 
was only specified by Topomer kernel, as Topomer distance was a special descriptor. For a given SVM 
model, 10 rounds of training were carried out by 10 different training sets, and the prediction accuracy 
was evaluated through the corresponding testing data sets. Predictive SVM model creation and evaluation 
were carried out with the svmpath software package 170. The svmpath implementation discovers the entire 
path of the SVM solution and provides an interface for user-defined kernel functions. The regularization 
and kernel parameters were determined by 10-fold cross-validation. 
5.3 RESULTS AND DISCUSSION 
The focus of this section is on the classification of human 5-HT1A ligands. Firstly, we demonstrate that 
some general molecular properties, such as properties mentioned in Lipinski’s Rule-of-Five and the 
number of rotatable bonds, exhibit limited discrimination power, as expected. Interestingly, the significant 
difference between intra-class and inter-class similarity measured by molecular fingerprints suggests the 
possibility of building a predictive agonist-antagonist classifier using these fingerprints. Next, the 
performance of different combinations of kernels and fingerprints is retrospectively investigated and 
analyzed through cross-validation.  
114 
 
5.3.1 Molecular Properties of Agonists and Antagonists 
The distribution of five molecular descriptors of 5-HT1A agonists and antagonists is plotted in Figure 5-2, 
including the properties mentioned in Lipinski’s Rule-of-Five and the number of rotatable bonds. The 
average molecular weights for agonists and antagonists are 373.75 and 414.05 Dalton, respectively. 
Accordingly, agonists possess on average 2.78 H-bond acceptors, while antagonists have on average 3.07 
H-bond acceptors. The analysis of rotatable bonds reveals that antagonists are relatively more rigid 
compared to agonists. The results are congruent with the TOGGLE model provided by Schwartz et al171. 
The flexibility of agonists is suggested through induction of a common molecular activation mechanism 
involving TM-V, TM-VI and TM-VII of the GPCR receptor. A recent publication on the human A2A 
adenosine receptor validates this hypothesis 172.  According to the TOGGLE model, agonists should be 
more flexible in order to adjust their conformation with the receptor’s conformational changes. 
Antagonists, however, are rigid and can hinder the movement of the receptor helixes upon binding 162. 
The subtle differences in these descriptors can hardly distinguish agonists from antagonists.  
 
 
 
Figure 5-2: The distribution of molecular properties 5-HT1A agonists and antagonists 
The properties include molecular weight, cLogP, the number of H-bond acceptors, the number of H-bond 
donors and the number of rotatable bonds.  
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Figure 5-3: Intra-class and inter-class similarity of 5-HT1A agonists and antagonists.  
 
Principal component analysis is a popular technique for dimension reduction and visualization. The 
principal components are linear combinations of original features and capture the maximum variance of 
high-dimensional samples. N-dimensional data usually produces N components, the variance of which is 
in descending order. Figure 5-4 plots the first two principal components of the reported five molecular 
properties. Agonists and antagonists are colored differently in this transformed chemistry space. The 
standard deviations of the first two principal components are 1.52 and 1.10, and the standard deviations of 
omitted components are 0.89, 0.70, and 0.44. Agonists and antagonists have significant amounts of 
overlap in the new coordinate system, suggesting that performing data mining on these traditional 
molecular properties may only yield limited accuracy. 
 
Figure 5-4: Principal component analysis of five molecular descriptors. 
The scatter plot of the first two components from molecular weight, cLogP, number of H-bond donors, 
acceptors and rotatable bonds.  
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Even though agonists share certain similarity with antagonists, the examination of intra-class and inter-
class similarities using compound library comparison173. Figure 5-3 suggests that they retain distinct 
molecular fragments (The distribution was generated by Tripos Sybyl Selector.  Intra-class similarity is 
defined as the pairwise Tanimoto coefficient calculation within agonist or antagonist compound collection; 
inter-class similarity refers to the pairwise compound comparison between the agonist and antagonist 
datasets.).  The average intra-class Tanimoto similarity of agonists and antagonists are 0.88 and 0.87, with 
a standard deviation of 0.11 and 0.12, respectively. On the other hand, the average inter-class Tanimoto 
score is 0.71 with a standard deviation of 0.11. The difference between intra- and inter-class similarities 
suggests the possibility of building a predictive agonist-antagonist classifier by data mining the structural 
patterns that define such similarity. 
5.3.2 Classification Performance Using Fingerprints 
The results of systematic comparisons of different molecular fingerprints and kernel functions are 
summarized in Figure 5-5 and Table 5-1. The average prediction accuracy of SVM models ranges from 
80.4% to 92.3%. As shown in Figure 5-5, non-linear classifiers that are derived from polynomial, RBF and 
Tanimoto kernel functions generally outperform linear classifiers. 
 
 
 
Figure 5-5: The performance of kernel and fingerprint 
The boxplot showing the distribution of prediction accuracy with combinations of molecular fingerprints 
and kernel functions.  
117 
 
 
Table 5-1: Average prediction accuracy of fingerprint/kernel combinations.  
 Linear Polynomial RBF Tanimoto 
FP2 0.878 0.919 0.919 0.912 
Unity 0.883 0.913 0.919 0.918 
MACCS 0.804 0.883 0.897 0.896 
PubChem 0.846 0.888 0.903 0.900 
Molprint 2D 0.912 0.905 0.923 0.909 
The results are calculated as the ratio between correctly predicted compounds and the total number of 
testing compounds out of ten rounds of validation. 
 
 
Out of 10 rounds of test calculations using the MACCS fingerprint as descriptor, the highest prediction 
accuracy of linear SVM models, which could be regarded as default approach for SVM, is still lower than 
the worst performance of any non-linear SVM models (Figure 5-5). The average performance of FP2, 
Unity and PubChem fingerprints with linear kernel is 87.8%, 88.3% and 84.6% respectively, which are 
approximately Δ 3% - 6% lower compared to non-linear kernels (Table 5-1). This outcome suggests that 
compound fragments may not make straightforward additive contributions to ligand-receptor interactions, 
i.e. considering the simultaneous influence of two or more functional groups could improve the quality of 
models. In this case, a non-linear model is a possible solution to capture the interaction among fragments. 
Although non-linear kernels outperform standard linear functions for these four types of fingerprints, 
Figure 5-5 shows that the Molprint 2D fingerprint consistently yields rigorous predictions regardless of 
kernel functions, with an average accuracy ranging from 90.5% to 92.3% (Table 5-1). This could be 
explained by the high sparsity and high dimensionality of the Molprint 2D fingerprint. In Molprint 2D, 
each heavy central atom and its surrounding heavy atoms uniquely define a pattern. In this study, the 
entire agonist and antagonist compound collection generates 6839 Molprint 2D patterns, while the lengths 
of FP2, Unity and MACCS fingerprints are 1024, 992 and 166, respectively. Out of 6839 Molprint 2D 
features, the number of features that a compound possesses is actually equal to the number of its heavy 
atoms, resulting in high sparsity. The purpose of kernel functions is to map original features to a higher, 
possibly infinite dimensional space so that a better linear classifier could be obtained in the new space. As 
Molprint 2D has already defined numerous features, a linear classifier is adequate to solve the problem 
and a solution in another high dimensional space does not necessarily lead to a significant improvement.  
Among non-linear kernels, RBF kernel and Tanimoto kernel are generally superior to the polynomial 
kernel although their performance is quite similar. Furthermore, Figure 5-5 and Table 5-1 show that the 
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RBF kernel outmatches the other three kernels no matter which type of fingerprint is used. Molprint 2D is 
the most favorable fingerprint because of its rich information, consistency and SVM kernel independency. 
Following Molprint 2D, FP2 and Unity fingerprints produce similar results, roughly 88% accuracy for 
linear kernel and 91% - 92% for non-linear kernels. PubChem and MACCS fingerprints could be ranked 
as last, given their relatively lower performance compared to FP2 and Unity (Table 5-1). As previously 
mentioned, Molprint 2D, FP2 and Unity fingerprints specify a set of rules for generating structural 
patterns, instead of predefining structural fragments or patterns. Thus, the interpretation of these 
fingerprints depends on the presented compound collection. On the other hand, PubChem and MACCS 
fingerprint preset a look-up table or structure dictionary. In this case, primal functional groups pertaining 
to distinct pharmacological or physico-chemical properties may not be readily defined in MACCS and 
PubChem fingerprints, but they may be well traced in FP2, Unity and Molprint 2D descriptors. To 
summarize, the best 2D SVM model is derived from the combination of Molprint 2D fingerprint and a 
RBF (or Gaussian) kernel, which exhibits 92.3% average accuracy on ten testing datasets. This 
conclusion is also consistent with Wasserman et al.’s findings174. 
5.3.3 Topomer Distance Kernel  
As previously mentioned, Topomer distance reported by Sybyl is an efficient 3D similarity metric and 
somewhat better than the traditional approach of 2D Tanimoto similarity175. In this section, Topomer 
kernel combined with Topomer distance is compared to the top-performing kernel, Radial Basis kernel, 
and 2D fingerprints, and the results are plotted in Figure 5-6.  
 
 
Figure 5-6: The comparison of Topomer kernel and RBF kernel 
The boxplot shows SVM prediction accuracy with Topomer distance and Topomer kernel, compared with 
traditional 2D fingerprints and RBF kernel. 
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Overall, using Topomer distance in SVM shows decent classification power with an average 90.9% 
accuracy. This is slightly better than the RBF kernel with MACCS and PubChem fingerprints. 
Nevertheless, this approach does not necessarily outperform the RBF kernel with other fingerprints, 
since the “gap” is statistically insignificant. In many virtual screening processes, 2D fingerprints 
perform better than 3D fingerprints or pharmacophore features176. The conclusion from our study is 
not an exception. Heuristically, 3D descriptors and 3D similarity metrics are supposed to be 
superior to traditional 2D approaches, especially when a query compound has a different scaffold 
from currently known compounds. Other work suggests that 3D descriptors can provide 
competitive similarity searching results in some scaffold hopping-oriented virtual screening 177.  
 
Consider an extreme case shown in Figure 5-7. Both compounds (L000022 and L000008) cannot be 
correctly classified by any 2D approaches in this study, as they have identical 2D fingerprints. Their 
Topomer distance is 0.26, indicating remarkable pairwise similarity. Generally, compounds with 
Topomer distance below 185 are regarded as similar 165-166, and identical compounds have zero Topomer 
distance. Unfortunately, the SVM model failed to identify L000008 as an antagonist using Topomer 
distance, when both compounds were present in the testing dataset. Recently, Guha et al. developed an 
index to detect the molecules that are very similar but have a large difference in activity. This 
phenomenon is named as “activity cliff” 178. In our case, the functionality of L000022 and L000008 
against the 5-HT1A receptor can be considered as another cliff, i.e. a functionality cliff. The functionality 
cliffs may provide some insights into the relationship between structure and functionality of GPCR 
ligands. 
 
 
 
 
Figure 5-7: Two stereoisomers that have distinct biological functionality 
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5.3.4 Model Interpretation 
In this study, linear classifiers and non-linear classifiers have been developed through SVM training 
algorithm. Linear classifiers make classifications based on a linear combination of structural fragments or 
features. As mentioned in the Methods section, the prediction of a testing sample is formulated as ƒw,b(x) 
= sign(wTx + b) in vector notation, or  ƒw,b(x) = sign(∑wixi + b), where xi ∈ {𝟎,𝟏} is one dimension of 
molecular fingerprints and represents a specific structural pattern. Note that x is descriptor vector; xi 
represents the descriptor of the ith compound, and xi is the ith element of vector x. 
Accordingly, the corresponding coefficient wi determines the contribution of the pattern to the final 
prediction. The pattern i that has a large associated |wi| has more influence on the prediction than the 
patterns with smaller |wi|. In other words, examining heavily weighted structural patterns may highlight 
the substructures associated with ligand functionality. The optimization of equation (1) yields a set of 
coefficients for support vectors, i.e. 𝜶, and w can be solved by equation w = ∑ 𝛼i𝑦i𝐱ini=1 . In this section, 
one example is given to illustrate a linear SVM model that is developed on the whole agonist/antagonist 
dataset using PubChem fingerprint as descriptor.  
 
 
 
 
Figure 5-8: Histogram displaying the distribution of elements in vector w. 
 
 
Figure 5-8 shows the distribution of elements in vector w, i.e. wi. As shown, the majority of wi reside in 
interval (-0.5, 0.5), suggesting that most of predefined PubChem features are possibly irrelevant to ligand 
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functionality. Only 26 patterns possess an absolute weight larger than 5, some of which are shown in 
Table 5-2. Besides certain substructures, distinct ring systems are observed in agonists and antagonists. 
According to the model, agonists prefer saturated or heteroatom aromatic rings. In contrast, simple 
aromatic rings are frequently observed in antagonists. Thus, extra caution should be taken to correlate 
these features with chemical modifications in order to achieve the desired biological profile, which was 
pointed out by Wassermann et al174. The support vector machine aims at minimizing generalization error, 
not causal inference. 
 
 
Table 5-2: List of structural patterns emphasized by a linear SVM classifier.  
 
Index Fingerprint Annotationa  Favored 
by 
Weightb 
187 >= 2 saturated or aromatic nitrogen-
containing 6-member rings  
Agonist 5.88 
194 >= 3 saturated or aromatic nitrogen-
containing 6-member rings 
Agonist 6.41 
650 O=,:C-,:N-,:C=,:O Agonist 8.22 
698 O-,:C-,:C-,:C-,:C-,:C-,:C-,:C Agonist 9.12 
860 CC1C( C )CCC1 Agonist 5.81 
    
257 >= 2 aromatic rings Antagonist -9.40 
261 >= 4 aromatic rings Antagonist -8.34 
597 O=,:C-,:C-,:C:C Antagonist -11.44 
647 O=,:C-,:N-,:C-,:N Antagonist -7.66 
674 N-,:C-,:N-,:C:C Antagonist -9.63 
a The implementation of PubChem fingerprint comes from the CDK software package, so the fingerprint annotation 
may not completely conform to PubChem standards. The substructures are given in SMILES or SMARTS notation. “=” 
means double bond, “-“ means single bond, “:” means aromatic bond, and “=,:” means either double bond or aromatic 
bond. 
b In this study, agonists are labelled as +1, while antagonists are labelled as -1. Thus, the presence of a pattern with 
positive weight “votes” for agonists or antagonists otherwise.  
c The index is zero-based, and it corresponds to bit position in the PubChem fingerprint. The fingerprint annotation is 
the description of each bit represented in the fingerprint. The last two columns show which group favors the patterns and 
their weights (wi) in the prediction. 
 
 
An interpretation of a non-linear classifier is more complicated, as the mapping mechanism original 
feature space x, 𝐱 ∈ {0, 1}d, to Hilbert space φ(x) is implicit. Therefore, it is impossible to explain the 
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model in the “feature level”.In the SVM methodology, the optimal decision boundary is only related to a 
few training observations, called support vectors. The presence or absence of other “non-support” vectors 
does not affect the model development. In the non-linear case, the prediction of a testing sample is given 
by the equation sign(∑ 𝛼i𝑦iK(𝐱ini=1 , 𝐱test)  + b), which consists of two components, support vector 
coefficients 𝜶  and “similarity score” between training and testing compounds. The final prediction 
generally is contributed by training compound i that shows a high similarity to the testing compound (K(𝐱i, 𝐱test)) and is heavily weighted by the support vector coefficient 𝛼i. As the decision boundary is 
determined by support vectors, we can examine the training compounds associated with a large value of 
𝛼i . The SVM model developed on all labeled compounds with Topomer kernel is illustrated. The 
distribution of 𝛼i𝑦i is characterized in Figure 5-9.  
 
 
 
 
Figure 5-9: The distribution of support vector coefficient 
The X-axis shows the product of support vector coefficient 𝜶𝐢 and compound label 𝒚𝐢. 
 
 
Similar to the appearance of Figure 5-8, the majority of training samples are not support vectors, except 
that the distribution of support vector coefficients has “thick tails” due to optimization constraint. The 
number of support vectors (𝛼i > 0.1) is 822, which is 48.4% of the whole training set. Mattera and 
Haykin 179 propose that a robust model may accommodate the condition that 50% of training data are 
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support vectors. Empirically, a large percentage of support vectors suggest overfitting the training data, 
while a lower percentage of support vectors may indicate lack-of-fit.  
 
5.4 CONCLUSION 
This chapter reports the investigation of linear and non-linear support vector machine (SVM) classifiers 
with the intention to distinguish agonists from antagonists of the human 5-HT1A receptor. The choice of 
molecular descriptors and kernel functions in SVM has been thoroughly discussed and analyzed. The test 
calculation shows that the Molprint 2D fingerprint, combined with RBF kernel function, yields the best 
prediction accuracy. Another innovation of the presented work is the integration of a 3D Topomer 
similarity distance into SVM through the proposed Topomer kernel function, without explicit vector 
representation of compounds. The mechanism of linear and non-linear SVM classifiers is illustrated by 
examining coefficient vector w and support vector coefficient vector α, respectively. Although only the 
classification of 5-HT1A agonists and antagonists is presented here, linear and non-linear SVM, as a 
generic classification tool, may be applied to address other challenges in computer-aided drug design.  
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6 GPU-ACCELERATED COMPOUND LIBRARY 
COMPARISON 
 
 
 
 
Chemical similarity calculation plays an important role in compound library design, virtual screening, and 
“lead” optimization. This chapter presents a GPU-accelerated method for all-vs-all Tanimoto matrix 
calculation and nearest neighbor search. By taking advantage of multi-core GPU architecture and CUDA 
parallel programming technology, the algorithm is up to 39 times superior to the existing commercial 
software that runs on CPUs. Because of the utilization of intrinsic GPU instructions, this approach is 
nearly 10 times faster than existing GPU-accelerated sparse vector algorithm, when Unity fingerprints are 
used for Tanimoto calculation. The GPU program that implements this new method takes about 20 
minutes to complete the calculation of Tanimoto coefficients between 32M PubChem compounds and 
10K Active Probes compounds, i.e., 324G Tanimoto coefficients, on a 128-CUDA-core GPU. 
  
125 
 
6.1 INTRODUCTION 
Combinatorial chemistry generates a large number of compounds and boosts the growth of various 
screening libraries. Thus, analysis and data mining of the vast quantity of compounds significantly 
contribute to the success of both virtual screening and high-throughput screening.180 Among the analysis 
schemes, chemical similarity calculation is a frequently used method in computer-aided drug design.181 
The concept of chemical similarity or molecular similarity is also heavily involved in molecular diversity 
analysis and combinatorial library design. Many methods have been established for this purpose, covering 
a wide range of molecular descriptors and data mining algorithms.66, 182-187 
Various cheminformatics algorithms have been developed for chemical similarity measurement. The 
Tanimoto coefficient between molecular fingerprints is still the most popular similarity metric, because of 
its computational efficiency and its relevance to biological profile 188-189. In addition, Database 
Comparison program in Tripos Sybyl98 uses Tanimoto coefficient to characterize the degree of similarity 
or overlapping between two compound libraries.190 Furthermore, Tanimoto calculation is also associated 
with modern machine learning algorithms, ranging from supervised kernel machine191 to unsupervised 
compound clustering.192-193 In these applications, an all-vs-all Tanimoto matrix, which contains Tanimoto 
coefficients between all pairs of compounds, needs to be calculated. This results in O(N2) time 
complexity, i.e., quadratic in the size of libraries. Despite the advance in computer hardware, exploring 
large chemical libraries, such as PubChem library, remains a substantial challenge.194-195 
With the emphasis on “green high performance computing”, the development of modern graphics 
processing units (GPU) points out potential solutions to these challenges. GPUs are specialized 
microprocessors for graphic rendering. Modern GPUs feature higher memory bandwidth and computing 
throughput in terms of floating point operations per second (FLOPS), compared to CPUs. Recently, GPUs 
have been applied to quantum chemistry and molecular dynamics, 196-197 as well as Tanimoto 
calculation.198-200 Haque et al.198  and Liao et al.199 reported sparse vector algorithm for all-vs-all 
Tanimoto matrix calculation on GPUs. The established sparse vector algorithm is proficient to process 
high-sparsity fingerprints. 
This chapter introduces a new algorithm to calculate Tanimoto coefficients between pairs of 
compounds, and to perform compound library comparison on GPUs. Different from Haque’s and Liao’s 
work , this algorithm achieves better performance when processing low-sparsity molecular fingerprints. 
Furthermore, compound library comparison can be executed on GPUs after Tanimoto coefficients are 
solved. In the present studies, we start with algorithm design, and then compare its performance with 
existing GPU and CPU algorithms using three different chemical libraries and three CPU or GPU systems. 
The results show that the program that implements this novel approach runs up to 39 times faster than the 
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Sybyl Database Comparison program and nearly 10 times faster than the existing GPU-based sparse 
vector algorithm. Furthermore, the program completes the calculation of 324G Tanimoto coefficients in 
20 minutes, for comparing 10K Active Probes compounds with PubChem library. The algorithm is 
implemented with graphical user interface (GUI) for ease of use. The binary, source code and user 
instruction are available at http://www.cbligand.org/gpu. The program can be customized to adapt any 
binary fingerprints and carry out kNN (k-nearest neighbor) search. 
6.2 METHODS AND CALCULATIONS 
6.2.1 Overview of Compound Library Comparison 
The concepts and details regarding the GPU-accelerated compound library comparison are described in 
this section. In cheminformatics, Tanimoto coefficient is one of the most popular chemical similarity 
indices, and is usually calculated based on binary molecular fingerprints. The Tanimoto coefficient 
between a pair of compounds that have molecular fingerprints a and b can be formulated as: 
abba
ab
NNN
NbaTanimoto
−+
=
)(
),(
 
where Nab is number of common “1” bits that occur in both fingerprint a and fingerprint b; Na is 
number of “1” bits in fingerprint a; Nb is number of “1” bits in fingerprint b.  In our calculation, Tanimoto 
coefficient is computed with Unity98 fingerprint as illustration, whereas other fingerprints can be applied 
as well. Unity fingerprint is a 992-bit binary vector, which encodes the presence or absence of a set of 
predefined structural patterns. 
The compound library to be compared to is named as reference library, while the other compound 
library is named as candidate library. The goal is to characterize how well the candidate library is 
represented in the reference library. Among established programs, Tripos Sybyl 190 examines the 
Tanimoto similarity between each candidate compound and its nearest neighboring compound (most 
similar compound) in a reference library. Let X denote an m × n Tanimoto matrix, in which Xi, j is the 
Tanimoto coefficient between the ith compound in candidate library and the jth compound in reference 
library. Finally, the distribution of y indicates the degree of overlapping between the two libraries, where 
y is an m-element vector and yi = max1≤ j ≤ n Xi, j for 1≤ i ≤ m. 
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Figure 6-1: Flowchart of similarity calculation on GPU 
The general workflow of compound library comparison on the computer hardware where a GPU is 
located 
 
Figure 6-1 shows the general diagram for compound library comparison on GPUs. First, Unity 
fingerprints are indexed and transferred to allocated graphical memory. Next, depending on the format of 
the indexed fingerprints, “Sparse Vector” kernel or “Integer Fingerprint” kernel is launched on a GPU to 
calculate the Tanimoto matrix, X. After the Tanimoto matrix calculation, a parallel reduction kernel is 
executed to identify the maximum of each row of X, i.e. yi. Finally, the distribution of yi is examined 
through computing and displaying its histogram.  
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6.2.2 Integer Fingerprint Algorithm on GPUs  
Tanimoto equation consists of three elements: Na, Nb and Nab. In library comparison, the number of “1” 
bits of each compound, Na or Nb, is used repeatedly. Thus, it is wise to pre-calculate Na and Nb in the 
fingerprint indexing procedure. In this algorithm, binary molecular fingerprints, such as Unity fingerprint, 
are saved into 32-bit integers. This approach reduces time and space complexity for low-sparsity 
fingerprints. First, one integer is capable of representing 32 fingerprint bits, so only 124 bytes are required 
to save the whole Unity fingerprint of any compound (Unity fingerprint has 992 bits). Furthermore, the 
throughput of calculating Nab can be guaranteed by efficient intrinsic “&” operator and population count 
(pop-count) instructions on GPUs. The “&” operator finds the common “1” bits between two 32-bit 
fingerprint fragments (A∩B), while the pop-count instruction returns the number of the common “1” bits. 
Therefore, the total number of common “1” bits between two fingerprints, i.e. Nab, can be obtained 
through applying “&” and pop-count instructions on every 32-bit fingerprint fragment.  
In GPU parallel programming, the ith thread block (or virtual GPU core) is responsible for the ith row 
of the Tanimoto matrix, Xi,●, and every thread in the block calculates one or more elements of Xi,●. Each 
thread block therefore compares a candidate compound to the whole reference library, and every thread in 
the block calculates the Tanimoto coefficients between the candidate compound and some reference 
compounds. For coalesced memory access, the reference and candidate library fingerprints are organized 
in column and row major 2D arrays, respectively. Figure 6-2A summarizes algorithm pseudo-code for a 
given thread block, and Figure 6-2B graphically illustrates the calculation procedure.    
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Data:    Na : the number of “1” bits of the ith candidate fingerprint; vector a contains the    
fingerprint fragments of the ith candidate compound; Njb 
Begin 
: the number of “1” bits of the jth 
reference fingerprint; vector bj contains the fingerprint fragments of the jth reference compound; 
M: the total number of compounds in the reference library; Dim: the number of fingerprint 
fragments or dimensions. Totally T threads are launched in a thread block (T = 256 in our 
implementation).  
Njb 
 
and bj reside in global memory. Fetch Na from constant memory to thread register; Fetch 
vector a from global memory to low-latency shared memory.  
for each thread with index t 
        for batch = 0 to ceil(M / T) - 1    
                j = t + batch × T 
                count = 0; 
                for k = 0 to Dim - 1  
                       tmp =  a[k] & bj[k] 
                       count += popc(tmp)  ‘ intrinsic population count function 
                end k  
                Tanimoto(a, bj) = count / (Na + Njb 
        end batch 
 - count) 
end thread t 
End 
(A) 
 
(B) 
 
Figure 6-2: Similarity calculation based on dense-format fingerprint 
(A) The pseudo-code for a GPU thread block to calculate the Tanimoto coefficients between a 
candidate compound and a reference library using integer fingerprint format; (B)Graphical 
illustration of Tanimoto calculation on a CUDA core. The GPU algorithm is designed to count 
the number of common elements between two 32-bit fingerprint fragments in one single step. 
(B)  
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6.2.3 Sparse Vector Algorithm on GPUs 
The calculation strategy of sparse vector algorithm is similar to the one of integer fingerprint algorithm 
previously mentioned: the ith thread block (or one virtual core) is responsible for the ith row of the 
Tanimoto matrix, and every thread in the block calculates one or more elements of that row. On the other 
hand, the sparse vector algorithm adapts an alternative approach to calculate Tanimoto coefficients 
between pairs of fingerprints, as reported by Haque et al. and Liao et al.198-199  
 
 
 
 
Figure 6-3: Illustration of data structure of sparse vectors.  
(A) original binary fingerprint format; (B) sparse vector format; (C) column major alignment for 
reference library; (D) row major alignment for candidate library 
 
Figure 6-3 illustrates the representation of fingerprints in sparse vector format. Figure 6-3A displays 
the fingerprints of the ith reference and jth candidate compounds in original binary format. Instead of using 
the binary format, the fingerprints can be indexed into sparse vector format as well. As shown in Figure 
6-3B, each element indicates the index, of which the bit is “1” in the binary format, and the indices are 
sorted in an increasing order. In Tanimoto matrix calculation, the fingerprints from reference library and 
candidate library are organized in a column-major (Figure 6-3C) and row-major (Figure 6-3D) layout in 
order to achieve coalesced memory access. Sparse vectors of a compound library are sorted according to 
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vector length with the intention of minimizing the possibility of divergent execution branches. For a 
specific pair of reference and candidate compounds, Figure 6-4 outlines the algorithm to calculate the 
Tanimoto coefficient between them. 
 
Data:    vector a contains the sparse-vector fingerprint of a candidate compound, a resides in 
GPU’s shared memory; Na : the length of vector a; vector b contains the sparse-vector fingerprint 
of a reference compound; Nb : the length of vector b; 
 
Begin 
count = 0; 
i = j = 0; 
while  i < Nb and j  < Na 
        buffer = b [i]          ‘retrieve an element from global memory to thread register 
        while j < Na and a[j] < buffer 
               j++ 
        end while 
        if a[j] == buffer 
                count++ 
        end if  
        i++ 
end while 
Tanimoto(a, b) = count / (Na + Nb - count) 
End 
 
Figure 6-4: Tanimoto coefficient and sparse vector fingerprint 
The pseudo-code for calculating the Tanimoto coefficient between a specific pair of compounds that are 
represented in sparse vector fingerprints   
 
6.2.4 Find Maximum Tanimoto and Create Histogram on GPUs 
A parallel divide-and-conquer algorithm is used to find the maximum values of Tanimoto coefficients. 
Every thread block is in charge of searching the maximum value from one row of the Tanimoto matrix. In 
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a block, threads independently find the local maximum values from disjoint sets of Tanimoto coefficients. 
Then, parallel reduction step determines the global maximum (yi) of each row.  
Despite its simple idea, histogram creation is a non-trivial job on GPUs, because GPUs have a limited 
amount of memory allowing low-latency random access. In this case, GPU threads maintain conflict-free 
counters to create sub-histograms in parallel. Finally, a 100-bin histogram is generated by merging all the 
sub-histograms. This histogram displays the distribution of yi and depicts the degree of similarity between 
two compound libraries.  
6.2.5 Computation Protocols 
The computing performance of the established GPU-accelerated algorithms was evaluated through 
comparing three compound libraries against each other. For the three libraries, 992-bit Unity fingerprints 
were generated by Tripos Sybyl software and formatted into the data structures required by sparse vector 
or integer fingerprint algorithms. 
 
 
Table 6-1:  The number of compounds and coverage statistics for three testing compound libraries.  
 
Librar
y ID 
No. of 
Molecules 
Lowest 
Coverage (%) 
Average 
Coverage (%) 
Highest 
Coverage (%) 
A 9902 5.2 19.8 43.2 
B 24755 5.3 18.7 44.4 
C 56079 2.4 19.1 41.8 
Coverage ratio is defined as the percentage of “1” bits in the 992-bit Unity fingerprint. Library A was 
generated from TimTec 10K-Active-Probes library (http://www.timtec.net/actiprobe-10k.html); Library B 
was generated from TimTec 25K-Active-Probes library (http://www.timtec.net/actiprobe-25k.html); 
Library C was generated from Maybridge Screening Collection. 
 
 
Details regarding the testing compound libraries can be found in Figure 6-1, including the TimTec 
libraries (Library A and B) and Maybridge Screening Collection (Library C). Sometimes, a data entry in 
SDF files may contain two or more separate structures, e.g., compound and organic solvent, and such 
entries have been removed from these libraries. The coverage statistics in Table 6-1 reflects the sparsity 
of Unity fingerprints, when applied on the sample libraries. 
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The GPU integer fingerprint and sparse vector algorithms were implemented in our CudaCLA 
program. The executable file, together with source code and documents, is available 
at http://www.cbligand.org/gpu. The program was compiled by Visual Studio C++ 2005 and CUDA 3.0 
toolkit, and implemented with graphical user interface. For comparison studies, we selected three 
computer systems, including:  
● Machine 1: CPU: Intel Xeon 5160 at 3.0 GHz 
● Machine 2: CPU: AMD Athlon 3800+ at 2.0 GHz; GPU NVIDIA Quadro FX 580 (32 CUDA cores 
at 1.12 GHz); NVIDIA drivers: 197.13 
● Machine 3: CPU: Intel Core i7 860 at 2.8 GHz; GPU NVIDIA Geforce GTS 250 (128 CUDA cores 
at 1.78 GHz); NVIDIA drivers: 197.13 
The performance of our GPU program was compared to the commercial Sybyl Database Comparison 
190 program. Sybyl Database Comparison program, as a CPU program, was tested on the three machines, 
while the performance of integer fingerprint and sparse vector algorithms were tested on GPUs of 
machine 2 and 3. It is worth pointing out that the Sybyl Database Comparison program is also based on 
Unity fingerprints. 
6.3 RESULTS AND DISCUSSION 
The GPU-accelerated compound library comparison is developed for the first time using integer 
fingerprint algorithm, and its performance is summarized in Table 6-2 and Table 6-3. For comparisons, 
the performance of sparse vector algorithm is listed in Table 6-4 and Table 6-5. In the tables, the 
calculation time includes the time spent on graphical memory allocation, data transfer, Tanimoto 
calculation using either algorithm, searching for the maximum values, and histogram creation (the 
procedures enclosed by dotted line in Figure 6-1). Tanimoto matrix calculation generally accounts for 
more than 95% of the GPU time. Therefore, kTaninotos/sec (kilo Tanimoto coefficients per second) is 
simply used as performance metric. The results from testing the Sybyl Database Comparison program on 
the three machines can be found in Table 6-6.  
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6.3.1 GPU-based Sparse Vector Algorithm Compared with Published Results 
Our implementation of sparse vector algorithm achieved an average throughput of 28634 kTanimotos/sec 
on GTS 250, the graphics device of machine 3 (Table 6-5). Haque et al. 198 attained 60900 to 64230 
kLINGOS/sec on the same GPU, GTS 250. Despite certain difference between Tanimoto and LINGO, the 
same underlying algorithms find the overlapping structural patterns. In addition, the sparse vector 
algorithm has a linear time complexity in the length of sparse vectors. The average length of sparse 
vectors in Haque’s work ranged from 29.31 to 31.65 out of thousands of possible patterns. On the other 
hand, the average of sparse vectors in our sample libraries ranged from 185 to 196 out of a total of 992. 
Given the lower sparsity of the Unity fingerprints and the longer length of the sparse vectors in this study, 
the performance of our implementation of sparse vector algorithm was comparable to Haque’s results. 
Similarly, Liao et al.199 reported that all-vs-all Tanimoto matrix calculation for PB83 library took 17.1 
seconds on device GTX 280 (240 CUDA cores). In their study, PB83 library contained 27674 molecules, 
and the maximum length of sparse vectors was 459. In our case, the library comparison of Library B to 
itself (Table 6-5) took 20.45 seconds on GTS 250 (128 CUDA cores). Library B contained 24755 
molecules and the maximum length of sparse vectors was 440, which was similar to PB83. Note that 
GTX 280 had higher memory bandwidth and more cores than GTS 250. Although these experiments were 
carried out with different machines, fingerprints and datasets, the side-by-side analysis showed that the 
performance of our implemented sparse vector algorithm was at the same magnitude of published results. 
Table 6-2: The computation performance using integer fingerprint algorithm on machine 2 
 
Reference and 
Candidate 
Libraries 
Time (sec) Throughput 
(kTanimotos/sec) 
Effective Bandwidth 
(GB/sec) 
A vs A 2.16 45477 5.75 
A vs B 5.30 46284 5.86 
A vs C 11.97 46398 5.88 
B vs A 5.25 46690 5.91 
B vs B 13.30 46086 5.84 
B vs C 29.61 46885 5.94 
C vs A 11.83 46974 5.95 
C vs B 29.58 46934 5.94 
C vs C 68.09 46184 5.85 
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Table 6-3: The computation performance using integer fingerprint algorithm on machine 3 
Reference and 
Candidate 
Libraries 
Time (sec) Throughput 
(kTanimotos/sec) 
Effective Bandwidth 
(GB/sec) 
A vs A 0.47 209507 26.43 
A vs B 0.95 257483 32.68 
A vs C 2.12 261684 33.18 
B vs A 0.94 261884 33.03 
B vs B 2.29 267136 33.90 
B vs C 4.85 286175 36.26 
C vs A 2.00 278064 35.17 
C vs B 4.80 288914 36.63 
C vs C 11.37 276519 35.03 
Table 6-4: The computation performance using sparse vector algorithm on machine 2 
Reference and 
Candidate 
Libraries 
Time (sec) Throughput 
(kTanimotos/sec) 
A vs A 22.11 4434 
A vs B 52.92 4631 
A vs C 122.75 4523 
B vs A 53.33 4596 
B vs B 126.63 4839 
B vs C 295.00 4705 
C vs A 122.14 4546 
C vs B 291.38 4764 
C vs C 674.17 4664 
Table 6-5: The computation performance using sparse vector algorithm on machine 3 
Reference and 
Candidate 
Libraries 
Time (sec) Throughput 
(kTanimotos/sec) 
A vs A 3.68 26636 
A vs B 8.71 28158 
A vs C 20.08 27658 
B vs A 8.63 28413 
B vs B 20.45 29963 
B vs C 47.35 29320 
C vs A 19.53 28429 
C vs B 46.54 29831 
C vs C 107.33 29301 
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6.3.2 Integer Fingerprint Algorithm versus Sparse Vector Algorithm 
Sparse vector algorithm is designed to handle high-sparsity molecular fingerprints. Nevertheless, many of 
the popular molecular fingerprints are binary and have low sparsity, such as Unity, FP2, MACCS, and 
PubChem fingerprints. The integer fingerprint algorithm is capable of attaining higher computation 
efficiency for these types of fingerprints, because it can process many fingerprint “bits” in a single 
iteration. On the contrary, the sparse vector algorithm scans through every present structural pattern to 
search for the overlapping ones. Moreover, the “while” and “if-else” statements in the algorithm easily 
result in divergent execution paths on GPU, which reduces the degree of parallelism. The advantage of 
integer fingerprint algorithm on low-sparsity fingerprint is demonstrated by the experiment. As shown in 
Table 6-4 and Table 6-5, the throughput of sparse vector algorithm varies from 4434 kTanimotos/sec to 
4839 kTanimotos/sec on the GPU of machine 2, and from 26636 kTanimotos/sec to 29963 
kTanimotos/sec on the GPU of machine 3. Integer fingerprint algorithm delivers much higher throughput 
ranging from 45477 to 46974 on the GPU of machine 2 (Table 6-2), and from 209507 kTanimotos/sec to 
288914 kTanimotos/sec on the GPU of machine 3. Among the nine cases, integer fingerprint algorithm is 
9.5 to 10.3 times faster than sparse vector algorithm on machine 2, and 7.9 to 9.8 times faster than sparse 
vector algorithm on machine 3.  
The performance of integer fingerprint algorithm is further assessed by effective memory bandwidth 
(the rate at which data is read from, and stored to graphical memory). The effective bandwidth of library 
comparison using integer fingerprint algorithm can be determined according to the following equation: 
 
Where n is the size of a candidate library, and m is the size of a reference library. Each virtual core 
reads a candidate fingerprint into cache and compares it to the whole reference library. As there are n 
candidate compounds and a Unity fingerprint occupies 124 bytes, the Tanimoto matrix calculation reads n 
× (m + 1) × 124 bytes from graphical memory. The number of “1” bits of reference fingerprints and 
candidate fingerprints are accessed by each core, which brings n × (m + 1) × 4 byte data. The Tanimoto 
matrix has n × m float-type (32-bit) elements. The matrix is accessed twice (matrix generation and 
searching for maximum Tanimoto coefficients). GPU therefore reads and writes n × m × 2 × 4 bytes. 
Finally, the array containing the maximum of each row of the Tanimoto matrix is accessed, which leads 
to input and output of n × 2 × 4 bytes. In fact, the effective memory bandwidth is somehow 
underestimated by this equation, because the total calculation time includes some other procedures, such 
as memory allocation and host-to-device data transfer. 
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As summarized in Table 6-2 and Table 6-3, the implemented integer fingerprint achieved average 
effective bandwidth of 5.88GB/sec on machine 2 and 33.59GB/sec on machine 3. The program from 
NVIDIA SDK17 was used to test peak memory bandwidth, revealing that the GPU of machine 2 had 
12.88GB/sec device-to-device copy bandwidth, and the GPU of machine 3 had 57.36GB/sec device-to-
device copy bandwidth. The program therefore made good utilization of hardware resources. 
Due to the use of intrinsic instructions (“&” operator and population count), integer fingerprint 
algorithm yielded much higher throughput than sparse vector algorithm regarding Tanimoto calculation. 
The analysis on effective memory bandwidth further depicted absolute computation performance. As a 
result, integer fingerprint algorithm is considerably superior to sparse vector algorithm when Tanimoto 
coefficient is measured on low-sparsity fingerprints, e.g., Unity fingerprint. 
6.3.3 Performance of GPU- and CPU-based Programs for Compound Library 
Comparison 
Table 6-6: The computation performance of Sybyl Database Comparison Program  
 
 Machine 1 Machine 2 Machine 3 
Reference and 
Candidate 
Libraries 
Time 
(sec) 
a Effective 
Throughput 
(kTanimotos/sec)  
Time 
(sec) 
a Effective 
Throughput 
(kTanimotos/sec)  
Time 
(sec) 
a Effective 
Throughput 
(kTanimotos/sec)  
A vs A 8.38 11689 34.38 2852 10.58 9267 
A vs B 23.60 10385 90.19 2718 29.38 8343 
A vs C 78.77 7049 306.57 1811 98.02 5663 
B vs A 21.96 11161 86.14 2845 27.78 8823 
B vs B 52.98 11569 208.63 2937 66.17 9260 
B vs C 190.91 7268 748.42 1854 235.45 5895 
C vs A 73.34 7568 284.55 1951 91.59 6061 
C vs B 176.48 7846 689.49 2013 225.55 6152 
C vs C 393.43 7988 1535.34 2047 511.54 6143 
a For easy comparison, the effective throughput is approximated assuming that the program finishes the whole 
Tanimoto matrix calculation, which is not necessarily required in practice. The throughput is in the unit of 
kTanimotos/sec. 
 
 
Table 6-6 shows that Sybyl Database Comparison, as a traditional CPU program, runs fastest on machine 
1, with an average throughput of 9169kTanomotos/sec. Nevertheless, the program yields an average 
throughput of 2336 kTanimotos/sec on machine 2 and 7290 kTanimotos/sec on machine 3. Thus, the 
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performance of Database Comparison program on machine 1 is compared to the GPU program. The GPU 
implementation of compound library comparison using integer fingerprint algorithm shows an average 
5.28 times speedup on the GPU of machine 2 (Table 6-2) in comparison with Sybyl Database Comparison 
program on machine 1 (Table 6-6). Further speedup can be seen on machine 3. Table 6-3 and Table 6-6 
show that the GPU implementation is up to 39.47 times as fast as the CPU program, and 30.44 times 
speedup on average. FX 580 (the graphic device in machine 2) is considered as a low-end or entry-level 
device, as it only has 32 CUDA cores. Nevertheless, the GPU program still runs much faster than the 
commercial CPU program. This is mainly due to the multi-core parallel computing architecture of modern 
GPUs. In the GPU program, multiple threads are launched concurrently for Tanimoto calculation, 
searching for the maximums, histogram creation, and so on.  
Additionally, the GPU program using sparse vector algorithm shows an average 3.26 times speedup 
relative to Sybyl Database Comparison program, when run on machine 3 (see Table 6-5 and Table 6-6). 
Nevertheless, the implementation using sparse vector algorithm is not necessarily as fast as the CPU 
program, when tested on machine 2. The integer fingerprint algorithm significantly outperforms the 
Database Comparison program even on low-end device, whereas the sparse vector algorithm only shows 
moderate speedup on machine 3. These results illustrate the fact that extra attention is required for GPU 
algorithm design and implementation in order to achieve optimal performance. 
6.3.4 Validation on PubChem Database 
The integer fingerprint algorithm was further tested on a large compound database with the intention to 
examine its scalability and consistency. In this experiment, Library A (9902 compounds) was compared 
with 32.79M PubChem structures (by April 2011). The computation was performed on machine 3, and 
324.69G Tanimoto coefficients were generated. Figure 6-5 plots the amount of aggregated time as a 
function of the number of PubChem structures. The whole process took 1279 seconds, and GPU time 
accounted for 94% of it, i.e., 1207 seconds. Thus, the average throughput was 269041 kTanimotos/sec, 
which resembled the results summarized in Table 6-3. Figure 6-5 also reveals that the elapsed time is 
strictly linear to the quantity of processed structures, suggesting that the program generates stable 
throughput regardless of diverse structures.  
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Figure 6-5: The plot of elapsed time versus processed PubChem compounds.  
Dashed line shows the elapsed GPU time as a function of the number of compounds. The GPU time 
includes time allocated for host-device data transfer, Tanimoto matrix calculation, histogram creation, and 
so on (Figure 6-1). The solid line demonstrates the total calculation time. This is equal to GPU time plus 
CPU time. CPU time is for hard drive I/O, task scheduling, etc. 
 
6.4 CONCLUSION 
The ever-growing chemical libraries demand the development of efficient algorithms and programs for 
chemical similarity calculation that plays a fundamental role in cheminformatics. As a similarity index, 
Tanimoto coefficient is widely involved in data mining of small molecules, such as compound clustering, 
diversity analysis, and k-nearest-neighbor search (kNN). The quadratic time complexity in the number of 
compounds could be a problem for these techniques, particularly when large compound datasets are 
presented.  Parallel Tanimoto calculation on modern GPUs points out a potential solution to these 
challenges. In this chapter, we report a GPU-accelerated integer fingerprint algorithm and its application 
for calculating Tanimoto coefficients. The test calculation shows that the integer fingerprint algorithm 
runs up to 10 times faster than the published sparse vector algorithm on GPUs, and up to 39 times faster 
than the CPU-based commercial program. The GPU-accelerated integer fingerprint algorithm produces 
high throughput for low-sparsity binary fingerprint. For example, more than 200 million Tanimoto 
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coefficients can be calculated every second on a decent device, such as GTS 250. With this speed, 
comparing a 9902 Active Probe compounds with PubChem library, that has totally 324G Tanimoto 
coefficients to calculate, can be completed in about 20 minutes. In this study, compound library 
comparison can be interpreted as 1-nearest-neighbor search. This approach could be easily upgraded to k-
nearest-neighbor search by a minor modification (The source code is accessible 
at http://www.cbligand.org/gpu). Additionally, the all-vs-all Tanimoto matrix calculation in the GPU 
program can also be adapted by other algorithms. Currently, we are conducting the application of the 
GPU-based algorithm to modeling quantitative structure-activity relationship for large datasets. 
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7 COMPOUND ACQUISITION ALGORITHM 
 
 
In this chapter, a compound acquisition and prioritization algorithm is reported for rational chemical 
library purchasing or compound synthesis in order to increase the diversity of an existing compound 
collection. This method was established based on chemistry-space calculation using BCUT (Burden CAS 
University of Texas) descriptors. In order to identify the acquisition of compounds from candidate 
collections into the existing collection, a derived distance-based selection rule was applied, and the results 
were well supported by pairwise similarity calculations and cell-partition statistics in chemistry space. 
The correlation between chemistry-space distance and Tanimoto similarity index was also studied to 
justify the compound acquisition strategy through weighted linear regression. Then, a case study is 
followed to demonstrate its application in real world chemical synthesis. As a rational approach for 
library design, the distance-based selection rule exhibits certain advantages in prioritizing compound 
selection to enhance the overall structural diversity of an existing in-house compound collection or virtual 
combinatorial library for in silico screening, diversity oriented synthesis and high-throughput screening. 
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7.1 INTRODUCTION 
   Although modern HTS technologies can screen millions of compounds more quickly and cheaply than 
ever before, it is still challenging for a small pharmaceutical company or an academic institution to cover 
the costs in the absence of significant funds. Moreover, interrogating a large number of compounds 
generates unmanageable false positives. Thus, it is particularly necessary and important to build high-
quality compound screening sets for some bioassays that have low screening throughput capacity or are 
limited by the availability of key reagents (e.g., antibodies, primary cells, or whole organism systems). In 
contrast to a large combinatorial screening collection that targets structural variations for structure-
activity relationship (SAR) studies, a high-quality screening compound set built by rational acquisition of 
structurally diverse compounds potentially improves the HTS/HCS hit rate while preserving resources.   
To build a compound collection for virtual screening or high-throughput screening, an ideal strategy seeks 
balanced tradeoff between overall molecular diversity and the number of compounds. Molecular diversity 
may be assessed by the variety of molecular properties, which is encoded by molecular descriptors such 
as physicochemical properties, topology index, or fingerprints.201 Enhancing molecular diversity or 
removing redundancy can be achieved by four categories of approaches: cluster-based method, 
dissimilarity-based method, cell-based method and optimization-based method.202 A cluster-based method 
is implemented to assign compounds into groups so that compounds possess higher within-group 
similarity than between-group similarity.203 Once compound similarity is solved, a hierarchy-clustering 
algorithm, such as neighbor joining, or non-hierarchy algorithm, such as K-means, can be carried out for 
clustering. The motivation for applying a chemical dissimilarity-based method is to maximize the total 
dissimilarity between each pair of nearest neighboring compounds.204 Relying on some linear or non-
linear binning procedure, a cell based method aims to cover more cells with a minimal number of 
compounds, categorizing compounds in the same cell as similar.60 An optimization-based approach 
enhances the diversity by optimizing the object function that may incorporate a set of descriptors to 
measure the molecular diversity in different criteria.205-206 Although the approaches involving molecular 
diversity are frequently mentioned, there is still no widely accepted quantitative procedure for the 
prioritization and acquisition of new compounds to increase the structural diversity of an existing 
compound collection. 
    Among various molecular descriptors, BCUT descriptors58-61 incorporate comprehensive information 
regarding molecular structure, atom property and more into decimal numbers. A general description of 
BCUT descriptors is given in section 2.2.3 Topological Descriptor. Creating BCUT descriptors is one of 
the most popular approaches to construct low-dimensional chemistry space and perform diversity 
analyses. The performance of BCUT descriptors has been validated through previous QSAR studies62-64 
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and successful applications in library design.207-208 While BCUT descriptors demonstrate the relevance of 
generating a representative PubChem library65 and diversity analysis,66 I am expanding their use for the 
acquisition of new candidate compounds from external compound collections, in order to optimize an 
existing in-house screening set and increase its overall diversity. 
    A compound acquisition and prioritization algorithm is established on the Euclidean distance in BCUT 
chemistry space. This method is validated using weighted linear regression between the Euclidean 
distance and similarity index. Results from two case studies demonstrate that the selected subsets of 
external candidate compound collections enhanced the overall chemical diversity of an existing in-house 
screening collection, according to chemistry-space cell partition statistics and similarity index. 
Discussions are also presented on distance cutoff value and disagreement between the chemistry-space 
distance and similarity index. The algorithm provides useful information to facilitate decision-making for 
acquiring new candidate compounds and prioritizing compound syntheses.  
7.2 ALGORITHM DESIGN AND EXPERIMENTAL PROTOCOLS 
7.2.1  BCUT Chemistry Space and Compound Acquisition Protocol 
The established compound acquisition and prioritization algorithm is based on BCUT chemistry-space 
calculation using the protocol reported.65 Briefly,  BCUT descriptors60 are defined by combining atomic 
descriptors for each atom and description of the nominal bond-types for adjacent and nonadjacent atoms 
into BCUT matrices. The value of each chemistry-space coordinate is specified as the highest or lowest 
eigen-value of BCUT matrix. In this project, the Diverse Solutions program (Tripos Sybyl 8.0) 5 was used 
to generate a set of default 2D BCUT descriptors that covered different scaling factors and atomic 
properties, including H-bond donor, H-bond acceptor, partial charge and polarity. The optimal 
combination of descriptors was selected automatically by the program to construct BCUT chemistry 
space, with the restriction that the correlation coefficient between any pair of BCUT descriptors was less 
than 0.25. 
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Figure 7-1: Motivation of compound acquisition protocol 
A graphic representation of BCUT chemistry space to illustrate the concept and effect of the density 
of an existing compound collection. The compound collection with low density (A) sparsely covers the 
BCUT chemistry space, while the one with high density (B) exhausts the chemistry space more 
specifically. The choice of distance cutoff value depends on the density of the existing compound 
collection. 
 
 
 
The computational protocol of the compound acquisition and prioritization algorithm using chemistry-
space distance calculation is summarized below: 
1. Initialization: define BCUT chemistry space and specify a distance cutoff value, c based on 
Distance Threshold calculated below. 
2. Iteration: for each compound, j, in the candidate compound collection, 
a. Calculate its distance to the nearest neighbor from the current compound collection, 
S: 
ij
i
j xyD −= min  
yj is the descriptor vector of candidate compound j, and xi is the descriptor vector of 
compound i in the current compound collection, S. 
b. If the distance to the nearest neighbor Dj > c, then add the compound j into the 
current compound set: S ← S + candidate compound  j. 
c. Go to step 2 to analyze next candidate compound. 
  
This method is rationally justified through the correlation studies between Euclidean distance in the 
BCUT chemistry space and Tanimoto coefficient from MACCS key fingerprints. The results are given 
later.  
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7.2.2  Distance Threshold 
By default, the distance cutoff value, c, is defined as the estimated density of the existing compound 
collection according to the equation, 
∑
=
≠ −=
N
j
jijii xxN
c
1
,min
1
 
where i, j are the compound indices for the existing collection. The density indicates how well the 
chemistry space was explored or exhausted in the previous experiment. Thus, the new candidate 
compounds are also expected to cover the chemistry space in a similar pattern. Figure 7-1 illustrates how 
the density of an existing compound collection affects the choice of acquired compounds. Candidate 
compounds with large distance to their nearest neighbors in the existing collection are considered 
dissimilar to the compounds in the existing collection, and such candidate compounds are recommended 
for acquisition (like points “a” and “b” in Figure 7-1A). On the other hand, the candidate compound, “c” 
in Figure 7-1A, is excluded from the acquisition list due to its short distance to its nearest neighbor, “d”.  
However, the compound, “f” in Figure 7-1B, is still to be acquired, although the distance to its nearest 
neighbor “e” is almost the same as the distance between “c” and “d” (Figure 7-1A). The different 
acquisition decisions for similar circumstance can be explained by the density of two existing compound 
collections. In Figure 7-1A, the established compound dataset may be primarily designed to search the 
chemistry space sparsely. The high-density dataset in Figure 7-1B may explore the chemistry space more 
thoroughly. Therefore, the decision-making relies on the profile of the existing compound collection. In 
this method, the default distance threshold is equal to the density of the existing compound collection.  
7.2.3 Molecular Diversity Analyses 
A structurally diverse compound collection is expected to cover well-defined chemistry space uniformly. 
The chemical diversity of a compound dataset may be measured in a binning procedure209. The binning 
procedure is used to generate “cells” in a multi-dimensional descriptor space. Each dimension is divided 
uniformly into a finite number of “bins”. The bin-definition defines multi-dimensional “cells”, which 
cover the entire space. The chemical diversity could be accessed by counting the number of filled cells. 
As illustrated in Figure 7-2, the concepts regarding a bin and a filled/void cell are given in a hypothetical 
plot of two-dimensional BCUT chemistry space. As shown in the plot, the acquired compound filling a 
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void cell is believed to increase the overall structural diversity. On the other hand, the new compound in 
the cell that already has compounds (red dots) from the existing compound collection does not contribute 
to increase structural diversity and is not recommended to be acquired or purchased.60  
 
 
 
 
Figure 7-2: Two-dimensional chemistry space and filled/void cells  
 
 
In this study, four-dimensional instead of two-dimensional chemistry-space was constructed. The entire 
space was partitioned into 1004 cells with the same volume by dividing each axis into 100 bins equally. 
Each cell was indexed by (I1, I2, I3, I4). Indices Ik were integers ranging from 0 to 99. A cell indexed by 
(I1, I2, I3, I4) represented a subspace R(I1, I2, I3, I4) = { (x1, x2, x3, x4): Ik × 0.1 ≤ xk< Ik × 0.1+0.1, k=1, 2, 3, 
4 }. Finally the number of filled void cells by candidate compounds was sorted out to describe diversity 
increment. 
Candidate compounds could also be compared to an established compound collection to characterize 
the degree of similarity between two compound datasets, according to molecular fingerprint.  This 
approach measures how closely the candidate compounds are represented in the existing compound 
collection by Tanimoto coefficient.14 The degree of similarity between candidate compounds and the 
existing compound collection was evaluated by Database Comparison program (Tripos Sybyl) based on 
UNITY fingerprint, as described below. 
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7.3 RESULTS AND DISCUSSION 
Similar to other drug screening centers or institutes, the University of Pittsburgh Drug Discovery Institute 
(UPDDI) faces the issue of building a high-quality chemical library in terms of library size and structural 
diversity associated with the cost of purchasing and storage.  In this section, the rationality of the 
compound acquisition and prioritization algorithm, together with its application, is presented through 
guiding candidate compound acquisition in order to increase diversity of the current PMLSC screening set 
that contains 230k compounds from the Pittsburgh Molecular Libraries Screening Center (PMLSC, 
pmlsc.pitt.edu). For this illustration, two commercial libraries, TimTec 3k Natural Derivatives Library 
(NDL)210-211 and TimTec 2k Active Probes Library (APL) were selected as candidate compound 
collections, from which compounds were prioritized and selectively deposited into the PMLSC screening 
set.  
 
 
Table 7-1: The specifications of BCUT descriptors for constructing four-dimensional chemistry space 
 
Diagonal Element Off-
diagonal 
Element 
Scaling 
factor 
Remove(R) or 
keep(K) hydrogen 
Use lowest(L) or 
highest(H) Eigen 
value 
GasTchrg 
(Atomic Charge) 
Burden 0.1 R H 
Haccept (HBA) Burden 0.9 R H 
Hdonor (HBD) Burden 0.75 R H 
Tabpolar (polarity) Burden 0.5 R H 
 
 
Four atom properties (partial charge, polarity, H-bond donor, and H-bond acceptor in diagonal elements) 
were considered to calculate BCUT. According to PMLSC screening set, the best combination of scaling 
factor and the choice of eigen-value were selected to construct chemistry space. The value of each BCUT 
descriptor was scaled to range from 0 to 10. The distribution of each BCUT descriptor of the PMLSC 
screening set is shown in Figure 7-3, and the specifications of BCUT descriptors are listed in Table 7-1. 
The correlation coefficient, r2, between any pair of dimensions was less than 0.11, suggesting that every 
dimension independently described different aspects of molecular properties.  
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Figure 7-3: The distribution of four chemistry-space descriptors for the PMLSC screening set 
(a) the histograms of atomic partial charge descriptor, (b) H-bond acceptor descriptor, (c) H-bond 
donor descriptor, and (d) polarity descriptor. 
 
 
In the compound selection or prioritization algorithm, high acquisition priority was assigned to the 
candidate compounds that had large chemistry-space distances to their nearest neighbors in the existing 
compound collection. For the validation of this method, 1991 pairs of compounds were selected 
sequentially from the Active Probes Library (APL) in order to study the correlation between Tanimoto 
coefficient (Tc) and chemistry-space distance through weighted linear regression. MACCS 9 key 
molecular fingerprints were then generated to calculate Tanimoto coefficient for these compounds pairs, 
and their chemistry-space distances were evaluated in the chemistry space defined by PMLSC screening 
set. Figure 7-4A displays the scatter plot of the raw Euclidean distance in chemistry space and the 
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calculated Tanimoto coefficient (Tc) similarity score of 1991 pairs of compounds in APL. The Tc values 
of 1991 compound pairs range from 0.023 to 1.000 and their distances range from 0.002 to 12.824.  
 
 
 
Figure 7-4: Correlation between Tanimoto Coefficient and Euclidean distance in BCUT chemistry space 
(A) The scatter plot between the Euclidean distance in BCUT chemistry space and Tanimoto 
coefficient (Tc) of 1991 pairs of compounds in Active Probes Library (APL). The fitted regression line 
and five labeled outliers are also shown. The Tanimoto coefficients are calculated according to MACCS 
fingerprint; (B) The scatter plot of Tanimoto coefficient (Tc) and transformed Euclidean distance for the 
1991 pairs of APL compounds with the weighted regression line. The weight for each point is its Tc 
value. 
 
 
For a correlation study, the distance in chemistry space was transformed to normalize its variance as a 
function of Tc (Figure 7-4B). As fingerprints were developed to measure compound similarity instead of 
dissimilarity,60 weighted regression was performed to emphasize the significance of high Tc values. 
Figure 7-4B shows the scatter plot of D×2 (D: chemistry-space distance along y-axis) and Tanimoto 
coefficient (Tc along x-axis) of 1991 pairs of APL compounds together with the fitted regression line. 
The regression equation was then solved as: 
 Tc2 ×+=× βαD
 
where α = 6.13, β = -5.23; and the correlation coefficient, r2, was 0.61.  
    The corresponding normal Q-Q plot of regression residuals is shown in Figure 7-4C. Q-Q plot is an 
effective technique to examine the distributions of two sets of samples by plotting quantiles against each 
other. According to the Q-Q plot, the distribution of regression residuals that were the difference between 
fitted values and corresponding observed values was close to standard normal distribution, allowing for 
hypothesis testing to examine the correlation of those two variables. Based on Figure 7-4B, hypothesis 
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testing resulted in a two-sided p-value < 0.0001, which was strongly against null hypothesis 0=β and 
favored alternative hypothesis 0≠β . This statistical result suggested a fine negative correlation between 
the chemistry-space distance and Tanimoto coefficient calculated by MACCS fingerprint. Therefore, 
candidate compounds with large distances to their nearest neighbors were expected to be dissimilar to the 
compounds in the existing compound collection, and acquiring such compounds would efficiently 
enhance the overall chemical diversity. 
    Despite favorable correlations, discrepancies still existed between chemistry-space distance and Tc, as 
illustrated by five pairs of labeled outliers in Figure 7-4A. The structures of the compound pairs are listed 
in Table 7-2. MACCS fingerprint based similarity Tc calculation did not detect the structural difference 
for the compound pair 1 (AP-49 and AP-50), showing a Tc value of 1.0 (Table 7-2). However, the 
distance between them was considered to be relatively large (distance = 1.16) in the BCUT chemistry 
space, which could reflect different π-conjugated systems between two compounds. The subtle feature is 
sometimes important for biological activities. On the other hand, the compound pair 2 (AP-526/AP-527) 
and pair 3(AP-230/AP-231) were quite similar with reported distance of 0.031 and 0.095 respectively, 
while the Tc value was less than 0.85, indicating structural difference between them. The large distances 
between compound pair 4 and pair 5 (distance = 6.65 and 4.61 respectively) were essentially due to the 
BCUT polarity descriptor. 
 
 
 
Figure 7-5: Histogram and probability density 
(A) The histogram of the distances between nearest neighboring compounds in the existing screening 
collection. (B) The normalized histogram with fitted exponential probability density function (PDF). The 
default distance cutoff value is 0.072. 
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Table 7-2: Five pairs of compounds illustrate some outliers in Figure 7-4A.  
 
Compound Pair Distance Tc 
 
AP-49 
 
AP-50 
1.16 1.0 
 
AP-526 
 
AP-527 
0.031 0.44 
 
AP-230 
 
AP-231 
0.095 0.53 
 
AP-1685 
 
AP-1686 
6.65 0.81 
AP-1665 
 
AP-1666 
4.61 0.85 
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For example, the calculated electric dipole of compound AP-1665 was 2.61 Debye, while the dipole of 
AP-1666 was 5.34 Debye (according to original structure and Gasteiger–Hückel charge). Thus, BCUT 
descriptors characterize structural topology together with atom properties and possess certain advantages 
for constructing low-dimensional chemistry space, compared to molecular fingerprint.  
 
 
The distribution of distances between all pairs of nearest-neighboring compounds in the PMLSC 
screening set is shown in Figure 7-5A.  The probability density function (Figure 7-5B) of exponential 
distribution was fit to the normalized histogram: .0,072589.0);exp(1)( ≥=−= xxxf λ
λλ
  
Thus, the expectation of distance between one pair of nearest-neighboring compounds was 0.072. As 
shown Figure 7-5B, λ  could be regarded as the density of an existing compound collection, so λ  was 
the default threshold for compound selection. In the present case, the distance threshold value, c, was 
equal to 0.072.  
    For comparison, different subsets of commercial compound collections (NDL and APL) were 
generated and compared to the current PMLSC screening collection, with the intention to justify the 
compound acquisition method. As shown in Table 7-3, 1648 compounds from NDL (NDL-B) and 1096 
compounds from APL (APL-C) were selected according to the acquisition protocol, using distance 
threshold 0.072. Alternatively, the top 1000 and 500 compounds were selected to create another two 
subsets, NDL-C and NDL-D respectively, after ranking NDL compounds descendingly according to their 
distances to the nearest neighbors from the PMLSC screening set. The same strategy was also applied to 
select 1500 and 500 APL compounds (APL-B and APL-D). 
 
 
Table 7-3: The average and standard deviation of Tc for different NDL and APL compound subsets, 
compared to the PMLSC screening collection.  
Natural Derivatives Library Active Probes Library 
Subset Size Mean/Stdev Tanimoto Subset Size Mean/Stdev Tanimoto 
NDL-A 3000  0.8593±0.11 APL-A 2000 0.8134±0.15 
NDL-B 1648 0.8211±0.11 APL-B 1500 0.7636±0.13 
NDL-C 1000 0.8071±0.11 APL-C 1096 0.7460±0.13 
NDL-D 500 0.7851±0.12 APL-D 500 0.7004±0.13 
The Tanimoto coefficients are calculated by Database Comparison program that is based on UNITY fingerprint. 
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To investigate the correlation between chemistry space distance and Tc in a larger scale, the whole NDL, 
APL and their subsets were compared to the PMLSC screening set using Database Comparison program. 
It is worth pointing out that Database Comparison program characterizes the degree of overlapping 
between two compound collections using UNITY fingerprint and Tanimoto coefficient. As subsets NDL-
C, NDL-D, APL-B and APL-D were not created by compound acquisition protocol, they might possess 
high intra-subset similarity. Database Comparison program was used to examine the between-collection 
similarity, i.e. comparing NDL or APL subsets to the PMLSC screening set, to show the effect of 
chemistry space distance on Tanimoto similarity index. Table 7-3 summarizes the sample mean and 
standard deviation of Tc values for different NDL and APL subsets, when compared to the PMLSC 
screening set. As shown in the table, the subset NDL-A, the whole NDL, possesses average Tc 0.8593 in 
comparison to the PMLSC screening set, whereas the subsets, NDL-B, NDL-C and NDL-D, have average 
Tc values of 0.8211, 0.8071 and 0.7851, when the number of acquired compounds is 1648, 1000 and 500 
respectively. A similar trend is also observed with the APL, which possesses an average Tc value of 
0.8134 to the PMLSC collection. The average Tc values between the APL subsets and the PMLSC 
collection decrease from 0.8134 to 0.7004, as the size of acquired compounds is reduced from 2000 to 
500.  
 
 
Figure 7-6: Distribution of Tanimoto Coefficients from Database Comparison 
(A) The distribution of Tanimoto coefficient (Tc) values for four NDL subsets: NDL-A with 3000 
compounds, NDL-B with 1648 compounds, NDL-C with 1000 compounds, NDL-D with 500 compounds; 
(B)  The distribution of Tanimoto coefficient (Tc) values for four APL subsets: APL-A with 2000 
compounds, APL-B with 1500 compounds, APL-C with 1096 compounds, APL-D with 500 compounds. 
The Y-axis is the percentage of Tanimoto values that fall into every 0.01 interval. 
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The Database Comparison program calculates the Tanimoto between all candidate compounds and their 
nearest neighboring compounds in the PMLSC screening set. Thus, a set of Tanimoto coefficients were 
reported after comparing NDL or APL to the PMLSC screening set, and a histogram was created to 
examine the distribution of these Tc values. The distributions of Tc values are plotted in Figure 7-6A for 
NDL subsets and Figure 7-6B for APL subsets. In Figure 7-6A, the solid line represents the density 
profile of Tc values between all the NDL compounds and their most similar counterparts in the PMLSC 
compound collection in 0.01 intervals. While the data shows 12% NDL compounds with Tc=1.0 to the 
PMLSC screening set (data point not shown in Figure 7-6A), the peak of the curve is around Tc = 0.91, 
indicating a relatively large portion of NDL compounds with Tc = 0.91. The distributions of Tc values 
from NDL subsets with size 1648, 1000 and 500 are represented by a dashed line, a dotted line and a 
dash-dotted line, respectively. Any of the three subsets contains less than 1% of compounds that possess 
Tc = 1.0 to the PMLSC collection. As the size of NDL subsets decreases from 3000 to 500, the 
distribution shifts to the lower Tc value, indicating that smaller subsets tend to be increasingly dissimilar 
to the PMLSC screening set.   
    Figure 7-6B reveals a similar pattern for APL. 15% of APL compounds have Tc = 1.0 to their most 
similar counterpart in PMLSC collection, while none of APL-B, APL-C and APL-D possesses more than 
1% of Tc that is 1.0 (data point not shown in the Figure). The peaks also shift towards the lower value of 
Tc as the size of APL subsets decreases. In general, the correlation between subset size and Tc 
distribution can be explained by the regression study as shown in Figure 7-4 above. Figure 7-4 reveals the 
negative correlation between Tc values and chemistry-space distance. In other words, the Tc value 
between a pair of compounds tends to decrease as their chemistry-space distance increases. As the NDL 
or APL candidate compounds were selected according to the distances to their nearest neighbors, smaller 
subset had larger average distance to the PMLSC screening set. Thus, the smaller subset tended to be 
dissimilar to the PMLSC compound collection, even if the similarity score was calculated by Database 
Comparison program based on UNITY fingerprint (Figure 7-6 and Table 3). While any novel candidate 
compounds would add certain structural diversity to an existing compound collection, the amount of to-
be-acquired candidate compounds should be carefully determined to balance the quality and quantity 
through the choice of distance cutoff value. The density of an established compound collection is the 
recommended distance cutoff value, because it reflects how the compound dataset explores the chemistry 
space. Furthermore, the chemistry-space distance between identical compounds is zero, because identical 
compounds have the same coordinate values. Import of any duplicate candidate compounds into the 
PMLSC screening set is avoided by applying an appropriate distance cutoff value. For example, 12% of 
compounds in NDL were duplicates to the PMLSC screening set and removed from the wish list. 
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Conversely, in the case studies, less than 1% of compounds present in NDL-B, NDL-C and NDL-D 
possessed Tc = 1.0 to the PMLSC screening set. This is attributed to the fact that a pair of compounds 
possessing Tc = 1.0, such as the compound pair 1 (AP49/AP50) from Table 7-2, may not necessarily be 
identical.  
    The similarity assessment from Database Comparison program described the degree of overlapping 
between two compound collections, yet it was unable to provide a quantitative measure of the overall 
diversity increment. Therefore, a “binning” procedure described in Methods section was applied to the 
BCUT chemistry space for diversity assessment. For the binning procedure, the bin size was required to 
determine the volume of “cells” in chemistry space. A large bin size would reduce the sensitivity of 
diversity measurement, where as a small bin size would trap most candidate compounds in void cells and 
make counting the filled void cells meaningless. A reasonable bin size could be determined in 
consideration of the size and density of an existing compound collection, or the regression analysis 
illustrated in Figure 7-4. For this study, the size of one bin was set to 0.1, which was at the magnitude of 
the density of the PMLSC compound collection. 
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Figure 7-7: The number of filled void cell versus the number of acquired compounds 
The plots of the number of filled void cells as a function of the number of candidate compounds that 
are selected sequentially or acquired by the compound acquisition method. Plot (a) is for NDL 
compounds and plot (b) is for APL compounds. 
Figure 7-7 visualizes the number of filled void cells by applying the established compound acquisition 
and prioritization algorithm and gradually relaxing the threshold distance value, c, until all the NDL and 
APL compounds were deposited into the PMLSC screening set. The X-axis denotes the number of the 
deposited compounds, while the Y-axis denotes the number of void cells filled by the corresponding 
compounds. Figure 7-7 shows an approximate linear growth of the number of filled cells (dotted lines), 
when less than 1500 NDL compounds or less than 1000 APL compounds are deposited into the PMLSC 
screening set (data points circled in Figure 7-7). At the early stage, the deposited candidate compounds 
surely filled a void cell due to the large distance to their nearest neighbors in the PMLSC compound 
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collection. As the number of acquired compounds increased, newly acquired ones tended to be closer to 
their nearest-neighbors, and some of them might be located in the same cells where some PMLSC 
compounds were already present. As the circled points marked in Figure 7-7, the derivative of the number 
of filled cells began to decrease after acquiring more than 1500 NDL compounds or 1000 APL 
compounds, respectively. Subsequently, fewer and fewer void cells were filled as more candidate 
compounds were acquired. Finally, the number of filled cells reached a plateau after depositing 
approximately 2500 NDL compounds with 1844 filled void cells, and 1500 APL compounds with 1290 
filled void cells. For comparison, candidate compounds from NDL and APL were sequentially merged 
into the PMLSC compound collection. Because the candidate libraries and the PMLSC screening set were 
prepared independently for the calculation, there was an equal probability to fill a void cell by any NDL 
or APL compound. 
    A close analysis of plots in Figure 7-7 also reveals that the solid lines, representing the number of filled 
cells under the sequential compound acquisition, demonstrate nearly linear growth with the number of 
candidate compounds. The dashed lines in Figure 7-7 represent the difference in the number of filled cells 
between the established compound acquisition method and sequential compound selection. The dashed 
lines reached the plateau when approximately 1700 NDL compounds and 1200 APL compounds were 
acquired. After the plateau of the dashed lines, the diversity analysis showed that the low priority 
compounds did not significantly fill the void cells or increase the diversity of the PMLSC screening set. 
Consequently, the plateau indicated the optimal number of compounds to be acquired under the current 
chemistry space binning procedure. This conclusion was also supported by the number of acquired 
compounds with the default distance threshold, which instructed us to acquire 1648 compounds from 
NDL and 1096 compounds from APL.  
 
7.4 CONCLUSION 
Through the application of BCUT descriptors, I have constructed multiple dimensional chemistry space 
for compound acquisition and prioritization. As pointed out above, high-quality diverse compound 
collections play a significant role in virtual screening and HTS/HCS campaigns. In general, a structurally 
diverse library, or representative subset, is constructed directly or indirectly from compound collections in 
order to minimize the experimental bioassay costs, but this may result in a failure to identify active 
compounds or promising “leads”, namely false negatives. Thus, thoughtfully expanding the screening sets 
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and testing these newly acquired compounds provide opportunities to cover more structural chemistry 
space, while avoiding duplicating the testing of structurally similar compounds. However, the acquisition 
of candidate compounds should be performed in carefully designed chemistry space that is within a 
biological meaningful context, because the interpretation of “diversity” is directly determined by 
chemistry-space coordinates. Cautions should be taken that solely blinded pursue of structural 
dissimilarity may bring in irrelevant compounds and impair the outcome of virtual screening or high-
throughput screening. 
In the compound acquisition protocol, candidate compounds are acquired or deposited into an 
existing compound collection according to Euclidean distance in BCUT chemistry space. In order to 
rationalize this approach, a regression analysis was carried out to model the correlation between 
chemistry distance and Tanimoto coefficient based on MACCS key. Statistical results indicated negative 
correlation between the two variables, supporting the conclusion that a pair of compounds tended to be 
dissimilar if the chemistry distance between them was large. Different sizes of NDL and APL subsets 
were then generated and compared to the PMLSC screening set in order to show the correlation between 
Tanimoto similarity index and chemistry space distance in a compound collection scale. Next, the 
diversity assessment was implemented to demonstrate how the number of filled void cells grew along 
with the number of acquired candidate compounds using either sequential selection or the compound 
acquisition protocol. We also wanted to point out that the choice of bin size would affect the diversity 
assessment as discussed above. The result illustrated the diversity increment by importing candidate 
compounds and helped to determine the optimal number of acquired compounds in a specific binning 
procedure.  
Taken together, the compound acquisition and prioritization algorithm using BCUT descriptors is 
capable of retrieving compounds from candidate compound collections to increase structural diversity of 
an existing compound dataset. Currently, this method is being used for prioritizing to-be-synthesized 
combinatorial libraries in order to enhance the diversity-oriented library design and synthesis; however, it 
could also be view as a necessary complement to the existing techniques for building quality chemical 
libraries for HTS/HCS and virtual screening. 
7.5 CASE STUDY 
This section describes the application of BCUT descriptors and derived chemistry-space-oriented 
selection rule, in order to determine whether the newly synthesized compound library contributes any 
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chemical diversity value to the existing NIH small molecular repository (SMR). The chemical structures 
of the synthesized compounds and synthetic route can be found in the following publication: 
Construction of a Bicyclic β-Benzyloxy and β-Hydroxy Amide Library through a Multicomponent 
Cyclization Reaction Li Zhang, Qing Xiao, Chao Ma, Xiang-Qun Xie, Paul E. Floreancig Journal of 
Combinatorial Chemistry 2009 11 (4), 640-644  
The established 3D chemistry-space BCUT metrics calculation and 2D fingerprint similarity 
calculation approaches are applied to analyze structural diversity of 43 compounds. All computational 
works were performed using a Linux PC/dual-core dual-CPU Xeon-based HPCC 30-processor Dell 
cluster, loaded with Tripos Sybyl molecular modeling package (version 8.0). 330K SMR compound 
library was downloaded from NIH Small Molecular Repository (SMR) 2. 57K Maybridge screening 
collection was downloaded from Maybridge website 3. As all the 43 synthesized compounds were chiral 
molecules, molecular conformation was considered as one of the key molecular features for diversity 
analysis. Tripos CONCORD 1 was used to generate 3D conformation for each library. 
Multi-dimensional chemistry space coordinates were calculated for each compound in the target 
library according to four main classes of atomic properties including atomic Gasteiger-Huckel charge, 
polarity, H-bond donor (HBD) and H-bond acceptor (HBA) attributes. BCUT descriptors were generated 
for both SMR and Maybridge libraries using DiverseSolutions 212. For visualization and dimension 
reduction purpose, the chemistry space was defined by the best three BCUT descriptors and raw 
descriptor values were rescaled to range from 0 to 10. A diversity analysis was performed by cell statistics 
under the chemistry space. 
To further evaluate the similarity properties of the new 43 sets compound library in comparing with 
the NIH SMR library, pair-wise Tanimoto coefficient (Tc) calculation was carried out based on 2D 
molecular fingerprint. The comparison of 43 sets versus SMR (330K) was done using the Tripos 
SELECTOR program. Molecular fingerprints were calculated using the standard Tripos UNITY 2D 
fingerprints and the data processes were carried out using Sybyl Molecular Spreadsheet 213. 
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Figure 7-8: 3D chemistry-space plots 
Plotting 43 synthesized compounds (red dots) in comparison with Maybridge chemical database (57K 
compounds, grey dots). Three axes were defined by atomic partial charge, H-Bond acceptor and polarity 
BCUT descriptors.  
 
 
Figure 7-8 shows a 3D chemistry-space plot of the newly synthesized 43 compounds versus a Maybridge 
library. As shown in Figure 7-8, eight points representing 23c, 24c, 23f, 24f, 23h, 24h, 23g and 24g filled 
a void cell ranging approximately from 5.31 to 5.47 along the GH-charge axis, from 5.97 to 6.17 along 
the HBA axis and from 5.69 to 5.79 along the Polarity axis. To approximate the density of Maybridge 
library locally, the number of compounds was counted in a unit cubic cell which was centered at (5.39, 
6.07, 5.74). The volume of void cell was 0.0033 and the local density of Maybridge library was 214, so 
214 × 0.0033 ≈ 0.7 compound was expected to be found in the cell. None of Maybridge structures were 
observed in that cell and eight synthesized compounds filled the void region instead. This calculation 
showed that the size of the void cell filled by 8 new compounds was reasonable and the diversity 
increased by filling the void was also significant. 
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Figure 7-9: A database similarity comparison of 43 compounds with SMR library  
 
 
Interestingly, Figure 7-8 also revealed that the chemistry-space coordinates of compound 23c, 23f, 23h, 
23g and 23i followed almost the same pattern as those of 24c, 24f, 24h, 24g and 24i did. They were 
arranged in the same order and distributed over the space in a similar manner. The difference between 
scaffold 23 and 24 was the chirality. This indicated that the molecular conformation generated by 
Concord and BCUT 3D descriptors reflected the property of those compounds. 
 
Figure 7-9 shows a distribution of Tanimoto coefficient (Tc) for each of 43 compounds in comparison 
with its most similar compound in SMR database, showing a mean TC values of 0.77 and a standard 
deviation of 0.06.  As 2D molecular fingerprints could not reflect the chirality, the compounds 23a and 
24a were indistinguishable under 2D fingerprint algorithm. Thus, there were totally 31 distinct 2D 
structures considered. It is generally accepted that Tanimoto coefficient value 0.85 214 is a threshold for 
UNITY 2D fingerprints. If the Tc value between a pair of compound is higher than 0.85, they are 
considered similar. 2D molecular fingerprint similarity calculations of two chemical libraries revealed 
that none of the compounds except three cases between two libraries possess a pair wise TC value higher 
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than 0.85. Four newly synthesized compounds and their nearest neighbors by TC were also illustrated in 
Figure 7-9. These results further confirmed that the newly synthesized compound library improved the 
molecular diversity of existing libraries. The combined 3D chemistry-space and 2D fingerprint pair-wised 
Tc similarity calculation approaches conclude that the newly synthesized compound library adds certain 
structural diversity value to the existing chemical libraries.   
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8 CONCLUSIONS AND FUTURE DIRECTIONS 
The following conclusion may be drawn from the plot studies in this thesis: 
It may be feasible to derive quantitative structure-activity relationship (QSAR) or structure-
property relationship (QSPR) from modern machine learning techniques and appropriate 
molecular descriptors. 
The novel ligand classification technique, LiCABEDS reported in Chapter 4, was successfully applied to 
the prediction of ligand functionality, selectivity and blood-brain-barrier passage. Its performance was 
validated and compared with other data mining techniques, including Naive Bayes classifier, Tree and 
support vector machine. LiCABEDS provides an alternative option to the mainstream QSAR/QSPR 
methods. For example, CoMFA was reported to study the structure requirement for 5-HT1A agonists and 
antagonists using a small set of compounds. On the other hand, the LiCABEDS models were derived 
from hundreds of compounds in cheminformatics database, and the algorithm design guaranteed a 
prediction throughput of a few thousand compounds per second. The implementation of LiCABEDS 
further demonstrated that QSAR/QSPR modeling could be as straightforward as similarity calculation. 
Molecular fingerprints exhibit decent performance in QSAR/QSPR studies. 
This dissertation reviews molecular descriptors in many categories, including frequently referred 
descriptors, for example, the number of H-bond donors. Many descriptors have been proven effective in 
predicting physicochemical properties, but variable selection and multivariate analysis are generally 
complicated in QSAR/QSPR modeling. Hybrid descriptors, including a diverse set of descriptors, seem to 
be the favored choice in publications. In this dissertation, MACCS, FP2, Unity, PubChem and Molprint 
2D fingerprints revealed their relevance to molecular property and bioactivity prediction. According to 
scientific papers and experiments described in this thesis, molecular fingerprints are good starting point 
for QSAR/QSPR modeling even if they may be not the best. 
Robustness, interpretability, and simple parameter tuning are major advantages of LiCABEDS. 
The valuable attributes of LiCABEDS were exemplified through case studies. The limited variance in its 
consisted components suggested the robustness of LiCABEDS for prospective predictions. Furthermore, 
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LiCABEDS models were interpreted by examining highly weighted decision stumps. Last but not least, 
the simple parameterization was shown to be another advantage of LiCABEDS. It was free of structure 
alignment and time-consuming parameter optimization. A large number of iteration steps produced 
models that were close to the optimal. Modeling using LiCABEDS did not involve much subjectiveness.  
Non-linear classifiers with appropriate parameters may outperform the linear classifiers. The 
distance or similarity between any pair of queries may be sufficient to develop a robust 
classification model, without explicit representation of explanatory variables. 
The use of non-linear kernel functions in support vector machine (Chapter 5) outperformed default linear 
kernel according to benchmarked dataset. This result indicated that the contribution of compound 
fragments to biological properties was not linear. However, the choice of kernel function and parameters 
was computationally expensive, but quite critical to model robustness. Tanimoto kernel and RBF kernel 
were generally the default non-linear choice, supported by recent publications. Tanimoto kernel is free of 
kernel parameter, while RBF kernel function is not. 
GPUs show significant performance advantage over CPUs regarding computationally expensive 
cheminformatics tasks, but extra attention must be paid to algorithm design and implementation. 
Computation power still remains as limitation for virtual screening. The GPU-accelerated chemical 
similarity calculation proposed a very efficient algorithm to calculate Tanimoto coefficients based on 
molecular fingerprints represented in dense array formats. Nowadays, famous molecular mechanics 
software, CHARMM, has already integrated GPU implementation in order to accelerate molecular 
dynamics simulation, which levels up molecular modeling to a new time frame. In the near future, it is 
expected to have more molecular modeling software targeting at GPU platform.  
 
Despite the novel approaches proposed in this thesis, mapping chemical structures to bioactivity space 
still remains as a significant challenge to both information science and artificial intelligence. First, 
extensive variability in bioassays and frequent false positives in HTS experiments demand robust and 
specific learning algorithms to catch meaningful information and predictive features from assorted data 
sources. Furthermore, learning algorithms are supposed to be capable of modeling numerous molecular 
properties and pharmacological properties, with the intention to insure the wide applicability in drug 
development projects, which may target at enzymes, GPCRs or other receptors. Finally, the developed 
predictive models are expected to be interpretable and chemically suggestive to bridge the gap between 
computer science and pharmaceutical science. Accordingly, the future directions of this thesis may 
include but not limited to: 
Developing effective ensemble learning algorithms and hypothesis selection methods for the 
predictions of ligand bioactivity and pharmacological properties 
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Linear and non-linear ensemble methods will be developed for classification and regression purposes in 
order to predict various ligand properties. Medicinal chemists refine the structures of “lead” compounds 
according to a set of empirical hypotheses drawn from observations in most cases. This approach is 
frequently referred as SAR (structure-activity relationship). In SAR studies, researchers usually attempt to 
derive certain heuristic trends or assumptions from experimental data. However, these hypotheses are 
usually put into practice without systematic validation and quantification. The motivation of this aim is to 
model the hypothesis-driven SAR: each hypothesis i, Hi, Hi ∈ ℋ, is quantitatively correlated with certain 
property of interest, y, through function f, i.e. y = f(Hi(x)). ℋ represents the possible hypothesis space 
and x represents chemical structure. However, in ensemble-learning framework the property (y) of any 
novel structure (x) is determined by weighted hypothesis ensemble: y = f(∑ wiHi(x)i ).  
Designing active learning strategies for iterative model refinement, together with retrospective and 
prospective model validation 
The dependence on training data restricts the applicability of supervised learning in many application 
domains. At the beginning stage of many drug design projects, the knowledge or annotated compounds 
may be not sufficient to develop supervised learning models. In this case, we propose active learning 
strategy to selectively acquire additional compound annotation through bioassays, and iteratively improve 
established prediction models. Compared to random compound annotation, this experimental design 
ensures early model convergence, but yields equivalently robust models. Most importantly, models are 
validated prospectively, which is considered as the most reliable way to assess generalization error. 
Implementing the proposed algorithms targeting at high-performance computing architecture and 
providing intuitive graphical interface for medicinal chemists 
Millions of chemical structures are deposited into public cheminformatics database annually. Data mining 
the vast database and making predictions on enormous virtual compounds are sometimes questioned due 
to the limitation of computation power. The advent of CUDA, NVIDIA’s solution to GPGPU (General-
purpose computing on graphics processing units), suggests an alternative path to scientific computing. 
Once implemented efficiently, arithmetic-intensive calculations can be accelerated up to 30 folds by 
GPUs, typically.  
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The overall goal of this thesis is to present an objective high-through computational 
methodology for computer-aided drug design in order to enhance the productivity of the 
pharmaceutical industry. As a relatively new research field, QSAR/QSPR modeling using 
modern machine learning techniques is still not widely accepted by medicinal chemists and 
pharmacologists. Nevertheless, statistical inference and machine leaning are proven to be 
helpful in many fields, and the pharmaceutical industry should not be an exception. Finally, the 
author would like to end this thesis by quoting prestigious statistician, George E. P. Box: "All 
Models Are Wrong But Some Are Useful." (George E. P. Box, 1979) 
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